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The human brain is arguably one of the most complex structures known to humankind. To 
understand the development, function, and dysfunction of this organ, both historical and 
modern neurological research methods have intrinsic limitations. Modern functional 
imaging and electrophysiological techniques obtain important data on the structural and 
functional aspects of specific brain regions but are unable to accumulate biomolecular 
information, whereas animal models of brain development allow for complete molecular 
interrogation, but show intrinsic morphological differences compared to native human 
brain tissue. In vitro modelling of human brain tissue through the differentiation of induced 
pluripotent stem cells (iPSCs) offers a completely novel method of studying human brain 
development. iPSCs can differentiate into any somatic cell derived from the three germ 
layers, and as such, can form cells of specific neural lineages from multiple brain regions. 
Furthermore, this differentiation in vitro follows the same principles of in utero brain 
development, and so can be used to model specific genetically-linked neurodevelopmental 
pathologies such as the epilepsies.  
 Neural cell differentiation within three-dimensional cell culture scaffolds offers a 
way of replicating a more in vivo-like microenvironment compared to standard planar 
culture. Therefore, the generation and optimisation of cytocompatible biomaterials to form 
these three-dimensional scaffolds will be integral for the future of in vitro neural tissue 
engineering. 
 This thesis focuses on the combination of both biomaterial engineering and iPSC-
based neurological development to assess the synergy of targeted neuronal cell 
differentiation within three-dimensional hydrogel environments. 
 Comparisons between alginate-based and collagen type I-based hydrogel scaffolds 
(with stiffness moduli comparable to that of native brain tissue) demonstrated both 
scaffold types retained high cell viability of encapsulated neural cells. However, only 
collagen-based scaffolds were shown to be conducive to neurite extension, whereas neural 
cells within alginate scaffolds displayed no neuritogenesis under differentiating conditions. 
Alginate hydrogels modified with matrix metalloproteinase-cleavable and laminin-binding 
epitopes were also non-conducive to neurite extensions but did induce changes in neural-
marker protein expression profiles of encapsulated neural cells relative to those within 
unmodified alginate and collagen hydrogels.  
vi 
 
 Human iPSCs (hiPSCs) were successfully differentiated into dorsal forebrain 
(excitatory) and ventral forebrain (inhibitory) neural lineages. Biomolecular analyses over 
the timeline of differentiation uncovered differences in the speed of neural differentiation 
and expression of maturation markers. Neurons derived from ventral differentiation 
pathways displayed enhanced functional profiles relative to neurons generated through 
dorsal differentiation strategies. 
 Neural differentiation of hiPSCs in three-dimensional collagen-based hydrogel 
environments enabled extensive neuritogenesis throughout the constructs. Gene 
expression analyses during neural induction and differentiation demonstrated significant 
differences in the maturation rates of hiPSC-derived neurons in three-dimensional 
environments relative to two-dimensional planar culture.  
 Finally, in order to generate more complex three-dimensional neural tissue 
structures using bioprinting methodologies; optimisation strategies to improve the 
printability of candidate biomaterials were developed. A coaxial bioprinting system was 
utilised by which to achieve a low stiffness “core” bioink that maintained neural 
differentiation and neuritogenesis, and a supportive “shell” hydrogel that generated 
enough structural integrity by which to bioprint multi-layered free-standing neural 
constructs.  
 In combination, the work presented in this thesis demonstrates the necessary 
biological assays for measuring positive markers of neural differentiation in candidate 
three-dimensional hydrogels and applies this knowledge to better understanding neural 
differentiation of hiPSCs within these environments. It also establishes a 3D coaxial 
bioprinting system by which to scale-up and tailor neural tissue construct design to 
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Chapter 1: General Introduction 
 
1.1 Background and Potential of Induced Pluripotent Stem 
Cells in Neurological Research 
 
1.1.1 Neurons Ex Machina 
The human brain is arguably one of the most complex structures known to humankind. 
Recent estimations of its cellular content put the total neuronal number at approximately 
86 billion cells, with estimated numbers of synaptic connections between these cells well 
into the trillions (Pakkenberg et al., 2003; Azevedo et al., 2009). Studies of human brain 
development, function, and disease have historically been undertaken through an array of 
methodologies including: posthumous observation, utilising electrophysiological & non-
invasive imaging techniques, and/or with the use of animal models. However, intrinsic 
differences between animal and human models of neurological diseases have resulted in 
poor rates of clinical translation and development of novel therapeutics (Matthews et al., 
2005; Kelava and Lancaster, 2016; Mungenast, Siegert and Tsai, 2016). To overcome this 
species gap in vitro models of brain development and disease derived from human stem 
cell populations offer more clinically-representative models from which to generate healthy 
and disease-state neural tissue for study.    
Induced pluripotent stem cells (iPSCs) have revolutionised and rejuvenated the 
field of stem cell science since their inception just over a decade ago (Takahashi and 
Yamanaka, 2006). Broadly speaking, stem cells all share two basic properties; the first is the 
ability to self-renew through cell division and the second is to differentiate into other cell 
types.  The number of cell types a stem cell can differentiate into is based on their 
“potency”. For example, bone marrow, in basic terms, is a large pool of multipotent stem 
cells that replenish the diverse subtypes of blood and immune cell lineages. Pluripotent 
stem cells (PSCs) can turn into any cell type derived from the three germ layers, and as such 
in nature primarily exist at the very early developmental stages of viable embryos. 
Extraction of cells from human blastocysts and their successful culture in vitro was the first 
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stepping stone into the long term culture and use of PSCs as models of understanding 
pluripotency, human tissue development, and potential uses in regenerative medicine 
(Thomson et al., 1998). These embryonic stem cells (ESCs), were and still are, an incredibly 
powerful type of stem cell that remain as the benchmark for in vitro pluripotency research. 
However, the necessity of harvesting them from early human embryos offered a logistical 
and ethical challenge to their widespread use.  
 ESCs remained the gold standard for in vitro PSC research, until a seminal paper 
from Takahashi and Yamanaka in 2006 showed the first induction of pluripotency in 
differentiated murine somatic cells through ectopic expression of four pluripotency-related 
factors (Takahashi and Yamanaka, 2006). From an initial twenty-four candidate genes the 
authors found that a combination of the factors; Oct4, Sox2, c-Myc, and Klf4 was sufficient 
to induce a state of pluripotency in formerly differentiated murine fibroblasts. These cells 
were termed induced pluripotent stem cells (iPSCs). This research was later repeated with 
human cell sources with the same “ Yamanaka factors” (Takahashi et al., 2007), and with a 
different cocktail of factors (Oct4, Sox2, Nanog, and Lin28) (Yu et al., 2007). These human 
iPSCs (hiPSCs) represented an incredible breakthrough in the field of stem cell research and 
disseminated a logistically simple way of reprogramming somatic cell types into PSCs 
without the ethical concerns of utilising ESC-derived cell lines. Another striking advantage 
to the use of hiPSCs is the ability to induce pluripotency in cells that are genetically 
identical to the cell source donor, creating the potential for rejection-free tissue 
regenerative therapies, genetically-linked disease modelling, developmental biology 
studies, and pharmacological testing on a patient-specific basis in vitro. This wide array of 
possible applications has resulted in a large volume of research in only a few years 
In short, the advent of this technology stands to remove a number of hurdles that 
had plagued stem cell research; namely issues of immune rejection, ethical concerns 
associated with utilising embryo-derived ESCs, and those of limited stem cell potency of 
somatic stem cell populations. The promise of iPSCs therefore lies in the relative ease of 
their generation from a spectrum of adult tissues, the promise of autologous regenerative 
therapies, and the lack of ethical concern with their derivation. In essence, they have the 
capacity to combine the advantages of both somatic stem cells and ESCs.  
The advantages discussed above have also spearheaded the use of hiPSCs in 
neurological research. The desire to develop in vitro patient-specific models of 
neurodevelopmental and neurodegenerative disease has resulted in vast swathes of 
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research for dozens of disorders (Mattis and Svendsen, 2011; Israel et al., 2012; Dajani et 
al., 2013; Imaizumi and Okano, 2014; Okano and Yamanaka, 2014). In parallel to this, 
research into human-specific neurodevelopment from “healthy” hiPSCs has begun to shed 
light on how brain tissue and regional brain structures form in utero and allow an 
unprecedented view into the regulation of these processes in vitro (Petros, Tyson and 
Anderson, 2011; Anderson and Vanderhaeghen, 2014; Kelava and Lancaster, 2016).  As this 
field of research continues to refine and expand, the potential scope for understanding 
numerous aspects of human neurobiology is remarkable.  
 That being said, no current iPSC-based neurological model is perfect, and potential 
limitations or problems with iPSC technology such as line-to-line differentiation variability 
(Hu et al., 2010), epigenetic or lineage memory (K. Kim et al., 2011), and chromosomal 
aberrations (Mayshar et al., 2010) are well documented. Even so, numerous usable and 
statistically sound models of neurological disease have been already documented from 
disease-specific iPSCs (Israel et al., 2012; Lancaster et al., 2013; Duan et al., 2014; Okano 
and Yamanaka, 2014; Mariani et al., 2015). Care must be therefore taken to ensure that 
robust, reproducible and ultimately representative iPSC-derived neural cell cultures are 
generated for each aspect of neurobiology under scrutiny. 
 Each stage of iPSC-technology can be tailored to the needs of the study being 
undertaken. This includes the source of somatic cells for reprogramming (e.g. fibroblasts, 
peripheral blood progenitors or epithelial-like cells from urine samples) and the type of 
reprogramming vectors used to either improve reprogramming efficiency or maintain 
genomic integrity. Neural induction and differentiation methodologies vary from study to 
study, utilising diverse morphogen signalling and/or forced neuronal transcription factor 
expression. Each method yielding differentially heterogeneous pools of cells that can be 
demonstrative of the in vivo processes these protocols aim to mirror. Finally, culture in 
biomimetic 2D or 3D environments can allow enhancement of neural differentiation, 
promotion of neural outgrowth and modulation of cell-cell synaptic activity. Each level of 
this process can help to build reproducible and physiologically relevant neurological models 
to help elucidate the true goal of iPSC-neural modelling: unearthing the processes of 
neurodevelopment and the aberrations leading to neurological disease. 
 The ability to derive a patient-specific pluripotent cell line opens an entirely new 
pathway for dissecting the pathology of diseases that were either impractical or impossible 
to study extensively in vivo. This is especially true in the field of neuroscience, and most 
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notably in the study of neurodegenerative and neurodevelopmental conditions (Marchetto 
et al., 2011; Mattis and Svendsen, 2011; Okano and Yamanaka, 2014). The ability to have a 
continuous, genetically relevant supply of neurons from patients with a specific 
neurological condition offers the chance to study the pathology of genetically-linked 
disorders throughout development in vitro; an impossibility in patients with late-onset 
conditions such as Parkinson’s Disease, Alzheimer’s Disease and Huntington’s Disease 
(Imaizumi and Okano, 2014).  
As well as degenerative conditions, iPSCs offer the chance to study early in utero 
developmental pathways and formation of embryological neural structures, such as human 
corticogenesis, which show inherent differences to animal models (Anderson and 
Vanderhaeghen, 2014). Understanding the formation (or malformation) of particular brain 
regions with the associated cytoarchitecture and neuronal diversity, will shed light on the 
temporal and spatial control of tissue generation, and offer insights into treatments of 
developmental disorders as well as human brain evolution. 
 
1.1.2 Somatic Cell Sources and Methods of iPSC Reprogramming 
This section will focus on iPSC reprogramming methodologies necessary for successful 
neurological development and disease modelling. Primarily, the generation of integration-
free and genomically “clean” iPSC lines as well as concerns for cell type selection for 
reprogramming; an area often overlooked in iPSC studies but an important consideration 
when long term and multiple clinical samples are to be processed. A large collection of 
general iPSC-derivation reviews are present throughout the literature (Maherali and 
Hochedlinger, 2008; González, Boué and Izpisúa Belmonte, 2011; Bayart and Cohen-
Haguenauer, 2013), this section will therefore represent a targeted review of the abundant 
sources available.  
 Reprogramming vectors can be broadly classified into 2 types: viral and non-viral 
(Fig 1-1). Viral vectors can then be sub-classified into integrating vectors, such as gamma-
retroviruses (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007) & 
lentiviruses (Carey et al., 2009; Chang et al., 2009), and non-integrating (or transient) 
vectors such as adenoviruses (Stadtfeld et al., 2008; Zhou and Freed, 2009) & Sendai virus 
(Fusaki et al., 2009). Although reported reprogramming efficiencies for viral integrating 
vector types are higher than the non-integrating vectors, they result in random integration 
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of the reprogramming factors into the target genome. This has implications for 
neurological-focused iPSC-derived modelling where genomic integrity may be key for 
understanding complex neurological pathologies: ensuring no genes are disrupted for 
certain lineage specifications and to make certain no oncogenic gene transformations have 
been generated (Bayart and Cohen-Haguenauer, 2013). For any regenerative applications, 
the presence of tumourigenic mutations or the in vivo reactivation of integrated 
pluripotency factors could be catastrophic. Some groups have tried to reduce the impact of 
integrative reprogramming elements by generating an excisable vector system that after 
generating a stable pluripotency shift within the target cells, can then be excised from the 
genome (Chang et al., 2009; Soldner et al., 2009).  While this methodology would in theory 
excise potentially oncogenic effects (through over-expression of genes such as c-Myc), it 
would still risk the generation of unforeseen recombination events that, in and of 
themselves, may damage the overall genomic stability of the target cell. 
  
 
Fig 1-1: Representation of strategies used for iPSC reprogramming of somatic cell 
types. Illustration from Bayart & Cohen-Haguenauer 2013. 
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Non-viral vectors offer an alternative transient system of delivery for the 
reprogramming factors. Such vectors include the transfection of the factors encoded in 
plasmids (Okita et al., 2008) or more stable episomal vectors (Yu et al., 2009). These 
vectors would generate the advantageous genomically “clean” iPSC lines, but reportedly do 
so at a lower efficiency than retroviral vectors (Yu et al., 2009). More recently, techniques 
have been developed to generate insertion-free iPSC lines without using DNA-based 
vectors. Instead they utilise either synthetic messenger RNA (mRNA) constructs of each 
pluripotency factor (Warren et al., 2010) or the reprogramming proteins themselves (Kim 
et al., 2009; Zhou et al., 2009). The relatively high reprogramming efficiency of the mRNA-
based technique makes them an appealing non-viral option for iPSC derivation. However, 
for multiple and ongoing iPSC banking projects, the cost of obtaining high amounts of 
synthetic mRNA may be a consideration. Reprogramming via use of the reprogramming 
proteins themselves as proof of principle is a very interesting result, however the very low 
efficiency of iPSC generation would not make them an ideal go-to methodology for general 
de novo iPSC banking and modelling projects (Fig 1-1).  
Another concern for deriving de novo iPSC lines is the choice of adult cell type to 
undergo reprogramming. For many disease modelling studies this is a commonly 
overlooked consideration, with the majority (approximately 80%) of published de novo iPSC 
lines generated from dermal fibroblasts (González, Boué and Izpisúa Belmonte, 2011). This 
is obviously of little concern in animal studies where tissue selection does not need to 
represent a clinically relevant situation. However, it should be a factor for research groups 
hoping to generate multiple disease-specific iPSC lines from human patients. Ideally, the 
harvesting of cells should be relatively non-invasive and generate a large enough pool of 
starting cells which can be easily cultured and stored. Fibroblasts have been heavily utilised 
in iPSC studies because they are a robust and easily expandable cell type. To obtain human 
dermal fibroblasts a skin punch biopsy must be performed by a trained clinician. Although 
this procedure is relatively non-invasive it must be performed under local anaesthetic and 
is still associated with a low risk of nerve injury and infection. Minimising the discomfort of 
patients while maximising the speed and ease of cell collection should be a principle 
concern for iPSC-based disease modelling research groups. Especially when studying 
idiopathic and familial conditions where multiple iPSC-lines need to be generated 
simultaneously for broad and statistically significant experimental analysis. 
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Since the seminal iPSC-generation research was first published, many studies have 
now looked at iPSC-reprogramming of a whole host of somatic cell types, some more 
clinically useful than others, for obtaining a starting cell pool. Human bone marrow-derived 
mesenchymal stem cells (BM-MSCs) (Park et al., 2008) and hepatocytes (Liu et al., 2010) 
have been reprogrammed into iPSCs, but with the obvious disadvantage of a much more 
invasive harvesting process than simple skin biopsies. Dental pulp stem cells (harvested 
from deciduous or “baby teeth”) are another source of cells that have been used in iPSC 
generation (Beltrão-Braga et al., 2011). This may not a viable or desirable option in adult 
patients where the harvesting of this tissue would involve the extraction of teeth (Tamaoki 
et al., 2010). A promising starting somatic cell pool may be keratinocytes. Although 
harvested in multiple studies from foreskin, keratinocytes have also been harvested and 
reprogrammed from hair follicles (Aasen et al., 2008). Cell harvesting in this instance would 
simply involve a single plucked hair from which to expand the keratinocyte population. A 
possible issue would be the very limited starting cell number, but may be offset by the 
much higher reprogramming efficiency of keratinocytes - reportedly up to one hundred-
fold more efficient and two-fold faster than fibroblast-reprogramming methodologies 
(Aasen et al., 2008). This is also mirrored by reprogramming of dermal papillae cells (also 
from hair follicles) which have a reported three-fold increase in reprogramming efficiency 
relative to dermal fibroblasts (Muchkaeva et al., 2014).  
Another promising minimally-invasive method of somatic cell harvest is via 
peripheral blood collection (Mack et al., 2011; Okita et al., 2013). The obvious advantage to 
this methodology being that it is widely used in clinical practice for a whole spectrum of 
diagnostic tests. Within this framework peripheral blood could be collected from patients 
with no additional harvesting procedure necessary and with minimal discomfort. However, 
a caveat to this procedure must be the removal of mature immune cells that have 
undergone V(D)J rearrangements. This genomic rearrangement, although limited to 
adaptive immunity genes, is not ideal for production of genomically representative iPSC-
lines. Hence the peripheral blood-based methodologies tend to selectively make use of 
CD34+ cells within the blood as a marker of a progenitor cell type that has not undergone 
this rearrangement.  
Finally, another intriguing source of cells for iPSC generation may be those 
collected from urine samples (Zhou et al., 2012; Xue et al., 2013).  Epithelial-like cells 
obtained through centrifugation of urine offer a completely non-invasive method of cell 
8 
 
harvesting. iPSC-lines derived in this way are still a recent development and as such has not 
been widely adopted by many research groups, however at least one research group has 
generated neural progenitors (and consequently mature neurons) from urine-derived 
somatic cells (Wang et al., 2013). 
 
1.2 Differentiation Strategies for iPSC-derived Neurons 
Differentiation protocols to derive neuronal and glial cell subtypes from iPSCs have largely 
been based on methodologies developed from ESC-differentiation, although differences in 
neural lineage differentiation efficiency have been documented between the two PSC types 
(Hu et al., 2010). Multiple varied protocols can be seen throughout the literature that result 
in neuronal differentiation (or more specific neuronal subtype generation) with varying 
efficiencies. The time frame for differentiation and neuronal maturation strategies also 
differs from protocol to protocol and depend on the target-cell-type.  
Broadly speaking, the two main methodologies of deriving neurons from iPSCs can 
be defined as those that utilise developmental morphogens to trigger a step-wise 
differentiation into neuronal lineages, and those that employ the transfection, and 
consequent expression, of known neurogenic genes. An overview of the basis for 
morphogen-derived neuronal patterning and direct transfection of neurogenic genes are 
outlined below. 
 
1.2.1 In Vivo Neural Tube Patterning Factors as a Basis for In Vitro 
Differentiation 
Differentiation protocols based around neural tube morphogen patterning take cues from 
known neurodevelopmental processes and attempt to recapitulate the in vivo system by 
sequential addition of signalling factors in vitro to direct specific pathways of 
differentiation.            
The neural tube is an embryonic structure that is the precursor of the central 
nervous system (CNS). Patterning factor gradients within this structure during development 
primarily form two axes; the dorsal-ventral axis and anterior-posterior axis (also referred to 
as the rostral-caudal axis) (Briscoe and Ericson, 2001; Petros, Tyson and Anderson, 2011; Le 
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Dréau and Martí, 2012). Signalling molecules form gradients within the neural tube that 
then act to define a precursor cell’s neural fate by way of its spatial and temporal location. 
Different neuronal and glial subtypes will then be generated dependent on the precursor 
cell’s location and therefore its exposure to relative amounts of specific morphogens along 
the two axes (Fig 1-2). Dorsal-ventral patterning is primarily derived from the interplay of 
three signalling pathways: Sonic Hedgehog (SHH), members of the Bone Morphogenetic 
Protein (BMP) family, and the Wingless-type MMTV integration site (Wnt) family. SHH is a 
ventralising ligand secreted from the floor plate of the neural tube and the notochord 
(Jessell, 2000), whereas BMPs and Wnts are released from the roof plate and trigger a 
dorsalising response in target cells (Le Dréau and Martí, 2012). In simple terms SHH 
signalling can be seen as a mechanism to derive ventral neural tube identity (and therefore 
ventrally-derived neuronal cell types) while BMP and Wnt signalling drive dorsal neural 
tube identity (and conversely a dorsally-derived neuronal lineage differentiation) (Briscoe 
and Ericson, 2001; Le Dréau and Martí, 2012).  
  
 
The anterior-posterior axis is established predominantly by retinoic acid (RA) which is 
secreted from the surrounding somitic mesoderm and notochord precursors (Pierani et al., 
1999). Higher RA concentrations denote a posteriorising (or caudalising) signal within the 
neural tube and hence are associated with hindbrain and spinal neuron positional 
Figure 1-2: Representation of morphogen gradients in the neural tube during 
embryological development of the central nervous system. Combinations of factors 
generate a dorsal-ventral (DV) axis and anterior-posterior (AP) axis. The spatial 
“coordinates” derived from these gradients trigger development of specific brain areas 
and neural cell types. BMPs, Bone Morphogenetic Proteins; WNTs, Wingless-type MMTV 




specification of the putative CNS (Maden, 2006). Another key signalling molecule in the 
formation of the anterior-posterior axis is the induction of fibroblast growth factor-8 (FGF-
8) signalling from the isthmic organiser. This region of the neural tube denotes the 
midbrain-hindbrain boundary and its signalling is integral to the formation of dopaminergic 
and serotonergic neurons (Goridis and Rohrer, 2002; Brodski et al., 2003).  
Strictly defined roles for these factors are still being elucidated and the above 
explanations are more of a crude overview by which in vitro differentiation strategies have 
been derived. Indeed, some of these inductive signals appear to have multiple roles: Wnt 
signalling has also been implicated as a posteriorising signal in developmental studies (as 
well as the dorsalising role explained above) (Yamaguchi, 2001). RA in differentiation 
studies in murine ESCs has also shown it to be a dorsalising signal as well as a posteriorising 
one (Okada et al., 2004). Retinoids have also been shown to help induce dorsal forebrain 
cortical lineages from iPSCs with high efficiency (Shi et al., 2012; Shi, Kirwan and Livesey, 
2012).  
 In vitro differentiation of iPSCs into neuronal lineages using these morphogens can 
be broken down into a series of steps that sequentially restrict the potency of the starting 
iPSC colonies. Firstly, with the generation of neural precursors, then patterning these 
precursors to recapitulate the positional specificity of a neural subtype within the neural 
tube, and finally to mature and enrich the desired neuronal lineage into functional 
networks that can undergo further in vitro study. 
 
1.2.2 Neural Induction of iPSCs In Vitro 
The first step in the in vitro differentiation pathway is to trigger a neural induction within 
the iPSCs to generate a patterning-competent pool of neuroepithelial progenitors. Multiple 
strategies have been used across iPSC and ESC lines that generate neural progenitors that 
show consistent gene expression markers regardless of their starting PSC cell type (Falk et 
al., 2012). There are three main strategies to induce this effect, namely; embryoid body 
formation, dual SMAD inhibition, and stromal cell-derived inducing activity (SDIA). As with 
the majority of this research, the seminal papers deal with a range of PSC types but 
ultimately have been utilised in iPSC differentiation strategies across the literature. It is also 
worth noting that not only do methodologies for neural induction vary greatly between 
studies, but also the nomenclature for the progenitor cell type that is initially generated 
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and the time course over which this cell type is propagated and matured. Studies have 
referred to this pool of cells as neural precursor/progenitor cells (NPCs), neuroepithelia 
(NE) or neuroepithelial progenitors (NEPs), neuroepithelial stem cells (NESs), and neural 
stem cells (NSCs). This may be a point of confusion, as although cultures of these 
progenitors will indeed alter their properties over time, the markers used to identify them 
tend to be the same across the bulk of studies, namely Nestin, Pax6 and Musashi-1 [for 
example (Watanabe et al., 2005; Shin et al., 2006; Nemati et al., 2011)]. Another point of 
possible misunderstanding is to equate the progenitor pool derived from iPSCs to primary 
culture NSCs. Primary NSCs harvested from foetal or adult brain are believed to be derived 
from radial glia-like stem cells which when cultured as neurospheres form a renewable 
source of NSCs (Reynolds and Rietze, 2005). However, these primary-NSCs lack many of the 
characteristics of iPSC-NPCs such as intrinsic neural architecture formation and differing 
marker expression (Elkabetz et al., 2008; Falk et al., 2012; Karus, Blaess and Brüstle, 2014). 
iPSC-NPCs should then be seen as a more developmentally early-stage stem cell than 
primary NSCs and care should be taken not to confuse the two types by name alone. 
Therefore, for the purpose of consistency this thesis will refer to PSC-derived pools of 
neural precursor cells as NPCs.       
 
1.2.3 Embryoid Body-Based Neural Induction 
The first technique that will be discussed is that of neural induction via embryoid body (EB) 
formation, also referred to as serum-free floating culture of embryoid body-like aggregates 
(SFEB). This is achieved through the culture of PSC-colony fragments in suspension. The 
cellular aggregates self-form into tightly packed EBs which if left in iPSC media will develop 
markers of all three germ layer lineages. However, when the growth media is exchanged 
for a serum-free media, the differentiation within the EBs becomes biased towards a 
neuroectodermal lineage (Okabe et al., 1996; Watanabe et al., 2005). An improvement on 
this basic protocol termed SFEBq was reported by Eiraku et al., by using U-shaped wells to 
accelerate the formation of PSC aggregates from single cell suspensions within a few hours 
rather than the days needed for reaggregation in  basic suspension culture (Eiraku et al., 
2008). When plated onto adhesive substrates these primed cells form structures termed 
“neural rosettes”. These can be mechanically separated and cultured independently to 
form a pool of multipotent NPCs which form the basis of further neural differentiation 
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strategies. The rosettes themselves are a self-organised two-dimensional recapitulation of 
the neural tube and not simply artefacts of in vitro NPC culture. They display apical-basal 
polarity (Falk et al., 2012), express specific early markers of iPSC-NPCs (Elkabetz et al., 
2008), and even more remarkably display neural crest cell generation developing at the 
periphery of the rosettes; similar to the spatial separation seen in vivo (Karus, Blaess and 
Brüstle, 2014). 
 
1.2.4 Dual SMAD Inhibition 
SMAD proteins are the principal signal transducers of the Transforming Growth Factor-β 
(TGF-β) signalling receptor superfamily. Dual SMAD inhibition is a technique that allows for 
monolayer induction of NPCs from iPSCs without the need for embryoid body formation. 
This restriction of lineage differentiation is achieved through the selective inhibition of both 
BMP and Activin/Nodal/TGF-β signalling pathways. The blocking of these pathways 
individually had previously been shown to aid neuronal differentiation of ESCs through the 
use of the protein Noggin for BMP-signalling inhibition (Lee et al., 2007; Elkabetz et al., 
2008) and the small-molecule SB431542 for inhibition of the Nodal/Activin/TGF-β pathway 
(Smith et al., 2008). The seminal paper that brought both of these strands together showed 
that the dual inhibition of these pathways was sufficient to induce NPC differentiation and 
subsequent neuronal maturation in completely defined conditions (Chambers et al., 2009). 
Multiple studies have used different compounds to elicit the inhibition of each 
pathway. For instance, BMP signalling can be inhibited using the recombinant protein 
Noggin, but also by the synthetic compounds Dorsomorphin (Shi, Kirwan and Livesey, 2012; 
Naujock et al., 2014; Stanslowsky et al., 2014) and LDN193189 (Kriks et al., 2011; Prè et al., 
2014). In general terms the NPC induction by dual SMAD inhibition is reportedly faster than 
that derived from the EB-based induction (Muratore et al., 2014) and is generally stated to 
work with high efficiency. However, a recent study looking at direct comparisons of neural 
induction from EB-based and dual SMAD inhibition approaches in iPSCs reported a lower 
neural induction with the dual SMAD inhibition technique (Muratore et al., 2014). 
It should also be noted that these two techniques are not strictly mutually exclusive. 
Recent studies have reported successful neuronal differentiation via induction of NPCs 
through a combination of dual SMAD inhibition during EB formation (Stanslowsky et al., 
2014; Qian et al., 2016). This is a clear demonstration that although vague divisions can be 
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made between stages of various differentiation protocols, this is a highly changeable 
sphere of frontier research and slight modifications and alterations to existing protocols are 
the rule and not the exception. 
 
1.2.5 Stromal Cell-Derived Inducing Activity (SDIA) 
The method of neural induction via SDIA is derived from the co-culture of iPSCs with 
specific stromal cell lines. These stromal cells (as a replacement for fibroblastic feeder cells 
in classical PSC culture) supply factors to the iPSCs that directly induce the generation of 
NPCs. The stromal cell lines used to trigger neuronal lineage differentiation are 
predominantly the PA6 (Kawasaki et al., 2000) and MS-5 (Lee et al., 2007) lines. Although 
this is still a widely used and completely valid technique, it does come with some 
disadvantages when applied to modern iPSC research. Firstly, it involves the use of an 
animal cell line, which for human iPSC regenerative research may make this technique 
difficult to apply clinically. Secondly, the system of induction is an undefined one and the 
factors necessary to drive this induction are not completely known or understood. 
However, some progress has been made by screening the stromal cells for elevated factors, 
and protocols do exist for neural induction using these so-called SPIE factors (Stromal cell-
Derived Factor-1, Pleiotrophin, Insulin-like Growth Factor-2 and Ephrin-B1) (Vazin et al., 
2009). As with all these techniques described above, extensive characterisation of NPCs 
must be undertaken to ensure reproducibility between separate induction experiments. 
This will be integral to in vitro studies into disease-modelling that may hinge on subtle 
differences in neuronal maturation between healthy and disease-specific iPSC lines. Any 
irregularities in the induction of neural subtypes could therefore mask or negate any 
phenotypic changes present between healthy and disease-specific lines. Therefore, 
undefined or stochastic NPC induction protocols may result in irreproducible downstream 
assays or therapeutic outcomes. 
 
1.3 Specific Neuronal Subtype Differentiation 
The next step in the chain of in vitro neuronal differentiation is the patterning of NPCs and 
subsequent maturation of the desired neural subtype. As stated above, these protocols 
take general cues from the in vivo patterning of the neural tube. That being said, the time 
14 
 
of exposure to patterning morphogens, the combinations & concentrations of signalling 
molecules or agonists, and the time of maturation before experimental analysis of post-
mitotic neurons differs greatly from study to study (Compagnucci et al., 2014). This chapter 
will therefore try to bring together an overall demonstrative consensus of many neuronal 
differentiation studies to obtain a broad picture of subtype specific factors (Fig 1-3). 
The stages of neuronal specification can be crudely broken down into; the neural 
induction step (covering the generation of pattern-competent NPCs); the patterning step, 
(in which suitable morphogens are used to recapitulate spatial location in the neural tube 
and therefore trigger lineage restriction); and the maturation step (where neurons are 
matured in media conducive to terminal differentiation and synaptogenesis) (Petros, Tyson 
and Anderson, 2011). This is not always the case, however, and some protocols throughout 
the literature do not use a pool of unpatterned NPCs, instead utilising a “pre-patterning” 
step that combines patterning factors with the early stages of neural induction. These 
protocols add patterning factors directly or soon after the start of neural induction of iPSCs 
and attempt to pre-determine neuronal lineage specification simultaneously with NPC 
generation [for example (Hartfield et al., 2014)]. However, it should be noted that reported 
efficiencies will vary from study to study and no definitive protocols exist for subtype 
differentiation. An overview of specific neural subtype differentiation protocols for 











Figure 1-3: In vitro methods of generating Neural Progenitor Cells (NPCs) and specific 
neural cell lineages from iPSCs. The morphogens used are predominantly derived from 
known in vivo signalling events. Solid blue lines indicate patterning of NPCs after neural 
induction. Dashed red lines indicate patterning during the NPC induction step. SHH, 
Sonic Hedgehog; WNT, Wingless-type MMTV Integration site; FGF, Fibroblast Growth 
Factor; EGF, Epidermal Growth factor; RA, Retinoic Acid; BMP, Bone Morphogenetic 
Protein; CNTF, Ciliary Neurotrophic Factor; JAG-1, Jagged-1; GDNF, Glial-cell Derived 
Neurotrophic Factor; BDNF, Brain-derived Neurotrophic Factor; TGF-β, Transforming 




1.3.1 Forebrain Lineages 
NPCs generated via the majority of neural induction pathways listed above and cultured in 
a basic neural maintenance media free of any morphogens, will differentiate into mature 
neuronal lineages (Hansen, Rubenstein and Kriegstein, 2011). More specifically this 
“default pathway” directs a neural lineage specific to dorsal forebrain cortical neurons 
(Zeng et al., 2010; J.-E. Kim et al., 2011; Shi, Kirwan and Livesey, 2012). This is true across 
neural induction strategies in murine ESCs (mESCs), human ESCs (hESCs) and human iPSCs 
(hiPSCs). Therefore an “uncontrolled” or “un-patterned” differentiation will create a 
neuronal culture rich in glutamatergic (excitatory) and, to a lesser extent, γ-aminobutyric 
acid (GABA)ergic (inhibitory) neurons (Gaspard et al., 2008; Li et al., 2009; Espuny-Camacho 
et al., 2013). This is an interesting point of fact as it displays a developmental bias to form 
anterior dorsal neural cell types in the absence of other neural tube patterning factors, and 
not simply a random assortment of neuronal cell lineages. This default dorsalisation effect 
can be further strengthened by the use of the SHH-signalling antagonist Cyclopamine, 
which near abolishes the presence of ventral/inhibitory neuronal subtypes (Gaspard et al., 
2008), or with the application of the dorsalising signalling molecule WNT-3A (Li et al., 
2009). This is also seen functionally where the electrophysiological properties of these 
“default” dorsal cultures do not alter firing properties under antagonism of GABA 
signalling, showing their low presence within these neural cultures (Kirwan et al., 2015). 
In general terms, neuronal cultures with a high proportion of glutamatergic 
neurons are said to have dorsal forebrain characteristics (mirroring the spatial coordinates 
of the neural tube from which they would be derived in vivo), whereas cultures with a high 
proportion of GABAergic neurons are said to be derived from ventral forebrain or 
“ventralised”.  
It has also been shown that the use of dorsal-ventral patterning factors can alter 
the percentage of excitatory and inhibitory neurons in this forebrain lineage pathway. 
Forebrain GABAergic interneurons account for about 20% of the neocortical neuronal cell 
number and develop from ventral in vivo structures termed the ganglionic eminences, 
namely the lateral ganglionic eminence (LGE), the caudal ganglionic eminence (CGE), and 
the medial ganglionic eminence (MGE) (Danjo et al., 2011; Arber and Li, 2013; Yan Liu et al., 
2013). The latter also containing progenitors of forebrain cholinergic neurons (Crompton et 
al., 2013). In utero these interneurons then undergo a large tangential migration into the 
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dorsal cortical tissues. Very high patterning concentrations of SHH (or purmorphamine – a 
SHH pathway agonist) have been shown to trigger GABAergic interneuron differentiation in 
in vitro PSCs (Maroof et al., 2010; Danjo et al., 2011; Goulburn et al., 2012; Ma et al., 2012; 
Arber and Li, 2013; Yan Liu et al., 2013; DeRosa et al., 2015) sometimes combined with 
antagonists of Wnt-based dorsalising pathways such as Dickkopf-1 (DKK-1) (Li et al., 2009).  
Through regulation of the concentration of ventralising signalling molecules it is 
possible to derive not only crude measures of GABAergic interneurons, but also define 
particular subsets of inhibitory NPCs derived from each of the ganglionic eminences. High 
concentrations of SHH (or its pathway agonists) generate pools of ventral NPCs displaying 
markers of the MGE and CGE neuraxis regions, whereas lower amounts instead generate 
medium spiny neuronal NPCs of the LGE (Danjo et al., 2011; Ma et al., 2012). These 
divisions can be further tailored by the addition of FGF-8 which increases the population of 
MGE-specific precursors, but is inhibited through the addition of FGF-15/19, while 
conversely CGE-specific precursor induction efficiencies are increased with FGF-15/19 
treatment and suppressed by FGF-8 (Danjo et al., 2011). Other GABAergic differentiation 
protocols have also found an enhancing effect of FGF-8 treatment when paired with a SHH-
agonist and IWP-2 (an antagonist of the dorsalising Wnt-signalling pathway) (Kim et al., 
2014). Interneurons derived in this way have been successfully transplanted into murine 
models of induced-epilepsy and display functional integration to a level that ameliorated 
the seizure activity (Cunningham et al., 2014). LGE-specific GABAergic NPC induction can be 
initiated through strict control and reduction of SHH or SHH-agonist concentration, to a 
level lower than is necessary for MGE and CGE differentiation, and therefore generate 
pools of NPCs with different marker compositions distinct from other GE and dorsal 
precursor cell types (Ma et al., 2012). 
 Interestingly, similar differentiation strategies have generated cultures enriched 
with forebrain cholinergic neurons (Crompton et al., 2013). Other strategies have combined 
SHH with the midbrain marker FGF-8, and further treatment with BMP-9, to generate high 
induction efficiencies of forebrain cholinergic neurons (Bissonnette et al., 2011).   
Surprisingly, other studies have reported GABAergic lineage differentiation based 
on NPC treatment with all-trans-retinoic acid (Chatzi et al., 2009; Addae et al., 2012) as a 
single factor that generates the specific ventral subtype, as well as in combination with 
FGF-2 (Goulburn et al., 2011) although the authors postulate these cells arise from a 
diencephalic rather than telencephalic origin. RA, as was discussed in the context of neural 
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tube patterning, is used as a posteriorising signal and is predominantly associated with 
hindbrain and spinal cord neuronal development. The majority of motor neuron and 
hindbrain neuron differentiation strategies discussed below (Section 1.3.3) utilise RA as a 
caudalising patterning signal. It is therefore intriguing how forebrain lineages may be 
formed from this treatment. The concentration and timing of treatment does however 
differ between protocols and indeed certain levels of RA and retinoids may encourage 
cortical induction without caudalising the NPCs to a noticeable extent (Shi et al., 2012; Shi, 
Kirwan and Livesey, 2012). Even FGF-2 treatment (as will be discussed below) utilised in a 
subset of GABAergic differentiation strategies and also a major component in many 
proliferation media for NPC propagation, can have caudalising effects on the NPCs 
themselves and can therefore generate more caudal neural subtypes (Falk et al., 2012; 
Zhou et al., 2016). 
Even more surprising is the report that treatment with Activin (a member of the 
TGF-β signalling family) could induce the differentiation of Calretinin-expressing CGE-
specific interneurons through the downregulation of SHH signalling and the upregulation of 
RA signalling events (Cambray et al., 2012). Both components of this result appear counter-
intuitive, but nevertheless highlight the esoteric nature of neural lineage differentiation 
both in vivo and in vitro.       
Hippocampal dentate gyrus (DG) neurons are derived in vivo from the most 
dorsomedial region of the telencephalon (Yu, Marchetto and Gage, 2014). Protocols 
focused on the differentiation of DG neurons from PSCs are quite sparse in the literature 
but successful attempts have utilised a combination of WNT-3A dorsalising morphogen 
together with brain-derived neurotrophic factor (BDNF) (Yu et al., 2014), as well as a 
combination of the dorsalising factors CHIR99021 (a Wnt-signalling agonist) and BMP-4 
(Sakaguchi et al., 2015). 
 It is worthy of note, that although a multitude of differentiation protocols exist for 
the generation of human neural subtypes through morphogen patterning as outlined 
above, the speed of differentiation and maturation of each cell type follows an intrinsic 
timeline that closely mimics that of in utero brain development (Espuny-Camacho et al., 
2013). Consequently PSC-derived cortical neural models derived from murine cell types will 
differentiate and mature on a much more compressed timeline than for human PSC-
derived cortical neural cultures (Van den Ameele et al., 2014; Kelava and Lancaster, 2016) 
(Fig 1-4 A). This intrinsic timing of cellular differentiation and maturation of human NPCs 
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also reveals in vitro temporal recapitulation of markers of corticogenesis indicative of in 
utero cortical lamination events (Hansen, Rubenstein and Kriegstein, 2011; Anderson and 
Vanderhaeghen, 2014). 
Development of the human cortex into a highly organised multi-layered laminar 
structure generated from the pre-plate primordium occurs in a regulated temporal and 
spatial manner, with each neuronal layer having distinct gene expression markers. The 
timing of this series of precursor differentiation and maturation events of each layer 
identity is preserved in in vitro PSC differentiation studies, allowing for an exquisite view in 
vitro of the protracted time of cortical layer development (Hansen, Rubenstein and 
Kriegstein, 2011; Espuny-Camacho et al., 2013; Anderson and Vanderhaeghen, 2014; 
Kelava and Lancaster, 2016). This faithful recapitulation of the inside-out nature of cortical 
lamination from early deep-layer neurons to later upper-layer neurons, followed by glial 
cell differentiation can form the basis of studying human-specific brain structures that may 
not be present or markedly reduced in brains of other animal models, such as the outer 
subventricular zone (Kelava and Lancaster, 2016) (Fig 1-4 B). Even implantation of human 
cortical NPCs into developing mouse brains did not accelerate the sequential maturation 
profile of the human cortical neurons, suggesting a level of tight control on these timing 
and maturation events that are not easily swayed by the cellular environment (Espuny-
Camacho et al., 2013). Other implantation studies of human cortical NPCs into embryonic 
murine cortex do show robust migration and integration into the post-natal brain, showing 
that even if intrinsic maturation timing is different, the human cells will still develop 





1.3.2 Midbrain Lineages 
A very high proportion of PSC-neural differentiation studies are based around midbrain 
dopaminergic neuron generation, compared to other neural lineages. Dopaminergic 
neuronal subtypes are strongly affected in Parkinson’s disease (PD) pathology, and hence 
many research groups have focused on its lineage specification as a basis to better 
understand the mechanisms of PD-related neurodegeneration.  These neurons in vivo are 
specified from the developing midbrain (Brodski et al., 2003). A large amount of FGF-8 
signalling denotes the midbrain-hindbrain boundary (the isthmic organiser) and as such, 
Fig 1-4: (A) The in vitro cortical differentiation of human and murine PSCs follows 
the same pattern of layer-specific development and intrinsic timing as is seen in 
utero. (B) Each cortical layer contains neurons of specific gene expression profiles 
that develop sequentially during the formation of the cytoarchitecture. Gliogenesis 
follows after the bulk of neurogenesis. Figures adapted from Anderson & 
Vanderhaeghen 2014; Hansen et al. 2011 
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FGF-8 treatment is a constant factor in almost all in vitro dopaminergic neuron 
differentiation strategies, together with the ventralising effect of SHH (Petros, Tyson and 
Anderson, 2011). Treatment with SHH triggers a strong ventralising signal which mirrors the 
in vivo discovery that true midbrain dopaminergic neurons develop from the floor plate 
(the most ventral mid-line portion) of the neural tube (Ono et al., 2007). Successful 
combinations of these factors to generate neurons with dopaminergic markers have been 
shown in hESCs (Koch et al., 2009; Kriks et al., 2011) and hiPSCs (Swistowski et al., 2010; 
Zeng et al., 2010; Kikuchi et al., 2011; Kriks et al., 2011; Stanslowsky et al., 2014) and have 
also been shown to be electrophysiologically active (Hartfield et al., 2014). These protocols 
include the use of patterning and pre-patterning (or “pre-rosette”) treatments with SHH 
and FGF-8 to obtain the target dopaminergic lineage. One of these studies showed 
improved in vivo dopaminergic marker presence and improved in vivo grafting of the 
generated neuronal pool when FGF-8 and SHH treatment was paired with canonical Wnt-
signalling (Kriks et al., 2011). The initial step used high amounts of SHH to ventralise the 
NPCs during induction into a floor-plate-like cell type which was then patterned with FGF-8 
and the Wnt-signalling activator CHIR99021. As with forebrain patterning methodologies, 
the use of Wnt-signalling was linked with dorsalisation of the NPCs, and hence in this 
method the timing and use of both ventralising and dorsalising signals is necessary for 
improving specific dopaminergic differentiation. This then reinforces the concept of the 
strong interplay between morphogen gradients within the neural tube in vivo and the fine 
tuning that is capable in vitro to derive neuronal subtype specificity.   
 A large portion of dopaminergic differentiation methodologies also report 
successful differentiation when utilising solely the stromal cell co-culture neural induction 
strategy (SDIA) outlined previously (Kawasaki et al., 2000; Zeng et al., 2004; Parmar and Li, 
2007). This leads to the conclusion that although neural induction is indeed possible with 
SDIA, the generated NPCs would in effect be patterned or at least biased for 
midbrain/hindbrain lineage differentiation. This pro-dopaminergic patterning of NPCs by 
SDIA has been utilised by other studies in conjunction with treatment of the patterning 
factors SHH and FGF8 (Perrier et al., 2004), while another study showed successful 
dopaminergic differentiation of hESCs using the SPIE factors (Section 1.2.5) as a neural 
inductive signal to trigger not only patterned NPCs but also dopaminergic lineage 
differentiation (Vazin et al., 2009). 
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 It is also interesting to note that NPCs propagated in long term culture in the 
presence of FGF-2 and epidermal growth factor (EGF), will default to a midbrain/hindbrain 
specification instead of forebrain lineages (Falk et al., 2012). This is probably due to the 
effect of FGF-2 which is a known caudalising signal in NPC patterning (Shi, Kirwan and 
Livesey, 2012; Karus, Blaess and Brüstle, 2014; Zhou et al., 2016). Under these conditions, 
the continuously propagated NPCs will be biased towards a midbrain or hindbrain lineage 
specification during maturation and not the “default” cortical lineage as in protocols that 
involve neural induction and maturation in a single continuous process from iPSCs 
(Anderson and Vanderhaeghen, 2014). 
 
1.3.3 Hindbrain and Spinal Lineages 
As with in vivo patterning of the neural tube, the specification of hindbrain and spinal 
lineages in vitro is dependent on the presence of midbrain and/or caudalising signalling 
molecules during or after neural induction. Serotonergic neurons in vivo are generated in 
an area of the rostral (or anterior) hindbrain (Goridis and Rohrer, 2002) and as with 
dopaminergic neuron development the midbrain-hindbrain organiser is integral for this 
specification (Brodski et al., 2003). Neural tube explant studies highlighted the necessity of 
not only SHH and FGF-8 signalling, but also pre-patterning with FGF-4 (probably derived 
from the primitive streak in vivo) as an inductive cocktail to drive serotonergic neuron 
differentiation ex vivo (Ye et al., 1998). These factors have since been shown to successfully 
generate serotonergic neurons from various PSCs in vitro (Barberi et al., 2003; Alenina, 
Bashammakh and Bader, 2006). Interestingly, higher serotonergic induction was reported 
using the MS5 SDIA induction method than with the EB-based neural induction (Alenina, 
Bashammakh and Bader, 2006). Another recent method of serotonergic neuronal 
differentiation employed a “single-step” induction of ESCs and iPSCs using only a 
monolayer culture of PSCs on a thick layer of Matrigel (a murine sarcoma-derived 
extracellular matrix product) and treatment with Noggin (a BMP-signalling antagonist) 
(Shimada et al., 2012). It is surprising that serotonergic differentiation was derived without 
the exogenous use of a separate neural induction step, nor any of the classical midbrain-
hindbrain signalling factors or FGF-4. A possible explanation for this may be the undefined 




 Successful cerebellar granule neuron differentiation protocols in the literature are 
predominantly based around more complex and sequential addition and removal of 
patterning factors throughout neural induction and maturation. One of the first studies 
reported in the literature, using mESCs, generated Math1+ cerebellar precursor cells and 
L7+ Purkinje cells. The ESCs underwent a SDIA neural induction followed by treatment with 
BMP-4 and WNT3a resulting in the formation of cerebellar precursors. Additional 
treatment with FGF-8 resulted in more Purkinje cells being generated (Su et al., 2006). 
Mature granule neurons have also been generated from mESCs through a stepwise 
exposure to a much wider array of morphogens through the EB-based induction method: 
Addition of WNT1, WNT3a, FGF-2, FGF-4, FGF-8, and RA trigger initial patterning. This in 
turn is followed by BMP-6, BMP-7 and Growth Differentiation Factor-7 (GDF-7) for further 
maturation, and then finally SHH and Jagged-1 (JAG-1) (Salero and Hatten, 2007). 
Functional cerebellar neurons from hESCs have also been generated with efficiencies over 
75% using the same array of morphogens listed above but in a five-step sequential process 
over the first thirty days of induction (Erceg et al., 2012). Cerebellar neural induction in 
vitro therefore seems to require tightly controlled midbrain, caudalising, early dorsalising 
and late ventralising signals by which to specify developmental identity. 
 Motor neuron (MN) lineage specification tends to rely on a strong caudalising 
signal (namely RA) and ventralising signal (either SHH or Purmorphamine) to promote 
specific differentiation. This basic concept of MN induction works consistently in mESCs 
(Barberi et al., 2003; Soundararajan et al., 2007), hESCs (Lee et al., 2007; Li et al., 2008; 
Koch et al., 2009) and hiPSCs (Hu and Zhang, 2009; Karumbayaram et al., 2009; Zeng et al., 
2010; Corti et al., 2012). Successful MN differentiation with these factors does not seem 
dependant or inhibited by any particular method of neural induction and positive MN 
differentiation is seen from SDIA-based protocols (Barberi et al., 2003; Lee et al., 2007) and 
EB-based inductions (Hu and Zhang, 2009; Karumbayaram et al., 2009; Zeng et al., 2010). 
hiPSC-derived MNs differentiated in this way are reportedly electrically active and 
functional after 10 weeks in vitro (Hu and Zhang, 2009; Karumbayaram et al., 2009) and 
have been successfully engrafted in murine models of Spinal Muscular Atrophy (Corti et al., 
2012). 
 It is also worthy of note that unlike forebrain lineage differentiation which may be 
inhibited in NPCs kept in long-term culture due to the caudalising effect of FGF-2, MNs can 
still be differentiated easily from long-term extended culture of NPCs (Koch et al., 2009). 
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1.3.4 Glial Cell Differentiation 
Glial cell differentiation, migration and maturation in vivo occurs predominantly after that 
of neuronal development and continues to do so postnatally (Barateiro and Fernandes, 
2014). This pattern of delayed glial differentiation also holds true for in vitro neural 
differentiation studies (Gaspard et al., 2008; Krencik et al., 2011; Emdad et al., 2012; Gorris 
et al., 2015). There are many reasons why the generation of glial cell subtypes 
independently from neuronal lineages would be advantageous. Firstly, for improved 
neurological modelling, astroglial cell subtypes are known to have pro-synaptogenic 
properties and may aid with generating more mature and in vivo-like neuronal networks 
(Christopherson et al., 2005; Hu et al., 2007; Hughes, Elmariah and Balice-Gordon, 2010; 
Kucukdereli et al., 2011; Clarke and Barres, 2013). Secondly, for disease-modelling studies, 
the role of glial cells may have an integral role in the pathology of the neurological 
condition and therefore could be studied in isolation or in tandem with neuronal 
populations: such as the toxic effects on hESC-derived motor neurons seen when co-
cultured with astroglial cells carrying an amyotrophic lateral sclerosis-related (ALS) 
mutation (Di Giorgio et al., 2008). Finally, for regenerative therapies, certain glial subtypes 
such as oligodendrocytes could be transplanted to generate autologous therapies for 
multiple sclerosis (Grade, Bernardino and Malva, 2013) or other CNS trauma (Nistor et al., 
2005), also demonstrated through astroglial-rich NPC transplantations into ALS-affected 
mice (Kondo et al., 2014). Because of the intrinsic delayed nature of gliogenesis from PSCs 
undergoing neural induction, many protocols to generate both astroglial and 
oligodendrocyte cell types in the literature do so over a longer time frame than for 
neuronal subtype differentiation.  
For astroglial differentiation of PSCs in vitro, many protocols utilise treatment with 
ciliary neurotrophic factor (CNTF) which has been shown to enrich Glial Fibrillary Acidic 
Protein-positive (GFAP+) cells (a marker of astroglial identity) in embryonic murine NSCs 
(Kanski et al., 2014), although not as a single factor within differentiation formulations. 
Such an example used treatment with both CNTF and FGF-2 by which to generate astroglial 
cell types from PSC-derived NPCs (Emdad et al., 2012). Other protocols utilise a 
combination of leukaemia inhibitory factor (LIF) and BMP-4 which has been shown in 
primary NSC culture to promote the differentiation of astroglial cells (Bonaguidi et al., 
2005) and which has also been successful in generating astrocyte lineages in vitro from 
hESC-derived NPC populations (Gupta et al., 2012; Kondo et al., 2014). A combination of 
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BMP-2 and CNTF was utilised in another study in the differentiation of astroglial lineages 
from PSCs, which also recognised heregulin (an alternative splice variant of neuregulin and 
member of the EGF-like ligands) as a strong inducer of astroglial cell phenotypes (Shaltouki 
et al., 2013). Long term culture of “patterned” NPC types with individual or combinations of 
the dorsal-ventral and rostral-caudal morphogens FGF-8, SHH, and RA results in astroglial 
subtypes from various developmental regions of the neural tube and that further 
treatment with CNTF at later time points in differentiation can aid to increase the presence 
of astroglial cell types, albeit over months of differentiation (Krencik et al., 2011). 
Early oligodendrocyte differentiation studies employed the use of insulin and 
Triiodothyronine (T3) as morphogens to induce oligodendroglial lineages during extended 
proliferation of NPCs generated by EGF & FGF-2, which all followed NPC induction via RA 
treatment of hESCs (Nistor et al., 2005). A similar protocol to the one above, together with 
a temporally controlled addition of Noggin (a BMP-signalling antagonist) increased the 
presence of cells displaying oligodendrocyte lineage markers (Izrael et al., 2007). Yet 
another study utilising long term NPC expansion through FGF-2 and EGF based media, 
enhanced oligodendroglial precursors through the early addition of platelet derived growth 
factor (PDGF-AA) with a later maturation triggering signal of T3 (Kang et al., 2007). The 
derivation of oligodendroglial cells from other patterned regions of the neural tube have 
also been investigated. Ventral spinal oligodendrocytes were successfully generated after 
patterning of hNPCs with both ventralising and caudalising morphogens; SHH and RA, prior 
to the addition of the oligodendrocyte maturation cytokines; PDGF-AA, insulin-like growth 
factor 1 (IGF-1), and T3 (B.-Y. Hu et al., 2009; Hu, Du and Zhang, 2009). Interestingly, the 
authors show a role for FGF-2 inhibiting motor neuron generation and instead favouring 
the formation of early oligodendroglial precursors, but that extended FGF-2 treatment 
inhibits the maturation of these precursors. This further demonstrates that tailoring the 
temporal exposure of the same morphogen, can have stark effects on downstream NPC 
differentiation. This again reinforces that these processes are both biochemical and 
temporal in nature, and that both have equal weight in development of these protocols. 
Other oligodendrocyte differentiation methodologies have used similar induction cytokines 
as listed above (FGF-2, EGF, PDGF-AA, IGF-1, and T3), together with further glial inductive 
signals; CNTF (as is used in astroglial differentiation protocols), ascorbic acid (AA) (Sundberg 
et al., 2010), and neurotrophin-3 (NT-3) (Czepiel et al., 2011) but each morphogen 
exposure controlled via specific temporal exposure. 
26 
 
As a method of further refining and enriching the NPC pool from neural lineage 
induced PSCs, some studies have employed a fluorescence-activated cell sorting (FACS) 
step within the protocol.  After initial neural induction, NPCs cultured in the presence of T3, 
RA, EGF, and FGF-2 triggered a radial glial-NPC identity, before FACS separation of cells 
displaying a CD133+ (prominin) plasma membrane marker. Final oligodendroglial 
maturation was prompted through exposure to PDGF, AA, T3, and Noggin (Gorris et al., 
2015). 
 
1.4 Transcription Factor-Induced Neuronal Differentiation 
Apart from the use of developmentally related morphogens to derive mature 
neuronal lineages from PSCs, some research groups have utilised forced expression of 
specific neural transcription factors (TFs) to induce precise neuronal subtype differentiation 
(Velasco et al., 2014). The transcription factors used are ones that are known to be 
functional in developmentally-early neural tissue patterning and can be thought of as 
downstream effectors of soluble morphogen patterning. Numerous neuronal cell types 
from forebrain to hindbrain lineages have already been generated from these TF-based 
methodologies (Allodi and Hedlund, 2014).  
Generally speaking, the neuronal cultures developed with this methodology 
reportedly have a much quicker neural identity induction time, in the scale of weeks until 
yielding electrophysiologically functional neurons, compared to morphogen-based 
protocols which may be in the scale of months (Kirwan et al., 2015; Odawara et al., 2016). 
Induction efficiencies are also consistently reported as much higher when direct forced 
expression of TFs drives neural differentiation; generally over 90% (Bissonnette et al., 2011; 
Zhang et al., 2013).   
Some neural subtypes seem to only require one neural TF to show lineage 
determination, such as Neurogenin-2 (Ngn-2) which can drive PSCs and PSC-derived NPCs 
to an almost completely pure cortical excitatory neuronal lineage (Zhang et al., 2013; Ho et 
al., 2016). Ascl1 alone has also been shown to convert human fibroblasts into functional 
neurons as a single exogenous factor, although this process can be enhanced when other 
concurrent factors are also transfected (Chanda et al., 2014). Other neuronal induction 
protocols require multiple neural TFs to trigger an efficient specific induction, such as 
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neurogenesis from hiPSCs through forced expression of both neurogenin-1 (Ngn-1) and 
Ngn-2 (Busskamp et al., 2014). Excitatory cortical neurons have also been induced and from 
murine fibroblasts using forced expression of the three factors Ascl1, Brn2 and Myt1l 
(Vierbuchen et al., 2010) and together with NeuroD triggered neuronal induction in human 
fibroblasts (Pang et al., 2011). 
Midbrain dopaminergic neurons differentiated from hiPSCs required the synergistic 
co-transfection of the Ascl1, Nurr1 and Lmx1a TFs (Theka et al., 2013). For spinal neural 
lineages, a combination of Ngn2, Isl1 and Lhx3 induced spinal motor neuron differentiation 
in mESCs. Interestingly, the replacement of Lhx3 with Phox2a generated a pool of cranial 
motor neurons (Mazzoni et al., 2013). This synergistic overlap between TFs is indicative of a 
system by which no one particular TF purely denotes each neural subtype (e.g. Ngn2 has 
been used both in excitatory cortical and motor neuron differentiation) or developmental 
location but instead neural tube signalling works in concert with multiple TFs in order to 
differentiate specific neural subtypes (Imayoshi and Kageyama, 2014). 
This is also evident when TF transfections are used in conjunction with soluble 
morphogen patterning to try and enhance the induction efficiency of particular neural 
lineages. The combination of forced expression of single or multiple TFs and different 
patterning morphogen compositions has potent effects on the subtype and homogeneity of 
neural subtypes during neural induction and differentiation. Patterning of hESC-NPCs with 
FGF-8 and SHH, during forced expression of Lhx8 and Gbx1, generates basal forebrain 
cholinergic neurons (Bissonnette et al., 2011; Duan et al., 2014). Similar patterning 
morphogen treatment with FGF-8, SHH and FGF-2 but with forced expression of Lmx1a will 
produce dopaminergic neurons from hESCs (Friling et al., 2009), but not to the high 
efficiency recorded in multi-TF transfection protocols. A similar protocol with the same 
soluble factors (but without FGF-2) and Lmx1a, expressed from a Nestin-enhancer, 
generated dopaminergic neurons from mESCs (Panman et al., 2011). FGF-8 and SHH 
priming with the forced expression of Phox2a or Phox2b instead of Lmx1a in mESCs will 
trigger differentiation into visceral motor neurons (Panman et al., 2011; Mong et al., 2014), 
however, replacing SHH with BMP-7 but retaining forced Phox2b expression, instead 
generated dorsal hindbrain noradrenergic neurons (Mong et al., 2014).  
Patterning with both ventralising (SHH) and caudalising (RA) signals can aid with 
other forced expression of single TFs in ESCs. For example, Nkx2.2 expression generates 
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high levels of serotonergic neurons, while Olig2 expression with the same morphogens will 
trigger somatic motor neuron differentiation (Panman et al., 2011). 
While the results of these TF-based studies are striking in terms of apparent 
induction efficiency, subtype specificity, and speed of neuronal functionality; they must be 
weighed against the possible disadvantages of forced gene expression and effects related 
to developmental genes activated out of order, or not in correct synergy with other 
associated genes. This is of course not to say that neural cultures generated in this way 
would be unsuitable for disease modelling or developmental applications; indeed 
cholinergic neurons produced from TF forced expression have already been used in an 
Alzheimer’s disease model (Duan et al., 2014). Experimental methodologies that would 
require quick differentiation and electrophysiological analysis from a very pure and 
reproducible iPSC-derived neuronal subtype may very well prefer TF-based methods to 
slower developmentally-based morphogen protocols. 
Even more intriguing is the finding that transdifferentiation of fibroblasts to neural 
subtypes can be achieved without ectopic expression of neural-associated TFs, and instead 
is possible purely from chemical induction. Induced neural stem cell-like cells (iNSLCs) were 
generated from murine fibroblasts after treatment with nine separate chemical factors 
alone (M. Zhang et al., 2016). 
 
1.5 Neuronal Subtype Enrichment 
Heterogeneous cell populations are often generated when utilising neural induction 
protocols from hPSCs. For developmental studies this may not be an issue as the native 
mixed generation, maturation and connectivity of neuronal and glial cell types are the basis 
of the assays being undertaken, and are known to follow embryological developmental 
timelines (Hansen, Rubenstein and Kriegstein, 2011; Van den Ameele et al., 2014; Kelava 
and Lancaster, 2016). Certain instances however, necessitate highly reproducible and high-
yield pools of specific neural progenitors or neuronal subtypes for study. This is most 
evident in degenerative disease modelling where the pathology of the disease is limited (to 
the best current knowledge) to a particular neuronal subtype, for example, dopaminergic 
neurons in Parkinson’s disease and motor neurons in Spinal Muscular Atrophy.  
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 One study performing a FACS-based screen of cell surface markers of NPCs 
differentiated from hPSCs at different stages of induction and differentiation identified a 
CD184+/CD271-/CD44-/CD24+ cell population that was able to distinguish between non-
induced hESCs (which do not express CD184) and non-NPC and neural crest cell 
contaminants (which express CD271 and CD44) thus selecting a “true” population of NPCs. 
After propagation and expansion of this cell pool into differentiation media the authors 
identified cell-surface combinations for glial pools of cells (CD184+/CD44+) and neuronal 
pools (CD184-/CD44-/CD15LOW/CD24+) if further cell sorting and purification was necessary 
prior to terminal differentiation and maturation (Yuan et al., 2011).  
 As well as cell surface markers, fluorescent protein reporters can be used to 
identify and sort specific neuronal lineages. When transfected either into the PSC line or 
NPC pool, these reporters can be driven by cell type-specific promoters or enhancers to 
ensure that the reporter is only expressed when the gene of interest is transcriptionally 
active. Examples of this technique have proven effective in identifying, sorting and 
enriching motor neurons via the use of a HB9-driven GFP reporter (Karumbayaram et al., 
2009), serotonergic neurons using a Pet-1 driven reporter (Shimada et al., 2012), and 
GABAergic interneurons with either an Lhx6- (Maroof et al., 2010), vGAT- (DeRosa et al., 
2015), or NKX2.1-driven fluorescent reporter (Goulburn et al., 2011). 
 There are some important caveats to the use of these reporter constructs for 
neuronal enrichment protocols, namely issues of transient gene expression, non-specific 
expression and timing of cell selection during differentiation. The gene of interest used to 
drive the promoter must be specific and robust enough to a particular subtype so that 
other developing lineages or proliferative cells are not falsely selected. For example 
tyrosine hydroxylase (TH) is a well-used marker for mature dopaminergic differentiation, 
however, TH is also transiently expressed in other cell lineages during development (Allodi 
and Hedlund, 2014). Thus, a purely TH-driven promoter would enrich for both 
dopaminergic and non-dopaminergic cell types depending on the stage of differentiation 
chosen for sorting. Other dopaminergic promoter-reporter constructs based around early- 
(Hes5), mid- (Nurr1) and late- (Pitx3) dopaminergic markers resulted in different recovery 
efficiencies and cell pool enrichments. The later and mid marker-reporters (Nurr1 and 
Pitx3) had higher purity cultures of dopaminergic neurons after FACS-based sorting than 
the earlier developmental marker Hes5 (Ganat et al., 2012). The trade off in using later 
markers rather than earlier ones is one of cell recovery efficiency and cell survival –
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whereby more mature post-mitotic neurons will tend not to survive FACS-based sorting 
protocols. 
 
1.6 Organoids for Studying Neurological Development and 
Disease 
Perhaps the most striking finding in recent years within iPSC-neural modelling is the 
development of tissue-specific organoid cultures. Organoids are three-dimensional (3D) 
cellular aggregates in which the contained stem cells differentiate and self-organise into 
structures reminiscent of in vivo tissue or functional elements of mature organs (Lancaster 
and Knoblich, 2014; Huch and Koo, 2015). Human PSC-derived NPCs will differentiate into 
neuronal lineages depending on patterning factors they are exposed to in vitro. Incredibly 
however, if the hPSCs undergo neural induction as 3D aggregates they will begin to self-
organise and recapitulate developmental structures indicative of early brain tissue (Karus, 
Blaess and Brüstle, 2014). These induced-aggregates will display neural tube-like 
morphology with the affiliated apical-basal polarity and gene expression patterns, and if 
left to develop over time will generate forebrain layered early-cortical structures (Mariani 
et al., 2012; Kadoshima et al., 2013) or cortical-spheroid structures (Paşca et al., 2015). 
These are defined loosely by the homogeneity of the contained cells and the complexity of 
the derived neural cytoarchitecture. The basis of this line of research was born out of the 
extended SFEBq neural induction protocols used previously for PSC-based neural derivation 
(Eiraku et al., 2008).  
A single aggregate may contain multiple early-cortical-like structures, but when 
cultured in Matrigel droplets and cultured in a spinning bioreactor, a much more 
continuous neuroepithelia is generated, enabling more defined cortical regions over long 
term culture (Lancaster et al., 2013) as well as discrete midbrain/hindbrain structural 
markers, and with a subset even developing retinal tissue. Organoids cultured in this way 
displayed discrete non-overlapping regions of cortical layering with gene expression of 
early- and late-born neural markers, an outer Reelin-positive layer, and even interneuron 
migration from ventral to dorsal regions of the organoid (Lancaster et al., 2013). Even 
though these organoids will develop in the absence of any exogenous factors, the 
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organoids themselves are responsive to neural-tube patterning morphogens that alter the 
region of the CNS they are generating.  
Ventralising of the organoids with a SHH pathway agonist triggered the enrichment 
of GABAergic neurons and an upregulation of adjacent LGE cell populations next to cortical-
like tissue (as is seen in vivo) (Kadoshima et al., 2013), and higher levels of MGE-like 
precursor pools, with concurrent lowering of LGE cell markers, was seen when the SHH 
agonist concentration was increased further (Kadoshima et al., 2013). This follows the same 
pattern as is seen in equivalent two-dimensional (2D) differentiation ventralisation 
protocols (Ma et al., 2012). 
In accordance with the 2D hiPSC-NPC differentiation methods – the default 
development of these organoids is one of a forebrain, cortical structure. But as with the 
patterning of the monolayer iPSC-NPCs, these organoids can themselves be patterned to 
develop into structures from other developmentally-early brain regions. The generation of 
hPSC-derived neural midbrain organoids can be triggered through the same addition of 
factors necessary to generate midbrain cell identities in 2D, namely SHH and FGF-8. These 
mid-brain organoids also produce neuromelanin and are functionally similar to primary 
dopaminergic neuronal cells (Jo et al., 2016). Single mESCs suspended in 3D Matrigel (or a 
synthetic matrix) undergoing neural induction will proliferate and form neural tube-like 
structures, termed neuroepithelial cysts. These cysts respond to patterning factors that 
both ventralise to floor plate identity and posteriorise the cysts to a more hindbrain or 
spinal cord identity, with the affiliated gene expression profiles (Meinhardt et al., 2014). 
hESC-derived organoid aggregates patterned with FGF-2, FGF-19 and SDF-1, suppressed 
forebrain identity and enhanced endogenous FGF-8 and Wnt signalling (a property of the 
midbrain hindbrain boundary in vivo). This in turn generated markers and organoid 
morphology consistent with early cerebellar-like tissue (Muguruma et al., 2015).  
These findings combine to point to the incredible discovery that not only can 
individual NPCs respond to exogenous patterning to derive specific subtypes, but that early 
neural aggregates can respond to similar signals and self-organise into a multitude of 
neurodevelopmentally relevant structures. This opens the door to an incredible tool by 




 As well as the implications for studies on brain tissue development these organoids 
have already shown that they can shed light on neurological disease on a patient-specific 
basis. hiPSC-derived organoids from patients with a CDK5RAP2-dependent pathogenic form 
of microcephaly also display neural hypoplasia and generate smaller organoids than non-
patient iPSC-organoids (Lancaster et al., 2013). Another study generated neural organoids 
from patients with an idiopathic Autism Spectrum Disorder that displayed differing neural 
subtype compositions to control organoids. The authors even managed to track this 
difference down to specific aberrant gene upregulations (Mariani et al., 2015). A multi-
faceted approach of using forebrain, midbrain and hypothalamic organoids has recently 
been used to model Zika virus infection and disease pathology in vitro (Qian et al., 2016), 
showing that the use of these organoids goes beyond genetically-linked neurological 
diseases and show promise in studying exogenous factors of brain disease and trauma.  
The fact that these organoid structures have now begun to help analyse and 
recapitulate developmental pathways and disorders show the true power of iPSC-based 
neural modelling and are paving the way for future 3D neurological research. Single cell 
transcriptome analysis of forebrain cerebral organoids show high fidelity to expression 
profiles from foetal neocortex (Camp et al., 2015) which further supports the paradigm of 
faithful recapitulation of developmental processes from these 3D in vitro models.  
All of the models discussed in this section contain inherent technical challenges and 
idiosyncrasies that will need to be resolved before wide-scale implementation and 
translation of PSC-based brain modelling projects (Brennand et al., 2015). Nevertheless, a 
vast amount of research has been undertaken to refine and improve both 2D and 3D neural 
differentiation protocols and models over a relatively short time-scale, and this is a source 
of optimism for the field. The combination of both stem cell biology and 3D growth 
environments is a fascinating area of research with untold potential for understanding 
embryological processes, degenerative or malformative disorders, and in unprecedented 
detail uncover how the brain builds itself. 
 
1.7 Biomaterials for Neural Culture 
The concept of disease modelling, or “disease in a dish”-technology, hinges on the faithful 
recapitulation of in vivo conditions in an in vitro model. The factors needed for accurate 
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neuronal maturation and survival must, by definition, recreate the in vivo 
microenvironment for disease phenotypes to be measurable. Many neurodegenerative 
conditions have undefined genetic components and unknown early-stage pathologies. The 
difference between a healthy neuronal state and a diseased one may begin as a subtle 
aberration. Also, measurable differences between control and disease-specific neurons 
may be present at the level of gene expression, synaptogenesis or detectable only with 
functional network formation. To simply have iPSC-derived neural cultures in a dish may 
not be enough to elucidate disease pathologies nor to study healthy neural development. 
Instead, techniques for accurately recreating in vivo environments by use of biomimetic 
constructs, may be integral for generation of pseudo-neural tissue and therefore complete 
disease and developmental modelling. Cell culture environments themselves can have 
profound effects on differentiation of stem cells, neurite outgrowth & axonogenesis, and 
ultimately the cytoarchitecture of neural cultures through modulation of cell-cell and cell-
matrix interactions. A wide variety of methods to modulate and enhance in vitro neural 
cultures are outlined and discussed below. 
 
1.7.1 Two-Dimensional Culture Conditions 
Planar neuronal differentiation and maturation of PSC-derived NPCs requires a plating 
substrate conducive to cell adhesion and promotion of neurite outgrowth. Throughout the 
literature the most frequently used substrates are Matrigel (a murine sarcoma-derived 
extracellular matrix product) or a combination of poly-ornithine & laminin (POL). Both 
Matrigel and POL have been used successfully in many PSC-neural differentiation studies 
with successful NPC differentiation on both substrates (Gaspard et al., 2008; Shi, Kirwan 
and Livesey, 2012; Naujock et al., 2014). A recent side-by-side study, however, reported 
that when using the EB method of iPSC-neural induction, Matrigel yielded higher 
percentages of MAP2-positive neurons after differentiation than aggregates plated on POL 
(>90% vs 56%) (Muratore et al., 2014). Other studies utilise non-biological growth 
substrates that have been modified to promote neuronal attachment and outgrowth. 
Poly(ester carbonate) functionalised with a laminin-derived peptide sequence resulted in 
higher levels of neural cell viability, neurite length and number of neurites per cell than 
growth on tissue culture plastic (Xing, Ma and Gao, 2014). A mix of native and synthetic 
elements in a hydrogel substrate composed of covalently linked Heparin and star-
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polyethylene glycol (PEG), functionalised with a fibronectin-derived peptide and FGF2, 
enhanced murine NSC survival compared to growth on a poly-lysine substrate 
(Freudenberg et al., 2009).  
 Substrate composition can also be modulated to generate growth surfaces of 
differing degrees of stiffness which have been shown to have strong effects on cell 
attachment, differentiation, and maturation (Discher, Janmey and Wang, 2005). 
Mesenchymal stem cells (MSCs) will favour neural differentiation when grown on soft 
substrates that have an elastic modulus similar to that of in vivo brain tissue; typically 
below 1kPa (Engler et al., 2006). More recently, a study has reported that hPSCs cultured 
on soft rather than stiff substrates (700Pa vs 75kPa) will show a bias for neuronal 
progenitor formation and mature neuronal differentiation (Keung et al., 2012). These 
findings are not in isolation; rat embryonic NSCs cultured on polydimethylsiloxane (PDMS) 
with a stiffness similar to brain tissue will extend longer neurites and have enhanced 
expression of pre-synaptic markers than stiffer PDMS substrates (Teixeira et al., 2009), and 
these cultures also enhanced astrocytic differentiation. Intriguingly, another study found 
that cortical neurons cultured on polyacrylamide or fibrin gels of varying stiffness show 
strong neurite extension regardless of stiffness, but that astrocytic growth and cell 
spreading was inhibited on soft substrates (Georges et al., 2006). The discrepancy between 
these two results may be due to the synergistic interplay of neural cells on equivalent 
stiffness of substrates but differing substrate compositions. Even though numerous studies 
implicate softer substrates in the promotion of neurite outgrowth and neural 
differentiation it has conversely been reported that synaptogenesis, voltage-gated calcium 
channel currents and neuronal networking of murine hippocampal neurons were all 
enhanced on stiffer rather than softer substrates (Q.-Y. Zhang et al., 2014). 
As well as the choice of substrate on which to differentiate neural progenitors, 
many studies have shown the importance of topographical features of 2D surfaces that can 
modulate, and to some extent control, neurite extension, arborisation and ultimately the 
networks formed on these surfaces (Hoffman-Kim, Mitchel and Bellamkonda, 2010). These 
topographies can be in the micro- to nano-scale and can be anisotropic (such as grooved 
surfaces or aligned fibres) or isotropic (such as nano-rough surfaces or geometrically 
spaced pillars) (Fig 1-5 A).   
Electrospun polymer fibres are widely used to generate aligned or randomly 
orientated nano-scale fibres for cell-topography interaction studies (Xie et al., 2010). It is 
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well documented that many neuronal cultures will tend to align and extend neurites in the 
direction of aligned fibres (Yang et al., 2005; Kim et al., 2008; Bourke et al., 2014; Xia et al., 
2014). However, different neuronal subtypes will display differing outgrowth patterns 
depending on the level of alignment and diameter of the polymer fibre. Murine NSCs will 
differentiate and extend neurites along both micro- and nano-scale polylactic acid (PLA) 
fibres but this effect is accelerated on smaller fibre diameters (300nm vs 1.5um) (Yang et 
al., 2005). Dorsal root ganglion (DRG) cells will tend to exclusively follow fibre alignment in 
a parallel fashion (Kim et al., 2008; Xia et al., 2014) (Fig 1-5 B) and will extend longer 
neurites than when grown on the same polymer in a smooth film (Mukhatyar et al., 2011). 
This alignment becomes less strict with smaller fibre diameters (300nm) which causes a 
more frequent perpendicular movement of the neurite (Wang et al., 2010). By contrast, 
embryonic rat hippocampal neurons will tend to extend processes both in a parallel fashion 
to the fibres, but also with regular perpendicular branching (Bourke et al., 2014). Polymer 
fibres can be further modified to enhance substrate-cell interaction, such as mixing the pre-
formed polymer with gelatin (a hydrolysed product of collagen type I) to enhance 
hydrophilicity and cell adhesion on the fibre mats (Alvarez-Perez et al., 2010).  
The results of neuronal outgrowths seen on fibre-based substrates is reflected 
when cells are cultured on micro-grooved surfaces. Embryonic rat hippocampal neurons 
grown on micro-grooved quartz will tend to extend processes parallel to wide grooves but 
perpendicular to narrow ones (of approximately 1μm) (Rajnicek, Britland and McCaig, 
1997). However, this pattern of contact guidance differed when hippocampal cells were 
harvested at different stages of development: Later embryonic neural cells favoured 
parallel alignment to the grooves, whereas cells from developmentally earlier embryos had 
an increased tendency for neurite outgrowth perpendicular to grooved topography. Similar 
patterns were seen on micro-grooved polypyrrole (PPy, an electrically conducting polymer) 
surfaces; neurons polarized and defined axons faster on grooved PPy than the smooth film 
and orientation was both parallel and perpendicular to the grooved topography (Gomez et 
al., 2007). Combinations of nano-rough and micro-grooved substrates also increase focal 
adhesion and human NSC differentiation and maturation compared to flat surfaces or each 
topographic feature alone (Yang et al., 2014).  
Isotropic micro-pillar topographies elicit differing effects on neuronal 
differentiation and outgrowth strictly depending on their size and spacing. Embryonic 
hippocampal neurons grown on micro-scale pillars will show greatest fidelity to the 
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geometry of the posts when the gaps between them are minimal, and generate a striking 
neurite growth pattern almost exclusively in strict right-angled trajectories (Dowell-Mesfin 
et al., 2004) (Fig 1-5 C). This effect was also seen when hippocampal neurons were cultured 
on micro-scale PDMS conical posts (Hanson et al., 2009).  
As mature neural cell types are electrically active, it has long been postulated that 
electrical stimulation of differentiating neural cultures will have positive and enhancing 
effects on neuritogenesis and maturation pathways. Electrical stimulation of neuronal 
cultures via the electrically conducting polymer polypyrrole (PPy) was demonstrated by 
Schmidt et al. about 20 years ago. PC12 cells, a neural-like cell line, showed similar cell 
attachment to the PPy substrate and tissue culture plastic, but after electrical stimulation 
of the PPy substrate, generated neurite lengths double that of cells cultured on 
unstimulated PPy (Schmidt et al., 1997). Electrical stimulation of PPy before cell attachment 
has also been shown to increase protein adsorption to the substrate from the surrounding 
growth media and therefore increase cell attachment and neurite outgrowth (Kotwal and 
Fig 1-5: (A) An overview of topographies utilised on two-dimensional surfaces to 
modulate neural cell morphology and maturation in vitro. (B) Aligned electrospun 
fibres, as an example of anisotropic surface topography, trigger neurite outgrowth and 
alignment of dorsal root ganglion-derived cells in the direction of the fibre alignment 
(scale bar = 100μm). (C) Micro-scale pillar topography causes perpendicular patterns of 
neurite extension and arborisation from primary hippocampal neurons [scale bars = 
4μm (black) and 100μm (white)]. Figure adapted from Hoffman-Kim et al. 2010, Xia et 
al. 2014, and Dowell-Mesfin et al. 2004 
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Schmidt, 2001). Electrical stimulation of this material may therefore aid outgrowth and 
attachment via direct interaction with the cells and the positive modulation of the basal 
PPy substrate through protein adsorption.  
In addition, electrical stimulation of neural cells cultured on electrospun fibres 
coated with PPy induce longer and more abundant neural processes than either factor 
alone (Lee et al., 2009), in a method that combines both topographical and electrical cues. 
 Further functionalization of PPy has also been tested with either the direct covalent 
attachment of neurotrophic factors (Gomez and Schmidt, 2007) or the doping of PPy with 
neurotrophic factors during polymerisation, in order to release them over time during 
neuronal culture (Thompson et al., 2010). In both of these cases, electrical stimulation was 
used synergistically with the biological effect of these growth factors to promote neuronal 
maturation. It has also been shown that extracellular electric fields can also promote and 
orientate neurites. Accelerated outgrowth and higher numbers of neurites were found on 
the cathodal side of neurons exposed to an extracellular electric field (Patel and Poo, 1982). 
Taken together; the tailored combination of biochemical, mechanical, 
topographical and electrical cues to a wide variety of neuronal subtypes and progenitors 
can generate strong, reproducible neurotrophic effects in 2D: modifying cell migration, 
axonal sprouting, dendritic arborisation, and even how and where neuronal networks form. 
The potential of combining iPSC-derived NPCs and programmable biomaterials is a 
powerful tool in engineering neural constructs that truly reflect more in vivo-like 
conditions, be they developmental or disease-state.  
 
1.7.2 Three-Dimensional culture conditions 
Although the level of customisation of 2D planar culture conditions is incredibly varied, it 
can be argued that neural cell encapsulation and growth in three-dimensional (3D) 
environments promote a more in vivo-like physiological setting. Cell-cell and cell-matrix 
interaction in 2D systems are confined to a single plane, with neural process outgrowths 
limited to two-axes and with the majority of cell surfaces exposed to the growth media. 3D 
cultures (with cells encapsulated within biocompatible scaffolds) allow for cell-cell contacts 
& neurite outgrowths in all directions, as well as complete interaction with the scaffold 
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matrix. Cell density can be modulated as can the composition of the matrix in order to 
generate a cell culture that has cytoarchitecture more representative of living tissue.                                                        
Hydrogels are a class of 3D scaffolds generated from networks of hydrophilic 
polymer chains. When hydrogels undergo sol-gel transitions they retain water content 
above 90% of their mass, and as such are highly suited to model in vivo-like cellular 
microenvironments. 
The diverse list of hydrogel biomaterials used for 3D neural differentiation or 
maturation of progenitors includes purified proteins or extracellular matrix (ECM) protein 
mixes such as Matrigel (Irons et al., 2008), laminin/entactin gels (Meinhardt et al., 2014), 
collagen type I (O’Connor et al., 2001), fibrin scaffolds (Montgomery et al., 2015; Robinson, 
Douglas and Michelle Willerth, 2017), and even decellularised porcine brain (DeQuach et 
al., 2011). Synthetic self-assembling peptides (SAPs) such as PuraMatrix have also shown 
promising recent use in 3D hESC-derived neural cultures (Ylä-Outinen et al., 2014) and 
primary neural cultures (Kaneko and Sankai, 2014). As well as peptide-derived matrices the 
literature is also filled with polysaccharide-based hydrogels that use both mammalian 
polysaccharides, such as the glycosaminoglycan hyaluronic acid (HA) (Wang and Spector, 
2009; Z.-N. Zhang et al., 2016), and non-mammalian substrates such as chitosan (Li, 
Wijekoon and Leipzig, 2014), alginate (Banerjee et al., 2009) and agarose (Balgude et al., 
2001). Results from material to material can be varied and depend on substrate 
composition, cell density and any modifications to the material, but as a very general rule; 
protein-based scaffolds tend to be more inherently conducive to neuronal differentiation 
and allow for more in vivo-like cell morphologies and cell-cell contacts than unmodified 
polysaccharide scaffolds. 
As well as being highly used as a 2D cell adhesion matrix, Matrigel has been used 
extensively and successfully in 3D neuronal cell culture for neural cell lines (McMurtrey, 
2014), primary cells (Irons et al., 2008), NSCs (Gelain et al., 2006; Koutsopoulos and Zhang, 
2013) and hESC- and hiPSC-derived NPCs (Lancaster et al., 2013; Moreno et al., 2015). It 
has also formed the cell-laden structural basis for high-density 3D neural cell cultures in 
large-scale perfusion devices (Cullen et al., 2007) and microfluidic 3D “lab-on-a-chip” 
perfusion devices (Moreno et al., 2015). Electrophysiological analysis of neurons cultured 
within Matrigel scaffolds confirmed the presence of abundant cell-cell synaptic events and 
mature network formation (Irons et al., 2008); a crucial property of biomaterials for use in 
neural tissue engineering. 
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 SAPs are short synthetic peptides (usually based around a repeating core Arginine-
Alanine-Aspartate-Alanine “RADA” motif) that can self-assemble under physiological pH 
and salt concentrations. The resulting hydrogel maintains a nanofibrous structure and 
porosity comparable with naturally occurring ECM structural proteins (Gelain et al., 2006). 
Unmodified SAP-scaffolds (i.e. containing only the repeat self-assembling motif) have been 
shown to generate a pro-neuronal biomimetic scaffold even without native protein binding 
motifs: hESC-NPCs differentiated in PuraMatrix (a commercially available SAP) display more 
branching events and thicker dendritic processes than the same cells grown on 2D Laminin 
cultures (Ylä-Outinen et al., 2014). Also, dopaminergic differentiation of mESCs and miPSCs 
was enhanced in 3D SAP scaffolds compared to 2D laminin culture and 3D Matrigel 
scaffolds (Ni et al., 2013). This specific dopaminergic neuron increase may be due to the 
non-animal-derived nature of the SAP, whereby undefined growth factors within the 
Matrigel may promote general cell viability and neuronal differentiation [as seen in (Gelain 
et al., 2006; Koutsopoulos and Zhang, 2013)], but may interfere to a certain degree with 
the patterning factors necessary for specific neuronal subtype lineage differentiation. As 
with 2D growth substrates, biomaterials for use in 3D scaffolds can be modified with 
peptide motifs with the aim of increasing cell-matrix interactions and therefore generating 
a truer in vivo-like microenvironment. SAPs have been synthesised with binding epitopes of 
native proteins such as laminin, fibronectin, collagens or other sequences (e.g. neuronal 
anti-apoptotic protein motifs) (Gelain et al., 2006; Li and Chau, 2010; Koutsopoulos and 
Zhang, 2013; Li, Chow and Chau, 2014). These functionalised SAPs have reportedly higher 
neuronal differentiation efficiencies of ESCs and NSCs than basal SAP scaffolds. A different 
format of SAPs based around a stacking aromatic fluorenylmethyloxycarbonyl (Fmoc) group 
covalently functionalised with laminin-binding moieties, has shown promise in rat models 
of ischemic stroke recovery (Somaa et al., 2017). The combination of this form of SAP 
together with hESC-derived NPCs allowed for an injectable delivery system into an in vivo 
model of cortical damage, that resulted in functional neural integration.   
 Collagen Type I (herein referred to as collagen) scaffolds are widely used 
throughout the literature as a go-to cell encapsulation material for numerous cell types, 
including neurons (Antoine, Vlachos and Rylander, 2014). Embryonic rat hippocampal 
neurons will show extensive neurite outgrowths and higher cell viability in collagen 
scaffolds than in parallel experiments with the same cell type encapsulated in agarose 
(O’Connor et al., 2001). In contrast to this, there are examples in the literature of positive 
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DRG neurite outgrowth in low concentration agarose, but this finding is quite rare (Balgude 
et al., 2001). As with SAP scaffolds, collagen can also be functionalised by covalent addition 
of protein-binding epitopes. DRGs cultured in collagen modified with both laminin and 
fibronectin motifs resulted in significantly higher MAP2 expression than unmodified 
collagen, the fibronectin motif alone, or a scrambled binding motif (Hosseinkhani et al., 
2013). Also, covalent modification of collagen with native laminin subunits resulted in 
greater cell survival of embedded NSCs (Nakaji-Hirabayashi, Kato and Iwata, 2012). 
An interesting use of collagen scaffolds was to determine neurite outgrowth when 
cells were exposed to 3D stiffness or mechanical gradients. Encapsulated DRGs extend 
longer neurites down a stiffness gradient rather than up one. This effect is greater than 
when neural cells were grown in uniform stiffness (Sundararaghavan et al., 2009). Also, 
overall DRG neurite extensions are longer in hydrogels of low collagen concentration than 
in higher concentration (and therefore stiffer) collagen hydrogels (Swindle-Reilly et al., 
2012). Collagen composite scaffolds containing a porous silk sponge as a model of cortical-
like white/grey matter layering allow for more brain-like cytoarchitecture with neurons 
retaining function and network formation (Tang-Schomer et al., 2014; Chwalek et al., 
2015), that was further enhanced with the addition of foetal ECM components into the 
collagen hydrogel (Sood et al., 2016).  
Neural cell electrophysiological activity is preserved in cells differentiated within 
collagen hydrogel matrices (O’Connor et al., 2000; Ma et al., 2004) and embryonic 
hippocampal neurons within collagen scaffolds show comparable electrophysiological 
profiles to those grown on 2D substrates (Xu et al., 2009). By segregating cell-seeded 
collagen hydrogels and connecting blank-hydrogels over a multielectrode array (MEA), 
pathways of synaptic functionality were traced throughout a layered neural structure in 
vitro (Odawara, Gotoh and Suzuki, 2013). All of which demonstrates that collagen 
hydrogels are inherently conducive to neural network formation and function, and that 
composites or structural cues within the hydrogels can even enhance the level of these 
formations. 
 Composite scaffolds containing both Collagen and HA (either through covalent 
crosslinking or simply a blending of material prior to cell encapsulation) show reportedly 
improved results for 3D neural culture, purely from a cell morphology and neurite 
outgrowth point of view (Brännvall et al., 2007; Wang and Spector, 2009). Also, HA 
scaffolds with embedded polycaprolactone (PCL) electrospun fibres (coated with laminin) 
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enhanced neurite lengths of SH-SY5Y cells (a human neuronal cell-line) when compared to 
the same fibres in 2D culture. Interestingly this increase was not found when the same 
fibres were utilised in a Matrigel equivalent scaffold (McMurtrey, 2014). A covalently-
modified form of HA that enables UV-driven crosslinking; HA-methacrylate (HAMA), has 
also been shown to enable iPSC-derived neural differentiation and migration assays (Z.-N. 
Zhang et al., 2016). 
 Direct comparisons between 3D NSC cultures composed of collagen, Matrigel, SAPs 
(RADA scaffold), and SAPs with functionalised peptide motifs, show significant differences 
in cell viability, differentiation and neurite outgrowth. Over long term culture, collagen 
scaffolds have been shown to have the lowest retention of cell viability, followed by 
Matrigel and then SAP scaffolds (Koutsopoulos and Zhang, 2013). Interestingly, even 
though long term viability was lower in Matrigel, the rate of NSC differentiation over the 
first 2 weeks was higher than in any of the SAP scaffolds. This may be due to the presence 
of undefined growth factors in this ECM-derivative promoting early cell responses 
(Koutsopoulos and Zhang, 2013). 
 As well as protein-based biomaterials for deriving scaffolds matrices, numerous 
polysaccharide hydrogels have shown promise in generating 3D neural cultures in vitro. 
Alginate (sodium alginate or alginic acid) is an anionic polysaccharide derived from brown 
algae that undergoes sol-gel transition through ionic crosslinking with divalent cations. 
Alginate hydrogels are a well characterised means to encapsulate cells in 3D with no 
significant cytotoxic effects (Andersen, Auk-Emblem and Dornish, 2015) and through 
generation of composite scaffolds are amenable to bioprinting technologies (Chung et al., 
2013). Rat NSCs encapsulated in alginate with an elastic modulus comparable to that of 
brain tissue show a twenty-fold higher level of β-III-tubulin expression than when 
differentiated in stiffer scaffolds (Banerjee et al., 2009) which mirrors the known 2D effect 
of substrate stiffness directly affecting stem cell differentiation pathways (Engler et al., 
2006). Typical neuronal morphology was not directly observed in this study and cells 
tended to form aggregates within alginate hydrogels. This finding is not in isolation; rat 
DRGs embedded in alginate will show little to no neurite outgrowths, but when embedded 
in Matrigel show neurite outgrowths seventeen-fold longer (Novikova et al., 2006). 
Alginate concentration and the concentration of the ionic crosslinker of each scaffold 
however can have stark effects on neural adhesion and morphology within the hydrogel 
scaffolds. For instance, “ultrasoft” alginate hydrogels, with sub-stoichiometric amounts of 
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calcium ion crosslinker, will allow for neurite extension in 3D scaffolds (Palazzolo et al., 
2015). Even on 2D alginate hydrogel substrates, neural attachment and extension are 
heavily dependent on lower overall calcium ion concentration and therefore the degree of 
crosslinking of the gel (Matyash et al., 2012, 2014).  
Even though mature neuronal networking is sometimes limited in unmodified 
alginate it has still been used as a platform for 3D neural induction protocols from mESCs 
(Li et al., 2011; Bozza et al., 2014), and hESCs & hiPSCs (Lu et al., 2012; Kim, Sachdev and 
Sidhu, 2013) and used as a scaffold in high throughput 3D hNSC toxicity arrays (Meli et al., 
2014). Neural induction efficiencies are reportedly higher in these 3D structures than direct 
terminal differentiation in suspension culture (Lu et al., 2012). It is telling however that cell 
aggregation and clustering are prominent in these 3D scaffolds and extensive networking 
beyond the boundaries of each cluster (despite having strong neural marker 
immunostaining) are infrequent, if present at all. Covalent functionalisation of alginate with 
full length-laminin or a laminin-derived binding peptide does seem to improve neural 
outgrowths of both hippocampal primary neurons and glial cell lines (Frampton et al., 
2011). A caveat may be the impressive cell densities in these constructs, which are much 
higher than those seen in other 3D scaffold studies. Other modified alginate constructs 
functionalised with an integrin-binding motif (Arginine-Glycine-Aspartate “RGD”) did show 
enhanced adhesion and differentiation of MSCs to neural lineages within the peptide-
modified alginate, but with cell seeding only after freeze-drying of the construct to 
generate anisotropic channels throughout the structure (Lee et al., 2015). 
 Chitosan is a deacetylated form of chitin; a polysaccharide found within the 
exoskeletons of crustaceans. Its high abundance and relatively low cost make it an 
appealing biomaterial for tissue engineering studies. However, primary cortical cells 
cultured in 3D chitosan hydrogels (with elastic moduli similar to that of brain tissue) will 
tend to maintain a rounded cell body and extend only a single neurite. The number of cells 
with neurites is increased when the chitosan is functionalised with poly-lysine (Crompton et 
al., 2007). Photo-crosslinkable methacrylamide chitosan (MAC) 3D scaffolds show poor 
induction of neuronal markers from rat NSCs even after functionalization with fibronectin-
derived binding motifs, but can be increased through the addition of soluble or immobilized 
interferon-gamma (IFN-γ). As with many alginate constructs, the morphological analysis of 
embedded neural cells via immunostaining for neuritogenesis is not overly convincing 
(Leipzig et al., 2011). This was also not improved by increasing the porosity of the scaffolds 
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by using mannitol crystals during crosslinking (Li, Wijekoon and Leipzig, 2012) or 
conjugation with perfluorocarbons to enhance oxygen release in the core of the gels (Li, 
Wijekoon and Leipzig, 2014). In both cases, NSCs displayed a rounded morphology lacking 
in prominent neurite extensions, even though neuronal markers were still present via 
immunocytochemistry. This leads to an almost counterintuitive conclusion, by which neural 
differentiation is still initiated in the cells throughout these scaffolds (leading to positive 
neuronal marker expression) but the cells themselves seem unable to generate extensive 
cell-cell connections outside of aggregates formed within the matrix, perhaps due to an 
intrinsic steric hindrance or lack of native adhesion moieties. 
 An intriguing solution to the lack of neurite outgrowth when neural progenitors are 
encapsulated in non-native matrices is the addition of protease cleavable peptides into the 
structure of a synthetic hydrogel (McKinnon, Kloxin and Anseth, 2013). mESC-derived 
motor neuron progenitors seeded in polyethylene glycol (PEG) hydrogels covalently 
crosslinked with matrix metalloproteinase (MMP) cleavable peptide sequences and 
functionalised with other binding epitopes (with moduli around 350Pa) showed robust 
neurite outgrowth and retained high cell viability, while stiffer moduli (>2kPa) induced 
almost uniform cell death. Scaffolds without the MMP-cleavable sequence showed no 
axonal outgrowth. This is a good demonstration that for 3D neural culture, simply having 
biomimetic binding motifs may not be enough to induce a true in vivo-like neuronal 
morphology and the ability for the cell to manipulate the surrounding matrix is integral to 
tissue-like recapitulation and development.  
This directed assembly of 3D growth cultures, rather than simple scaffold-based 
cell encapsulation, may be able to pre-form necessary cytoarchitecture relevant for 
particular areas of neural tissue modelling and in vivo-like recapitulation. Assembly of cell-
laden hydrogel “building blocks” already has precedent in the literature and can combine 
processes such as emulsification, photolithography, microfluidics, micromoulding, and 
bioprinting (Kachouie et al., 2010). As well as being able to accurately arrange cell types in 
3D environments it also allows the possibility of developing pseudo-vasculature in the 
derived 3D culture and perhaps even targeted delivery of trophic factors (Kang et al., 2016). 
A bio-printable scaffold material formulated from alginate, carboxymethyl-chitosan, and 
agarose has been demonstrated to support hiPSC-derived neural differentiation within in 
silico-designed construct architectures (Gu et al., 2017). Similarly, a hand-held bio-printing 
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technique with a peptide-functionalised gellan gum “bioink” has been able to recapitulate 
printed laminar structures representative of layered cortical tissue (Lozano et al., 2015). 
3D environments can also be generated from colloidal layering of cell-coated silica 
beads (45μm in diameter). Different neural subtypes attached to separate “pools” of beads 
will self-assemble into arrays when added into a growth chamber. In essence, each layer of 
beads can be tailored in composition to form highly controlled 3D arrangements, with 
functional synaptic connections measurable between multiple layers of cell-laden beads 
(Pautot, Wyart and Isacoff, 2008) that showed asynchronous patterns and differential burst 
firing timings than seen from basic 2D neural network formation (Frega et al., 2015). 
Taken all together, the array of biomaterials and fabrication technologies available 
for processing both 2D and 3D growth substrates for neural tissue engineering is vast (Fig 1-
6). Covering all aspects of intrinsic biomaterial properties, binding moieties, substrate 
stiffness, topographical patterning, and functionalisation; the ability to completely tailor in 
vitro environments for any conceivable aspect of neurological modelling and combine them 
with additive fabrication technologies, electrode arrays and microfluidic devices will be at 




1.8 Thesis Aims and Structure 
Modern neurological research into human neurodevelopmental and neurodegenerative 
pathologies has been revitalised with the advent of induced pluripotent stem cell 
technology. The generation of genomically-clean, patient-specific and developmentally 
representative neural models in vitro has broad promise for not only understanding brain 
development and dysfunction, but to also act as a foundation stone for full regenerative 
therapies and drug efficacy & toxicology studies.  
In addition to this, the rise of additive fabrication technologies such as 3D 
bioprinting within the biomedical field, holds great promise for generating more 
representative tissue-like constructs from an ever-increasing array of synthetic and 
biological materials.  
The ideal in vitro modelling system would therefore involve the combination of 
iPSC-derived neural cultures differentiated within tailored 3D matrices allowing for the 
Figure 1-6: Overview of the possible material and cellular components of in vitro 
iPSC-derived neural cultures. Growth material selection may be in two- or three-
dimensions and be of biological or synthetic sources. Modifications of materials can 
be through covalent functionalisation or the formation of composites, and can be 
processed into differing shapes and topographies. iPSC-derived neural cells can be 
patterned to specific subtypes and be combined with other neural cell lineages to 
develop brain-like architecture when combined with the 2D/3D scaffold materials. 
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development of a highly representative in vivo-like tissue constructs that contain specific 
neural cell subtypes from particular brain regions, in the appropriate cytoarchitecture, to 
create developmental- or disease-related network formations. 
For this holistic approach to modelling brain biology to work fully and faithfully “in-
the-dish”, each element of its construction must be assayed; to ensure reproducible and 
developmentally representative neural cell differentiation from iPSCs; and to develop the 
appropriate assays of biomaterials from which to build the 3D in vivo-like environments for 
the derived cell types to interact with and form native cellular architecture and function.  
Broadly speaking, this body of work will focus on achieving the following aims: 
 To assay an array of candidate biomaterials for use as the basis for three-
dimensional neural tissue scaffolds by focusing primarily on the biomolecular and 
biophysical responses that the matrices induce in embedded neural cells. 
 To generate forebrain-specific excitatory and inhibitory neural cell populations 
from human iPSCs. The development of both of these cell types in vitro is integral 
for modelling not only true human forebrain development but also as the basis for 
disease-specific modelling of forebrain-derived pathologies such as the epilepsies.  
 To compare the effect of iPSC-neural differentiation within the most promising 3D 
biomaterial candidate and to compare this to differentiation on 2D planar culture, 
in order to ascertain how differentiation strength, speed and efficiency is affected 
through 3D culture. 
 To determine the biomaterial characteristics that maintain potential for neural cell 
maturation and differentiation in vitro, but also allow for 3D bioprinting processes 
that would enable more complex neural tissue-model architecture to be formed, 
beyond the capability of currently available bioinks.  
 
Chapter 2 focuses on the development and assaying of candidate biomaterials for 3D 
neural cell culture using a neural cell-line as a proxy for hiPSC-derived neural cell cultures. 
The materials under investigation are alginate and collagen type I, both with and without 
the formation of composite gels with a Matrigel-equivalent ECM mix termed “ECL”. 
Alginate scaffolds with covalent peptide-functionalisation with matrix metalloproteinase 
(MMP) cleavable motifs and laminin-derived binding moieties are also generated and 
tested in parallel to unmodified scaffolds. The majority of assay techniques focus on 
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biomaterial properties through the lens of cellular responses, and therefore positive and 
negative results of each scaffold are based on; retention of cell viability, conduciveness to 
neurite extension and native morphology, gene & protein expression of differentiation-
associated markers, and comparisons to 2D differentiation benchmarks. 
 
Chapter 2 Hypotheses:  
1. The neuritogenic potential of embedded neural cells in unmodified alginate 
hydrogels is low in comparison to collagen scaffolds, and this morphological 
difference is reflected in neuronal gene and protein expression. 
2. Modification of alginate hydrogels with MMP-cleavable and laminin-binding 
peptide motifs will attenuate the morphologically restrictive nature of the 
hydrogel. 
3. Candidate biomaterials for neural tissue engineering can be assessed through 
changes in neural gene and protein expression in synergy with morphological 
assessment of neuritogenesis 
Chapter 2 Findings:  
 Using aqueous carbodiimide chemistry; double-ended MMP-cleavable and laminin-
binding peptide motifs can be covalently bonded to alginate polymers with high 
efficiency. 
 Collagen type I, alginate and peptide-modified alginate hydrogels all allow for high 
retention of metabolic activity/cell viability of encapsulated neural cells during scaffold 
gelation, as well as over the time course of neural differentiation. 
 Collagen type I hydrogels (both with and without ECM protein components) allow for 
neurite extension of encapsulated PC12 neural cells over the same time course as 2D 
planar differentiation.  
 Low concentration alginate hydrogels are non-conducive to neuritogenesis of 
encapsulated differentiating PC12 neural-like cells. This effect is not ameliorated by the 
addition of extracellular matrix proteins.  
 Peptide-modified alginate hydrogels also do not allow for neuritogenesis of 
encapsulated neural cells. 
 The canonical neuronal protein markers β-III-Tubulin and GAP43 increase in expression 
over the time course of neural differentiation in 2D and 3D culture. These increases do 
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not reflect the neuritogenic potential of the hydrogel scaffolds and are highly 
expressed in alginate and alginate-peptide scaffolds which restrict neurite formation. 
 Other neuronal protein markers MAP2, P-MAP2, NF-H, and NF-L do show stark 
differences in expression profiles during neural differentiation in the various 
biomaterial scaffolds. These markers therefore represent more reliable measures of 
neuritogenic potential of candidate biomaterials. 
 
Chapter 3 focuses on the development of differentiation strategies of human iPSCs into 
both excitatory and inhibitory forebrain neuronal cell populations using neural tube 
patterning factors in 2D. These distinct cell populations develop separately embryologically, 
but following pre-natal migration, form complete forebrain-cortical structures and 
networks. This chapter follows the molecular timings and comparisons between distinct 
neural developmental pathways from hiPSCs in vitro and tracks the timings of subtype 
development, loss of pluripotency, neuronal maturation markers, synaptic machinery, and 
neurotransmitter receptor apparatus. As well as biomolecular markers of maturation and 
development, this chapter also studies the functionality of the cells through assaying of 
intra- and extra-cellular electrophysiological recordings of derived neural cell types. By 
tracking the generation of these cell types in parallel will allow for the formation of more 
complete and representative forebrain/cortical models. 
 
Chapter 3 Hypotheses: 
1. hiPSCs can be efficiently differentiated into mature neural cells over 60 days of 
differentiation and display markers of subtype specificity, forebrain regionalisation, 
and pre- & post-synaptic machinery. 
2. Neural cell cultures can be efficiently patterned into dorsal (excitatory) and ventral 
(inhibitory) neuronal subtypes over a parallel time course. 
3. Both dorsal and ventral neural cultures mature at equivalent rates and display 






Chapter 3 Findings: 
 hiPSCs undergoing neural induction via dual-SMAD inhibition pathways generate NPCs 
with high efficiency over 7-14 days. 
 Further maturation of NPCs without exogenous signalling morphogens will derive 
neuronal cells with extensive neuritogenesis after 28 days of differentiation and both 
neuronal and glial-lineage cell types by Day 60 of maturation. 
 Neural cell cultures differentiated for 60 days will express markers of; cortical and 
forebrain localisation; excitatory glutamatergic neuronal subtype; pre- & post-synaptic 
components; and glutamate- & GABA-sensitive neurotransmitter subunits. 
 Ventral patterning of NPCs, through the use of a sonic hedgehog-pathway agonist, 
generates mature neurons of a predominantly inhibitory GABAergic cell type after 60 
days of differentiation and show heavily reduced cortical marker expression. 
 Ventral-patterned neural cells show slight enrichment of neuronal associated markers 
at the gene and protein level in comparison to the default (dorsal) induction pathway. 
 Both dorsally- and ventrally-patterned matured neuronal cells can fire an action 
potential under intracellular current stimulation. Multiple action potentials can be 
evoked from ventrally-patterned neuronal cells depending on the current stimulus 
level, demonstrative of a more mature phenotype than is seen in dorsally-patterned 
neurons. 
 Transient sodium and potassium currents are both present after stimulation of 
dorsally- and ventrally-derived neurons. Both current levels are higher in ventrally-
patterned cultures, indicative of a more mature ion channel composition phenotype. 
However, potassium currents in neurons from both patterning methodologies are low, 
showing an overall immature phenotype for all neurons assayed.  
 
Chapter 4 will combine the differentiation pathways outlined in Chapter 3 and compare 
them to iPSCs differentiated within the top candidate biomaterial scaffold determined from 
Chapter 2. This chapter will elucidate the morphology of iPSC-derived neural cells within 
the scaffold and determine the rate of maturation of the 3D neural cultures when directly 
comparing to differentiation in 2D planar culture, using gene expression profiling. This 
chapter will also ascertain whether scaffold composition has an influence on the 
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morphogen patterning of embedded NPCs (either positively or negatively) as this may be 
an important factor when generating mixed neural subtype-specific 3D scaffolds. 
 
Chapter 4 Hypotheses: 
1. Differentiation of hiPSC-derived neural cells within 3D collagen type I hydrogels will 
enhance the speed and strength of neuronal differentiation and maturation 
compared to 2D culture. 
2. The 3D hydrogel environment does not negatively impact the dorsal-ventral 
patterning of encapsulated hiPSC-derived NPCs during differentiation. 
 
Chapter 4 Findings: 
 hiPSC-derived NPCs differentiating within 3D collagen type I scaffolds undergo 
neuritogenesis in all three axes throughout the hydrogel over 60 days of 
differentiation. 
 3D encapsulated neural cultures express protein markers of post-mitotic neuronal 
generation as well as pre-synaptic machinery. 
 Enhanced NPC marker expression was seen within ventrally-patterned neural cells but 
not with dorsally-patterned neural cultures when encapsulated in 3D hydrogel 
environments. 
 3D Ventral cultures show early peak expression of neuronal and synaptic markers 
significantly above the levels of 2D cultures and 3D Dorsal neural cultures. 
 By later time points of differentiation: neuronal, axonal and synaptic marker expression 
are lower in 3D microenvironments than in 2D planar culture, suggesting an inhibition 
of maturation. 
 Excitatory and inhibitory neuronal subtype marker expression are preserved in 
dorsal/ventral patterning in 3D environments, but with lower levels of expression than 
is seen in planar differentiation. 
 Dorsal cortical localisation markers are observed in both 2D and 3D Dorsal neural 
cultures. In 3D scaffolds however, early-cortical markers (REELIN, TBR1) display 
expression profiles lower than in 2D differentiation, and late-cortical markers (CTIP2, 
SATB2) show enhanced expression relative to 2D Dorsal cultures. 
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 3D Ventral neural cultures show significantly high expression spikes of GABABR1, 
NMDAR1 and AMPAR1 neurotransmitter receptor subunits, not seen in 3D Dorsal 
differentiation. By later time points of maturation, these markers tend to show lower 
expression in 3D cultures compared to 2D differentiation. 
 Neuronal generation is not limited within 3D hydrogel scaffolds, but functional 
maturation does appear to be restricted under these experimental conditions.  
 Astrocytic gliogenesis is enhanced in 3D differentiation environments compared to 2D 
cultures.  
 
Chapter 5 will focus on aspects of bioprinting neural tissue and the biomaterial 
considerations that maintain positive neural differentiation and network formation, but 
balancing this with the constraints of developing bioinks that are conducive to additive 
fabrication technologies. Modifications and methodologies of printing neural tissue 
constructs from existing biomaterials utilised in Chapters 2 and 4 will be explored. 
 
Chapter 5 Hypotheses: 
1. Unmodified alginate or collagen hydrogel compositions will demonstrate low 
intrinsic bioprintability. 
2. Combining a pro-neuritogenic collagen-based “core” bioink and a structurally 
robust cytocompatible alginate “shell” bioink will allow for self-supporting coaxial 
bioprinting suitable for neural tissue-modelling. 
3. Segregation of the core and shell bioinks will be maintained under physiological 
conditions and maintain cell viability and neuritogenesis of encapsulated neural 
cells. 
 
Chapter 5 Findings: 
 Low concentration collagen and alginate hydrogel solutions show poor bioprinting 
traits. 
 Alginate and gelatin composite bioinks show differential printing characteristics heavily 
dependent on concentration and ratio to each other. A 3% alginate and 5% gelatin mix 
was found to have promising properties for a bio-printable material. 
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 Coaxial printing of a collagen-based core material designed to be amenable to neural 
cell differentiation, and an alginate-gelatin shell bioink surrounding the core adding to 
the structural integrity of the scaffold, was developed. 
 Core/shell separation was conserved throughout the printing process and could form 
two-layer in silico designed grid structures. 
 Acellular versions of the scaffold construct could be handled manually and maintained 
structural integrity after storage under physiological conditions. 
 Separation of core and shell biomaterial components was demonstrated through 
fluorescent-bead loading of the core material, which displayed continued core/shell 
separation after maintenance at 37⁰C. 
 Neural cell encapsulation and growth within the bioprinted core component of the 
coaxial scaffold demonstrated the retention of high cell viability by day four post-
printing. 
 Neuritogenesis was prevalent by day 7 of differentiation post-print within the coaxial 
scaffold. Demonstrating conduciveness to neural differentiation within the core 
collagen-based bioink.  
 
Chapter 6 is the final conclusion and discussion chapter pulling together analysis from all of 
the previous chapters and to frame the work in the context of the field as it currently 
stands. It will also contain speculations and recommendations for future directions of this 
research as well as possible inherent limitations. 
 
1.9 Notes on Usage 
Throughout the results chapters within this thesis, the plural form of personal pronouns 
(“we/our” rather than “I/my”) have been used as a stylistic preference to be more in line 







Chapter 2: Biomaterial Optimisation for 
Three-Dimensional Neural Culture 
 
2.1 Introduction 
For any in vitro modelling of human neurodevelopment to be successful, it is critical that 
the growth and assay conditions of neural cell cultures accurately reflect and recapitulate 
the in vivo environment as closely as possible. To this end, many studies have focused on 
developing three-dimensional (3D) growth environments for neural cell differentiation and 
culture rather than simple planar culture. The potential advantages of this approach 
include; greater degrees of cell-cell interaction; enhanced paracrine effects (owing to a 
more restrictive diffusion rate of secreted signalling molecules); increased cell-matrix 
interactions allowing for cell migration, cell aggregation & self-organisation within three-
dimensional space; and the responsiveness of differentiating neural cells to material moduli 
(and other biophysical properties) representative of native tissue (LaPlaca et al., 2010). 
 Scaffold matrices that allow for complete encapsulation of cells and are conducive 
to neurite extension, is a prerequisite to one of the most important facets of in vitro neural 
tissue engineering: that of active synaptic network formation. Candidate scaffold materials 
must be selected on the basis of not only being permissive to this morphological 
development of neural cells, but possibly its enhancement to a level not demonstrated in 
basic two-dimensional (2D) culture.  
 Hydrogels are 3D scaffolds generated from networks of hydrophilic polymer chains. 
When transitioning into their gelled form they can retain water content above 90% of their 
mass, and as such, are highly suited to model in vivo-like cellular microenvironments (Drury 
and Mooney, 2003). They have been used extensively throughout the literature as scaffolds 
for tissue engineering of multiple tissue types (Kachouie et al., 2010).  Many biological and 
non-biological polymers can be used to form neural tissue hydrogels (see Section 1.7.2), 
but this chapter will focus on two commonly used natural biomaterials; alginate and 
collagen type I.  
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Alginate (sodium alginate or alginic acid) is an anionic polysaccharide derived from 
brown algae that undergoes sol-gel transition through divalent cation crosslinking. Alginate 
hydrogels have been widely used for three-dimensional neural cell culture (Banerjee et al., 
2009; Frampton et al., 2011; Andersen, Auk-Emblem and Dornish, 2015) and as a key 
biomaterial in additive fabrication technologies such as bioprinting (Chung et al., 2013). The 
use of alginate scaffolds as a basis for three-dimensional neural differentiation from murine 
and human pluripotent stem cells also has precedence within the literature (Li et al., 2011; 
Lu et al., 2012; Kim, Sachdev and Sidhu, 2013; Kuo and Chang, 2013; Bozza et al., 2014), 
with differentiation efficiencies reportedly higher in these gels than parallel neural 
inductions in suspension culture (Lu et al., 2012). Although the baseline properties of 
unmodified alginate hydrogels have shown promising results in upregulating levels of 
neuronal markers in embedded neural stem cells (Banerjee et al., 2009; Meli et al., 2014), 
the ability for neural cells within alginate scaffolds to undergo extensive neuritogenesis is 
restricted without ultra-low concentrations of alginate within the hydrogel and sub-
stoichiometric amounts of the ionic crosslinker (Matyash et al., 2012, 2014; Palazzolo et al., 
2015).  
Greater success on this front has been reported either through covalent 
modification of the alginate itself or through the formation of composite gels containing 
blends of other biomaterials to help aid cell attachment and morphological development. 
For example; the enrichment of alginate hydrogels with fibronectin helped ameliorate the 
lack of encapsulated dorsal root ganglion (DRG) sprouting (Novikova et al., 2006) and 
composite alginate microbeads formed with gelatin (a hydrolysed product of collagen type 
I) showed a higher proliferative capacity of neural stem cells (NSCs) than that seen in 
standard suspension culture (Song et al., 2014).  
Rather than simple blending of hydrogel components to form enhanced scaffolds, 
covalent modification of alginate with peptide motifs designed from extracellular matrix 
attachment epitopes can add a biomimetic element to the hydrogels not present in the 
basic polysaccharide structure. The covalent addition of Arginine-Glycine-Aspartic Acid 
(RGD) cell adhesion ligands to the alginate backbone using aqueous carbodiimide chemistry 
was first shown by Rowley et al. as a way of promoting cell attachment to alginate hydrogel 
surfaces (Rowley, Madlambayan and Mooney, 1999). This type of functionalisation with the 
fibronectin-derived RGD ligand however, did not improve 3D neural culture of primary 
neurons or glial cell lines, whereas functionalisation with either full-length laminin or a 
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laminin-derived binding peptide did improve neural outgrowth in alginate hydrogels 
(Frampton et al., 2011).  
The presence of rounded-cell morphology and lack of cell spreading without 
modification of alginate hydrogel environments (or using ultra-soft under-crosslinked 
compositions) has been overcome by the addition of matrix metalloproteinase (MMP)-
cleavable motifs into the scaffold backbone for culture of mesenchymal stem cells  
(Fonseca et al., 2011). Showing that not only is cell attachment integral to successful 
interaction with the three-dimensional environment, but that local proteolysis and the 
ability for cells to remodel their surroundings is key to morphological changes and cell 
function. This is of course combined with the synergistic factors of  low hydrogel modulus, 
native binding epitopes, as well as overall porosity derived from limited dry mass 
composition and crosslinking conditions. This concept has also been successfully shown in 
3D motor neuron cultures, although through modification of a synthetic polyethylene 
glycol (PEG) scaffold, rather than an alginate-based one (McKinnon, Kloxin and Anseth, 
2013). 
Type I collagen (referred to herein as “collagen”) is a mammalian extracellular 
structural protein that can form in vitro hydrogel scaffolds. Collagen scaffolds have been 
widely used for tissue engineering purposes due to their innate cell adhesion properties, 
biocompatible nature and multiple hydrogel fabrication technologies (Antoine, Vlachos and 
Rylander, 2014). As with alginate, multiple studies have used collagen as the basis for 
three-dimensional neural tissue constructs (O’Connor et al., 2001; Sundararaghavan et al., 
2009).  Functionalisation with both fibronectin and laminin binding motifs, however, results 
in significantly higher neuronal marker expression in encapsulated dorsal root ganglion 
cells (Hosseinkhani et al., 2013) and covalent attachment of individual laminin subunits 
triggers an increase in cell survival of embedded neural stem cells (NSCs) (Nakaji-
Hirabayashi, Kato and Iwata, 2012).   
Although much has been done to individually assess and modify both alginate and 
collagen scaffolds, very little has been shown that directly compares the effect of each 
biomaterial on the biomolecular process of neural differentiation and to directly compare 
different subsets of biomaterial hydrogels to each other and to 2D culture. Positive results 
for marker expression data may not reflect adequate neuronal outgrowth or cell-cell 
contact generation, and conversely, the presence of neurite morphology may not 
56 
 
necessarily invoke molecular changes during differentiation to a higher degree than in 
planar culture.  
 The aims of this chapter are to contrast five candidate biomaterial hydrogels: 
alginate (Alg); alginate composites with a Matrigel equivalent, termed “ECL” (Alg + ECL); 
collagen (Coll); collagen composites with ECL (Coll + ECL); and a peptide-functionalised 
alginate (Alg-Pep) which contains both metalloproteinase-cleavable and laminin-binding 
motifs representative of native extracellular matrix. These three-dimensional hydrogel-
embedded neural cultures will ascertain which combination of functionalised or composite 
hydrogels elicit the strongest upregulation of differentiation markers and which allow the 
greatest degree of neurite extensions and in vivo-like morphology.     
To streamline this process, experimental work in this chapter will be undertaken 
using a pheochromocytoma (PC12) neural-like cell line as a proxy for human iPSC-derived 
neural cells. The ability of the PC12s to mirror morphological changes of differentiating 
neural cells as well as expression of neuronal markers is well documented (Ohuchi et al., 
2002; Das, Freudenrich and Mundy, 2004; Won et al., 2015). By using this cell line rather 
than iPSC-derived or primary neurons, a much more condensed, stable and higher-
throughput molecular analysis can be used to ascertain which hydrogel configuration and 
composition best supports neuronal cell differentiation and thus is the most promising for 
downstream hiPSC-based differentiation in three-dimensional scaffolds.  
 Other than basic material properties such as matching moduli to native tissues and 
gelation conditions, the focus of this chapter will be one devoted to that of the neural 
tissue outcome – namely; what are the effects of each biomaterial on these differentiating 
neural-like cells in relation to cell viability, cell morphology, and the expression of neural 








2.2 Materials and Methods 
2.2.1 Cell Culture 
Adherent PC12 cell cultures were maintained in a proliferation media composed of 
Dulbecco’s Modified Eagle Media (DMEM) (Lonza), 5% Foetal Bovine Serum (FBS) (Gibco), 
10% Horse Serum (Gibco), 2mM L-Glutamine (Gibco), 100U/ml Penicillin and 100μg/ml 
Streptomycin (Gibco). Cultures were incubated at 37⁰C and 5% CO2. Cells were passaged 
using a 0.025% Trypsin Dissociation Buffer for 5 minutes at 37⁰C before re-plating in growth 
media. Differentiation of PC12s was triggered using a differentiation media composed of 
DMEM (Lonza), 1% Horse Serum (Gibco), 2mM L-Glutamine (Gibco), 100U/ml Penicillin, 
100μg/ml Streptomycin (Gibco), and 50ng/ml Nerve Growth Factor (NGF) (Sigma). Over the 
course of differentiation, media was changed every 2 days. For expansion, cells were grown 
in 75cm2 tissue-culture coated flasks, whereas for 2-dimensional differentiation 
experiments; PC12s were grown on Collagen I pre-coated 75cm2 culture flasks (Corning). 
After differentiation, cells were harvested using the dissociation procedure described 
above and pelleted by centrifugation. Cell pellets were stored at -80⁰C prior to molecular 
analyses.  
 
2.2.2 Preparation of 3D Scaffolds 
PC12s were harvested (as described above) from growth flasks at 37⁰C for 5 minutes. Cell 
counts were performed using trypan blue (Thermo Fisher Scientific) staining and quantified 
using a haemocytometer. The cell density for each cell-laden hydrogel was 1x106 cells/ml.  
Alginate hydrogel scaffolds were formed in sterile de-ionised water at a final 
concentration of 0.5% (w/v) Sodium Alginate (Sigma), 1x HEPES Buffer pH 7.4 (20mM 
HEPES [Sigma], 150mM NaCl [Sigma]), 15mM CaCO3 (Sigma), and 30mM Gluconolactone 
(Sigma). Scaffolds with ECL (“+ECL”) contained a final concentration of 0.05mg/ml ECL Cell 
Attachment Matrix (Millipore). All components listed above were mixed by pipetting prior 
to cell addition. The 1:2 CaCO3:Gluconolactone molarity ratio ensures a balanced end pH 
but triggers the solubility of CaCO3. 200μl of the hydrogel solution was added per well of a 
48-well tissue culture plate to form each scaffold. Scaffolds underwent gelation at 37⁰C for 
15 minutes before addition of 0.5ml differentiation media per well. For peptide-
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functionalised alginate (Alg-Pep) hydrogel scaffolds the process of formation was the same 
but final concentration of alginate solutions was split 1:1 between the MMP-modified 
alginate (0.25% w/v final) and the Laminin-modified alginate (0.25% w/v final) creating an 
overall 0.5% (w/v) alginate concentration with an even mixture of each alginate-peptide 
type. The process of functionalisation and characterisation of peptide modified alginate is 
outlined in sections 2.2.9 and 2.3.1.  
Collagen hydrogel scaffolds were formed in sterile de-ionised water at a final 
concentration of 0.4mg/ml Collagen Type I from Rat Tail (Corning). Collagen hydrogel 
gelation was triggered with the addition of 0.23x of the added collagen volume of 0.1M 
NaOH (Sigma), and 1x HEPES Buffer pH 7.4 (20mM HEPES [Sigma], 150mM NaCl [Sigma]) 
before mixing with cells. Scaffolds with ECL (“+ECL”) contained a final concentration of 
0.05mg/ml ECL Cell Attachment Matrix (Millipore). Collagen and NaOH working volumes 
were mixed (to trigger neutralisation) prior to addition to buffered cell suspensions. 200μl 
of the hydrogel solution was added per well of a 48-well tissue culture plate to form each 
scaffold. Scaffolds underwent gelation at 37⁰C for 30 minutes before the addition of 0.5ml 
differentiation media per well.  Approximately 70% of media volume was exchanged every 
two days over the time course of differentiation for all hydrogel types.  
 
2.2.3 Scaffold Digestion and Cell Retrieval 
Cells from 3D differentiation experiments were harvested at Day 1, 3 and 7 for molecular 
analyses. Media was removed from alginate scaffold wells and the scaffold was de-gelled 
with the addition of 50mM Sodium Citrate (Sigma) in 1x Hank’s Buffered Saline Solution 
(HBSS) (Gibco). Scaffolds were left at 37⁰C for 15 minutes prior to trituration and transfer 
to centrifugation tubes. For Collagen-based scaffolds, differentiation media was exchanged 
for 0.5ml DMEM containing 0.05mg/ml Collagenase Type 1 (>125U/mg, Worthington 
Biochemical Corporation) per well. Scaffold digestion took place at 37⁰C for 45 minutes 
prior to trituration and centrifugation of cell pellets. Cells from four scaffolds were pooled 






2.2.4 Metabolic Activity and Cell Viability 
Cell viability in 3D cultures was determined with an AlamarBlue (Thermo Fisher Scientific) 
metabolic assay. 50μl of AlamarBlue was added into each scaffold-well which contained 
0.5ml of differentiation media. Experimental plates were incubated for 4 hours at 37⁰C. 
200μl aliquots were removed from each well and transferred to opaque 96-well assay 
plates (Corning/Sigma). Fluorescence readings were measured on a FLUOstar Galaxy Plate 
Reader (BMG) with an excitation wavelength of 550nm and an emission filter of 590nm. 
Each time point was averaged from scaffold triplicates, and each triplicate from 4 biological 
repeats. Statistical analysis was completed using GraphPad Prism software (version 5). For 
intra-scaffold data, a one way-ANOVA with Tukey’s post-hoc test was used to ascertain 
statistical significance between time points. For inter-scaffold data, a two-way ANOVA with 
Bonferroni post-test was used to determine statistical significance between scaffold types 
at each time point.  
 
2.2.5 Western Blot Assay 
Cell pellets were resuspended in 100-200μl of M-PER Mammalian Protein Extraction 
Reagent (Thermo Fisher Scientific) and mixed gently at room temperature for 10 minutes. 
After centrifugation at 10,000xg for 15 minutes the supernatants were transferred to new 
1.7ml microfuge tubes and stored at -80⁰C until needed for downstream assays.  
A colourmetric Bradford assay was used for total protein quantification, calibrated 
against a Bovine Serum Albumin (BSA) (Sigma) standard curve. 2μl of each protein sample 
was utilised for protein quantification together with 200μl of 1:5 diluted Bradford Reagent 
(Bio-Rad). Absorbance readings at 590nm were measured on a FLUOstar Galaxy plate 
reader (BMG).  
For SDS-PAGE; protein samples were denatured at 70⁰C for 10 minutes in the 
presence of NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) and NuPAGE Sample 
Reducing Agent (Thermo Fisher Scientific). Protein samples were separated on BOLT 4-12% 
Bis-Tris Gels (Thermo Fisher Scientific) at 150V for 45 minutes. Molecular weight estimation 
was achieved with parallel loading of Precision Plus Protein Kaleidoscope Prestained 
Protein Standards (Bio-Rad). Protein lanes were transferred on to nitrocellulose 
membranes (GE Healthcare Life Sciences) using Semi-Dry Transfer (Bio-Rad) at 20V for 70 
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minutes in Bjerrum Schafer-Nielsen buffer (48mM Tris, 39mM glycine, 1.3mM SDS, 20% 
Methanol). Successful protein transfer was confirmed with Ponceau S stain (0.1% w/v) in 
acetic acid, and de-stained through washing in Tris buffered saline (TBS) with 0.05% Tween-
20 (TBST) (50mM Tris, 150mM NaCl, pH 7.6). Membranes were blocked for 1 hour at room 
temperature in either 5% (w/v) low fat milk powder in TBST or 5% (w/v) BSA in TBST. 
Membranes were incubated with primary antibodies overnight in the block solution at 4⁰C 
on a plate rocker: anti-TUJ1 (Covance MMS-435P, 1:2000), anti-GAP43 (Millipore AB5220), 
anti-MAP2 (Cell Signaling Technology #4542, 1:2000), anti-Phospho-MAP2-Ser136 (Cell 
Signaling Technology #4541, 1:2000), anti-neurofilament-H (Cell Signaling Technology 
#2836, 1:2000), anti-neurofilament-L (Cell Signaling Technology #2837, 1:2000) & anti-
GAPDH (Cell Signaling Technology #5174, 1:5000). Membranes were washed three times in 
TBST prior to addition of secondary antibodies. Membranes were incubated with secondary 
antibodies in block solution for 1 hour at room temperature on a plate rocker: Goat-anti-
Mouse-HRP (Millipore, 1:10,000), Goat-anti-Rabbit-HRP (Millipore, 1:10,000). Membranes 
were washed a further three times in TBST and once in TBS prior to chemiluminescent 
detection. Imaging of protein bands on membranes was achieved on a ChemiDoc MP 
system (Bio-Rad) after incubation with Western Lightning® Ultra chemiluminescence 
substrate (Perkin Elmer). For semi-quantitative analysis of protein expression, band 
intensities were recorded using ImageJ software (NIH). Protein bands of interest were 
calculated relative to the housekeeping gene band intensity in each lane. Statistical analysis 
was performed using two-way ANOVA and Bonferroni post-tests in GraphPad Prism 
software (Version 5). Data is shown ± standard error of the mean with significance denoted 
when the p-value ≤0.05. Three biological repeats were completed for each scaffold-type at 
each time point.  
 
2.2.6 Gene Expression 
Relative gene expression analysis was performed using quantitative polymerase chain 
reaction (qPCR) methodology. Firstly, RNA was purified from frozen cell pellet samples 
using the RNeasy Plus Mini Kit (Qiagen) as per the manufacturer’s instructions into a total 
elution volume of 50μl nuclease free water. RNA concentration was determined using an 
Ultraspec 2200 Pro Spectrophotometer (GE Healthcare Life Sciences) and RNA integrity was 
confirmed by running samples on a 1% Agarose (w/v)-EtBR TAE gel under electrophoretic 
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conditions for 40 minutes at 80V followed by imaging on a ChemiDoc MP (Bio-Rad) to show 
sharp ribosomal RNA banding. 
 cDNA was generated from 1μg of each RNA using the Omniscript Reverse 
Transcription Kit (Qiagen) with 1μM oligo dTs (Qiagen) and 1U/ml RNase Inhibitor (Qiagen). 
Reverse transcription reactions took place at 37⁰C for 80 minutes in a 20μl reaction 
volume. On completion of the reaction, samples were further diluted with 20μl of nuclease 
free water (Integrated DNA Technologies). cDNA samples were stored at -20⁰C until used in 
qPCR reactions.  
 
  
qPCR analyses were completed as duplex reactions using TaqMan Gene Expression 
Master Mix (Applied Biosystems) in 10μl reaction volumes. The TaqMan assay probes used 
are listed in Table 2-1. Reactions were run on a RealPlex Mastercycler (Eppendorf) with the 
following parameters: 50⁰C for 2 minutes, 95⁰C for 10 minutes, followed by 40 cycles of 
95⁰C for 15 seconds and 60⁰C for 1 minute. Data were analysed by the ΔΔCt method in 
Microsoft Excel and statistical analyses performed in GraphPad Prism (Version 5) using two-
way ANOVA with Bonferroni post-test analysis. Data is shown ± standard error of the mean 
with significance denoted when the p-value ≤0.05. Three biological repeats were 
completed for each scaffold-type at each time point.  
 
2.2.7 Rheological Measurements 
Storage moduli were measured using an Anton Paar MCR 702 TwinDrive rheometer with a 
25mm-diameter 2⁰-angle measuring cone (Anton Paar, #79039). 170μl of each scaffold 
Table 2-1: List of TaqMan assay probes used in PC12 gene expression analyses 
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solution was used in each measurement. Crosslinking was monitored during 1Hz 
oscillations and 1% strain at 37⁰C. Final storage moduli were calculated from when the rate 
of change of the moduli reached plateau. Rheological data is presented as mean ± standard 
error of the mean from three separate experiments. Statistical significance was calculated 
in GraphPad Prism software using one-way ANOVA with Tukey’s post-test.  
 
2.2.8 Live Cell and Immunofluorescence Microscopy 
Live cell images were taken on an EVOS XL Core Cell Imaging System (Thermo Fisher 
Scientific) and processed on ImageJ software (NIH). 
Three-dimensional scaffolds for immunocytochemistry were fixed for 1 hour at 
room temperature in 10% neutral-buffered formalin solution (Sigma) and permeabilised for 
1 hour at room temperature in 0.5% Triton-X-100 (Sigma) in phosphate buffered saline 
(PBS) (137mM NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4). Samples were blocked 
overnight at 4⁰C in 5% goat or donkey serum (Millipore) in PBS before incubation with 
primary antibodies (also in block solution) overnight at room temperature; anti-TUJ1 
(Covance MMS-435P, 1:1000). Constructs were washed three times for 1 hour each in PBS 
before addition of secondary antibodies; goat-anti-mouse IgG AF488 (Invitrogen A11029, 
1:2000) in block solution overnight at room temperature. Constructs were washed three 
more times in PBS before addition of DAPI (Sigma) for 1 hour, for cell nuclei visualisation. 
For phalloidin staining (Texas Red-X Phalloidin, Thermo Fisher Scientific), constructs 
were fixed and permeabilised as described above. A working concentration of phalloidin 
stain was made at 1:100 dilution with PBS. Constructs were incubated with the stain 
overnight at 4⁰C, before an overnight wash in PBS at 4⁰C.  
Image acquisition was performed using a Nikon Ti Eclipse microscope equipped 
with a fully automated A1 confocal laser (A1R, Nikon) and processed with NIS-Elements 
software (Nikon, version 4.20).  
 
2.2.9 Synthetic Peptide Functionalisation 
100mg of each crude peptide extract (>30% purity) (Wuxi Nordisk Biotech) were purified 
using reversed-phase High-Performance Liquid Chromatography (HPLC) and confirmed 
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using Ninhydrin stain (Sigma) and Mass Spectroscopy (see appendix 2.5.1). The purified 
MMP-peptide (with sequence GGYGPVGLIGGK) and the Laminin-peptide (with sequence 
GGSDPGYIGSRGGK) were then lyophilized and stored at -20⁰C prior to use.  
 A 1% (w/v) alginate solution (Sigma) was formed in a 2-(N-morpholino) 
ethanesulfonic acid buffer (MES buffer) (0.1M MES [Sigma], 0.3M NaCl [Sigma], pH 6.5); 
buffer conditions outlined in previous peptide carbodiimide-based functionalisation 
protocols (Fonseca et al., 2011; Ferris et al., 2015). Under stirring conditions, the reaction 
components N-Hydroxysulfosuccinimide (Sulfo-NHS, Sigma) and N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, Sigma) were added to the 
MES buffered alginate at a ratio of 31.1mg/g alginate and 27.4mg/g alginate respectively. 
This resulted in a molarity ratio of 1:2 sulfo-NHS:EDC. The solution was mixed at room 
temperature for 15 minutes prior to the addition of either the MMP- or Laminin-peptide at 
a ratio of 10mg/g alginate. The mixture was further stirred for 20 hours at room 
temperature. The reaction was quenched with the addition of hydroxylamine (Sigma) at a 
final concentration of 5mM for 10 minutes. Unreacted peptide species were removed from 
the reaction mix during dialysis for 4 days at room temperature using Spectra/Por 3 Dialysis 
Membranes (MW3500, Spectrum Laboratories). Peptide-functionalised alginates were then 
lyophilized and stored at -20⁰C until use in quantification analysis and hydrogel formation.  
 Quantification of the degree of peptide functionalisation utilised UV-Vis 
absorbance of the tyrosine (Y) residues within each peptide sequence. A standard curve 
was generated using a 2% (w/v) alginate solution in deionised water with standard dilutions 
of 2.5 or 2mg/ml, 1mg/ml, 0.5mg/ml, 0.25mg/ml, and 0.0625mg/ml of each purified 
peptide. Absorbance was measured from 210nm to 300nm on an Ultraspec 2200 Pro 
Spectrophotometer (GE Healthcare Life Sciences) with base alginate as the blanking 
solution. Peptide-functionalised alginates were also formed in 2% (w/v) solutions for 
absorbance assays. The peak absorbances at 275nm of the standard curve peptides 
allowed for a linear regression model to be generated in GraphPad Prism software, and 
peptide-crosslinking efficiency was calculated from this model. 







2.3.1 Generation of Peptide-Functionalised Alginate  
The array of both positive and negative results of unmodified alginate as a hydrogel 
scaffold for neural tissue engineering throughout the literature prompted the generation of 
a novel functionalised version of the biomaterial for direct experimental comparisons. The 
functionalisation outlined here utilised double-ended covalent binding of peptide motifs 
using aqueous carbodiimide chemistry. Two separate peptide motifs were generated, one 
containing an MMP-cleavable moiety (termed “MMP-peptide”) and the other around a 
laminin-derived binding epitope (termed “Laminin-peptide”) (Fig 2-1). Each peptide was 
crosslinked to the alginate backbone through both the peptide’s N-terminal amine group 




Fig 2-1: Chemical structure and amino acid sequence of the peptides used to 
functionalise alginate hydrogels. The MMP-peptide contains a metalloproteinase 
cleavable sequence (PVGLIG). The laminin-peptide contains a laminin-derived cell 
adhesion moiety (SDPGYIGSR). Both peptides have C-terminal lysine (K) residues 
(shown in green) for amine cross-linking to the alginate chains allowing for both N- 
and C-terminal covalent bonding. The aromatic tyrosine residues (Y, orange) allow 
for UV-Vis absorbance and quantification of peptide crosslinking efficiency. 
65 
 
The formation of chemical crosslinking events therefore utilised the carboxyl side chains of 
alginate polymers and the terminal amine groups of the synthetic peptides.  
Peptides were also designed with an internal aromatic side chain-containing amino 
acid; tyrosine (Y). In the MMP-peptide this was added within a glycine spacer region to 
keep it separate from the MMP-cleavable domain, whereas in the laminin-peptide the 
tyrosine residue is a native component of the binding moiety.   
 The tyrosine residue allows for a UV-Vis absorption at approximately 280nm due to 
the aromatic side chain. As a single tyrosine residue is contained within each peptide, this 
then acts as a strong linear marker of peptide crosslinking and therefore of reaction 
efficiency. Absorbance spectra of each peptide of differing concentrations and mixed 
within alginate solutions showed both the absorbance at 230nm derived from peptide 
bond absorbance and at 270-280nm derived from the tyrosine-specific absorbance (Fig2-2 
A). 
 
Fig 2-2: (A) Absorbance spectra of each peptide by which to derive concentration 
standard curves. Peaks around 230nm represent peptide bond absorbance. Peaks 
around 275nm represent Tyrosine side-chain specific absorbance. (B) Standard 
curves of peptide absorbance at 275nm for each peptide. Linear regression analysis 




Plotting of each peptide concentration with absorbance at 275nm (the wavelength 
at which peak absorbance was seen) showed a strong linear relationship between 
absorbance and peptide concentration (Fig 2-2 B) with coefficient of determination (R2) 
values calculated as 0.9995 and 0.9971 for the MMP-peptide curve and laminin-peptide 
curve respectively. 
From this, the degree of peptide functionalisation after aqueous carbodiimide 
crosslinking was ascertained. For the MMP-peptide the covalent attachment conditions 
resulted in a degree of functionalisation of 4.05mg of peptide per 1g of alginate. This 
equates to a crosslinking reaction efficiency of 40.5% (Table 2-2). For the laminin-peptide 
the carbodiimide-derived crosslinking resulted in functionalisation of 4.68mg of peptide per 
1g of alginate (Table 2-2). This had a slightly higher reaction efficiency than that of the 
MMP-peptide, with a calculated 46.8% crosslinking efficiency. 
 
 
 As well as determining mass-based figures of the crosslinking process, the overall 
molarity of each peptide that would be present in the final hydrogel scaffold was 
determined. The peptide modified alginate hydrogel scaffold (herein referred to as Alg-
Pep) used in future cell experiments was formed by combining in equal measure each of 
the MMP- and Laminin-alginates, generating a hydrogel solution with both cell attachment 
and cell degradable motifs to ensure the greatest potential for positive neural cell 
interaction with the hydrogel scaffold. Therefore, the peptide molarities listed in Table 2-2 
represent the concentration of each of the peptides in the final hydrogel solution.  
 
Table 2-2: Measures of peptide functionalisation of alginate following carbodiimide 
crosslinking of each peptide. Peptide molarity is based on the final 0.25% (w/v) of 
each modified alginate in final hydrogel scaffolds. Functionalisation degree is shown 
in milligrams of peptide per gram of alginate. Reaction efficiency is a measure of 




2.3.2 Modulus Testing of Candidate Neural Scaffold Materials 
The effect of hydrogel modulus can elicit stark morphological and biomolecular changes of 
attached or embedded neural cells and their precursors. Higher levels of neural 
differentiation have been recorded within hydrogels that have degrees of stiffness similar 
to those of native brain tissue (<1kPa) (Banerjee et al., 2009). To ascertain whether each 
hydrogel composition had comparable storage moduli, rheological measurements of each 










The obtained storage moduli for all hydrogels were all below 60Pa, and therefore 
well within the limits of other neural hydrogel models with stiffness equivalent to brain 
tissue modulus estimates (<1kPa). Alginate scaffolds showed the highest storage modulus 
of 58.1Pa, which was reduced in composite gels containing the Matrigel equivalent cell 
attachment matrix (ECL) to 43.2Pa. This decrease reached statistical significance, showing a 
Fig 2-3: Rheological measurements of the candidate biomaterials for 3D in vitro neural 
tissue engineering. Alg, alginate; Alg + ECL, alginate composite with ECL; Coll, collagen 
type I; Coll + ECL, collagen type I composite with ECL; Alg-Pep, peptide-modified 
alginate. Data shown as mean ± standard error of the mean. Statistical significance is 
displayed relative to; Alg (*), Alg + ECL (#), and Coll (α). *,α p≤0.05, ***,###p≤0.001 
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consistent negative impact on hydrogel stiffness in alginate gels when formed with ECM-
derived protein mixtures. In contrast, collagen scaffolds showed much lower storage 
moduli than either of the alginate composite hydrogels, with measurements of 3.1Pa. 
Conversely, collagen when blended with the ECL protein mixture showed a slight increase 
in scaffold modulus to 4Pa. Both of the collagen scaffolds showed significantly lower 
material stiffness when compared to both the alginate and composite alginate scaffolds.  
The peptide modified alginate hydrogel (Alg-Pep) displayed an intermediate 
storage modulus, between the alginate and collagen constructs, of 15.4Pa. This drop in 
hydrogel stiffness following the carbodiimide-based peptide-crosslinking chemistry is not 
unexpected as the peptide conjugation reaction does exploit carboxylic acid groups on the 
polysaccharide molecule which otherwise would be utilised in the divalent cation 
crosslinking process. The recorded storage modulus of the Alg-Pep hydrogels was 
significantly lower than both alginate and alginate composite scaffolds, and significantly 
higher than the base collagen hydrogel. 
 
2.3.3 Metabolic Activity and Viability of Neural Cells within 3D 
Scaffolds 
To ascertain whether candidate biomaterials have a negative impact upon encapsulated 
cell survival both during the process of gelation and throughout cell culture is a key 
assessment of the suitability of each material to form in vitro tissue-like constructs.  
 PC12 cells fully encapsulated in each of the biomaterials were assayed for cell 
viability during the first 7 days of differentiation. Cell viability assays that rely on the 
assessment of individual cell survival using multiple fluorescent dyes and microscopy 
techniques are powerful tools in two-dimensional culture but become more difficult when 
assaying cells encapsulated within three-dimensional hydrogels, especially with 
epifluorescent microscopy techniques. Inherent biases in field selection, dye diffusion and 
background fluorescence from differing field depths make quantifiable viability assays 
difficult in three-dimensional constructs. To this end, this viability assay is based on 
metabolic activity across the whole construct as a proxy for measuring quantifiable cell 
survival and comparisons across each hydrogel scaffold type without such biases. 
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 The AlamarBlue viability assay was undertaken for all cell-laden hydrogel scaffolds 
on the day of gelation (Day 0), and Day 1, Day 3 and Day 7 post gelation. Experiments to 
ensure that no acellular hydrogel interference of the assay were also performed (data not 
shown). No statistically significant differences in cell metabolic activity (viability) were 
detected between the scaffold types after the initial gelation procedures on Day 0. This was 
mirrored by the finding at Day 7, which also showed comparable viability levels between all 
of the tested constructs (Fig 2-4 A).  
  
Fig 2-4: Metabolic activity/viability assays of PC12s encapsulated within each 
hydrogel scaffold over 7 days of differentiation. (A) Inter-scaffold analysis of cell 
viability over the time course. (B) Intra-scaffold analysis of cell viability over the 
time course. Data shown as mean ± standard error of the mean. Statistical 




The only differences in metabolic output (as a measure of cell viability) between 
the hydrogel subtypes that reached statistical significance was between 3D Alg and 3D Alg-
Pep constructs at Day 1 and 3D Alg + ECL and 3D Alg-Pep constructs at Day 3. In both cases 
the cell viability in the peptide modified hydrogel was lower than that of the base alginate 
and composite alginate scaffolds. All other viability measurements at Day 1 and 3 were 
comparable between all of the construct subtypes. 
 When looking at cell viability within the same scaffold type over the time course of 
differentiation, it is clear that metabolic activity increases to a statistically significant 
degree, showing that measured cell viability is not only maintained during the experimental 
timeline, but also significantly increases in all cases (Fig 2-4 B).  
 From these data, it can be demonstrated that all of the candidate hydrogel 
materials maintain comparable cell survival during each gelation protocol and that cell 
survival, proliferation, and metabolic activity increases during the process of cellular 
differentiation to the same degree by the end of the experimental timeline. 
 
2.3.4 Morphological Analysis of Encapsulated Neural Cells 
The success of biomaterials for use in in vitro neural tissue engineering is not only based on 
maintenance of cell viability, but also its conduciveness to allow for morphological changes 
such as neurite extension, cell migration and the formation of functional cell-cell contacts 
such as synapses.  
Successful candidate biomaterials for three-dimensional neural tissue engineering 
should have the properties that promote equivalent cell morphology and neurite extension 
attained in planar culture, as well as be representative of those seen in native neural tissue. 
PC12s differentiated in two-dimensional culture over 7 days displayed strong 
morphological changes and extensive neurite extensions increasing in length and density 
over this time course (Fig 2-5). Rounded cell morphology is observed during the growth 
phase of PC12 culture (Day 0), but after the addition of differentiation triggering media 
PC12s rapidly undergo neuritogenesis that is visible by Day 1 with large widespread 





Live cell imaging of PC12s encapsulated in the base and composite (+ECL) hydrogel 
scaffolds after differentiation showed stark contrasts between the alginate- and collagen-
based scaffolds. After 7 days of differentiation within alginate hydrogels no neurite 
extensions were seen with any of the encapsulated cells, instead, round cell clusters were 
formed within the hydrogel that appear isolated from one another (Fig 2-6 A). This 
formation of cell aggregates without neurite extensions was also seen in the alginate 
composite blended scaffolds containing the ECL protein additive. In contrast, PC12s 
encapsulated within collagen matrices tended to show less cell clustering than cells within 
the alginate hydrogels and also allowed for the formation of neurite extensions into the 
hydrogel scaffold (Fig 2-6 A, white arrow heads). This same pattern of cell growth was also 
seen in the collagen composite scaffolds containing ECL.  
Fig 2-5: Live cell imaging of PC12s differentiating over 7 days in two-dimensional 
planar culture. Cell spreading and extensive neurite extensions increase during 
the differentiation process from very rounded cells at Day 0 to a strong neuronal 




This stark contrast in cellular morphology was also observed when investigated 
using fluorescent immunohistochemistry and confocal microscopy. β-III-Tubulin 
immunostaining of cells within alginate constructs showed tightly clustered multi-nuclear 
cell clusters, that although showed expression of this neuronal marker, did not display 
neurite extensions. This morphology was also seen after phalloidin staining, which binds 
strongly to filamentous actin (F-actin) fibres. Within the alginate hydrogels, PC12s displayed 
a strong punctate phalloidin staining pattern at the plasma membrane of the cell showing 
the presence of F-actin, but none that indicate neurite extension or cell morphology 
changes beyond the rounded morphology seen in bright field images (Fig 2-6 B).   
PC12s differentiated within collagen-based hydrogels displayed pronounced 
morphological changes with less rounded cell morphology and highly prevalent neurite 
extensions into the hydrogel matrix after 7 days of differentiation (Fig 2-6 B, white and 
black arrow heads).  β-III-Tubulin immunostaining and phalloidin staining of PC12s within 
collagen scaffolds again demonstrated a strong expression of the neuronal marker protein 
that displayed neurite extensions in all three axes of the hydrogel. The phalloidin stain 
showed a less punctate form than was seen in alginate-embedded PC12s, and a more 
continuous formation of F-actin around the cell body and within the numerous neurite 




Fig 2-6: (A) Live cell images of PC12s in alginate (Alg) and Collagen (Coll) scaffolds after 7 
days of differentiation, both with and without ECL addition. Scale bars represent 
100μm. (B) Bright field and confocal images of PC12s embedded in alginate and collagen 
hydrogels for 7 days with β-III-Tubulin (green), phalloidin (red) and DAPI (blue) 
fluorescent staining. The right-most panel displays z-depth colour coding of the neural 
cells and neurite extensions. Bright field scale bar represents 50μm. Confocal images are 




 The above data shows that the simple blended alginate hydrogels with extracellular 
matrix components were insufficient to overcome the inert nature of alginate hydrogels to 
induce a true in vivo-like neuronal morphology as in planar culture and in the 3D collagen 
scaffolds.  
 Using live cell imaging, direct comparisons of cellular morphology between PC12s 
encapsulated in alginate scaffolds and those in the peptide modified alginate (Alg-Pep) 
revealed similar levels of cell clustering and rounded cell morphology (Fig 2-7 A). The cell 
clustering within alginate and peptide-functionalised alginate was more apparent under 
fluorescent immunohistochemical staining of the neuronal marker β-III-Tubulin (Fig 2-7 B). 
Even with this degree of hydrogel modification no qualitative difference could be observed 
between PC12s encapsulated in the base hydrogel relative to the alginate scaffold 
containing MMP-cleavable and cell-adhesion moieties.  
 
 Although no gross cellular morphological changes could be seen between these 
two scaffold types, it is worthy of note that some clusters within the functionalised alginate 
Fig 2-7: (A) Live cell imaging of PC12s encapsulated in alginate (Alg) and peptide-
modified alginate (Alg-Pep) hydrogels after 7 days of differentiation. Scale bars 
represent 50μm. (B) Fluorescent immunostaining of β-III-Tubulin (green) and DAPI 
(blue) of PC12s encapsulated in each of the hydrogels after 7 days of 
differentiation. Scale bars represent 50μm. BF; Bright Field. 
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scaffold did show a halo-like effect around the cluster of cells with punctate structures 
visible in the hydrogel, that were seen in a lesser degree in the base alginate hydrogels (Fig 
2-7 A). The presence of these elements appeared stochastically and were not accompanied 
with evidence of neuritogenesis, however, this phenomenon may be indicative of local 
proteolysis or ostensibly an enhanced cellular interaction with the peptide-modified 
alginate hydrogel. 
 
2.3.5 Protein Analysis of Differentiating Neural Cells in Three-
Dimensional Scaffolds 
As well as morphological changes of cells within hydrogel scaffolds during neural 
differentiation; neuronal protein markers have been used to ascertain and quantify the 
strength, speed and efficacy of neural differentiation protocols and can be directly 
compared between two- and three-dimensional neural cell culture. 
 As the morphological differences were so stark between the subsets of three-
dimensional scaffolds it was reasonable to assume that these differences would be 
reflected in molecular analyses of the PC12s during differentiation and allow for a more 
directly quantifiable system of elucidating the biomaterials most conducive to neuronal 
differentiation and directly compare this to planar differentiation.  
 When looking at the canonical neuronal markers β-III-Tubulin and Growth 
Associated Protein 43 (GAP43) from PC12s differentiated in two-dimensional culture over 
the course of 7-days, the relative amounts of these proteins mirrored the morphological 
changes induced within the cells and increased over time (Fig 2-8). It was also noticeable 
that a baseline constitutive expression of these markers could be seen within PC12s 
(expression at Day 0) even without induced differentiation and while still in a proliferative 
state (Fig 2-8). Surprisingly, this same pattern was seen in all five hydrogel scaffold 
formulations over the course of differentiation. Intriguingly, the level of expression within 
the alginate-based scaffolds was higher than that of the collagen hydrogels, showing 
upregulation of these proteins does not necessarily follow that of morphological changes 
and neuritogenesis, and instead are triggered via the induction of differentiation even in a 
sterically restrictive biomaterial scaffold.           
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Semi-quantitative analysis of the protein levels for these markers revealed strong 
differences between the differentiation of PC12s in planar culture and those differentiated 
in each of the hydrogel subtypes. β-III-Tubulin protein levels in PC12s from both alginate 
and alginate + ECL scaffolds showed a statistically significant increase in expression in 
comparison to two-dimensional planar differentiation and differentiation within collagen 
scaffolds by Day 1 (Fig 2-9). This difference lessened as time in culture increased but was 
still present to a statistically significant degree between the base alginate and both 
collagen-type scaffolds by Day 7.  
 
 It is also interesting to note that the protein expression of β-III-Tubulin from cells 
within Alg-Pep hydrogels more closely resembled the lower levels seen within collagen 
constructs, rather than the unmodified alginate hydrogels, and this difference was 
statistically significant at both Day 1 and Day 3 of differentiation (Fig 2-9).  
 A similar pattern was also observed when looking at GAP43 protein expression 
which showed close agreement between protein levels from planar PC12 cultures and the 
three-dimensional alginate ±ECL hydrogels over all time points of differentiation (Fig 2-9). 
These GAP43 levels showed either a strong trend or statistically significant lower intensity 
value in both subtypes of collagen hydrogels. As with the levels of β-III-Tubulin; GAP43 
protein expression in Alg-Pep scaffolds more closely mirrored the lower levels seen in 
Fig 2-8: Western Blot expression data of neuronal protein markers of PC12s 
differentiated in two-dimensional culture (2D) and within the five hydrogel three-
dimensional scaffolds (Alg, Alg+ECL, Coll, Coll+ECL, and Alg-Pep) at Day 1, 3 and 7. 
77 
 
collagen hydrogels (±ECL) rather than the expression seen in the alginate gels in the earlier 
time points of differentiation. This effect is reversed by Day 7, by which time the GAP43 
expression level in Alg-Pep scaffolds was comparable to alginate scaffolds and statistically 
higher than in the collagen gels (Fig 2-9).  
  
While the protein expression patterns of both β-III-Tubulin and GAP43 showed 
similar expression patterns during the course of differentiation, but with a difference in the 
strength of expression for each scaffold type; other neuronal-associated proteins showed 
large differences between neural cells differentiated within hydrogel scaffold subtypes and 
Fig 2-9: Semi-quantitative analysis of Western Blot data for β-III-Tubulin and GAP43 
from PC12 cells differentiated in 2D planar culture and in 3D hydrogel scaffolds over 7 
days. Data is shown as means ± S.E.M. Statistical significance is displayed relative to; 2D 
(*), 3D Alg (#), 3D Alg + ECL (α), 3D Coll (φ), and 3D Coll + ECL (ψ). *,#,α,φ,ψ p≤0.05, 
**,##,αα,φφ,ψψ p≤0.01, ***,###,ααα,φφφ,ψψψ p≤0.001  
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planar culture and offered more direct analysis of protein expression relating to neural cell 
morphological changes.  
 Microtubule-associated protein 2 (MAP2) is a dendritic protein involved in the 
regulation of microtubule assembly and neuritogenesis (Sánchez, Díaz-Nido and Avila, 
2000). The expression pattern of the MAP2 (C/D) isoform appeared to differ strongly 
between neural cells differentiated in two-dimensional planar culture and those within 
differing hydrogel scaffolds (Fig 2-8). In planar culture, the pattern of MAP2 protein level 
decreased over the course of differentiation with a constitutively high expression in 
proliferative (Day 0) PC12s. This pattern was directly mirrored by the signal of Phospho-
MAP2-Ser136 (P-MAP2), a phosphorylated form of the MAP2 protein, with high initial 
protein expression that declined during culture. Differential expression of both MAP2 and 
P-MAP2 in alginate (±ECL) versus collagen (±ECL) hydrogel scaffolds is striking, with PC12s 
differentiating in collagen scaffolds showing a similar but slower pattern of MAP2 and P-
MAP2 decline during the time course. Neural cells within alginate scaffolds however, 
showed almost no expression of MAP2 or P-MAP2 from Day 1 onwards. This is the first 
sharp divide in protein expression seen between neural differentiation within the two 
scaffold types so far. Interestingly, the pattern of MAP2 and P-MAP2 expression in the 
peptide-functionalised alginate again followed the pattern of collagen scaffold expression 
rather than that of the base or ECL-composite alginate scaffolds. 
 Stark differences in neuronal protein marker expression between differentiating 
cells within hydrogel subtypes continued when looking at the regulation of the neuron-
specific intermediate filaments Neurofilament-Light (NF-L) and Neurofilament-Heavy (NF-
H). In the case of PC12 differentiation in two-dimensional culture, the levels of NF-L 
diminished over time relative to the Day 0 signal, whereas NF-H expression increased over 
the course of differentiation, suggestive of differential timings and roles of these filaments 
during the differentiation process (Fig 2-8). The collagen (±ECL) and alginate (±ECL) 
hydrogel cell scaffolds had clear and contrasting expression patterns of these proteins over 
the course of differentiation. Cells within alginate hydrogels, both with and without ECL 
composites, displayed a low level of NF-L signal over 7 days that increased over time, with a 
double-banded positive signal at Day 7. Conversely no NF-L signal was seen in cells 
differentiated in collagen hydrogels at any time point during the differentiation (Fig 2-8). 
Intriguingly, the expression pattern of NF-L from cells differentiated within Alg-Pep 
scaffolds showed a semi-consistent expression pattern with the double banding seen from 
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late time points from alginate derived samples at all time points during differentiation. So 
even when previous marker expression from Alg-Pep constructs more closely resembled 
those of collagen-derived samples, the presence of this NF-L signal was more similar to that 
of an alginate (±ECL) derived cell protein sample.  
 In contrast to NF-L protein expression, no NF-H signal was seen within 
differentiating PC12s within base or composite alginate scaffolds at any time point, 
whereas strong banding was seen from neural cells differentiated in the collagen hydrogels. 
The expression pattern derived from collagen scaffold samples however, did not follow the 
same pattern as is seen from planar differentiated samples, and instead had a peak 
intensity at Day 1 that declined during differentiation.  
 The NF-H protein expression in cells differentiated in the Alg-Pep matrices diverged 
from the pattern seen in the alginate and collagen scaffolds and instead displayed the 
pattern seen from cells in two-dimensional culture; with an increase in expression over the 
7-day time course.  
  
2.3.6 Gene Expression Analysis of Differentiating Neural Cells in 
Three-Dimensional Scaffolds 
The large differences seen in protein expression patterns for the array of neuronal markers 
from PC12s differentiating in two-dimensional and three-dimensional environments seen 
above, raise the question of how these protein levels are regulated. Whether the 
regulation of these proteins expressed in environments conducive to neuritogenesis occur 
at the gene expression level or post-transcriptionally will allow for a better insight into how 
these genes and proteins work in concert over the course of neural cell differentiation.   
 qPCR analysis of the genes β-III-tubulin, Gap43, Map2, Nf-l, and Nf-h was 
completed for 7-day differentiation of PC12s in each of the five three-dimensional hydrogel 
scaffolds and two-dimensional planar culture to make it directly comparable to the protein 
expression analysis completed above. 
 Gene expression levels of these neuronal markers in general showed a relatively 
high level of constitutive expression which, for the majority of genes, showed limited up- or 
down-regulation when looking at fold changes of mRNA expression (Figs 2-10, 2-11).  
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 β-III-tubulin mRNA expression displayed a general trend of slight upregulation over 
the time course of differentiation for the majority of 2D and 3D differentiation conditions 
(with the exception of Alg-Pep encapsulated PC12s, which showed a slight downregulation 
at Day 1). Although this upregulation never reached a 2-fold increase in expression and 
showed no statistically significant differences between any of the two- and three-
dimensional growth conditions at any stage of differentiation.  
 
A similar pattern was seen for Gap43 gene expression during differentiation, albeit 
with overall higher fold-changes than the Day 0 constitutive expression. In early stages of 
Fig 2-10: Inter-scaffold quantitative PCR (qPCR) analysis of β-III-Tubulin, Gap43, Map2, 
Nf-l and Nf-h mRNA expression in PC12 cells during differentiation in two-dimensional 
culture (2D), alginate hydrogels (3D Alg), alginate and ECL protein mix composite 
hydrogels (3D Alg + ECL), collagen hydrogels (3D Coll), collagen and ECL protein mix 
composite hydrogels (3D Coll + ECL), and peptide-functionalised alginate hydrogels (Alg-
Pep). Data is shown as mean values ± standard error of the mean of three independent 
experiments. Statistical significance is denoted by * p≤0.05, ** p≤0.01, *** p≤0.001. 
81 
 
differentiation (Days 1-3) the level of Gap43 mRNA was highest in the two-dimensionally 
differentiated neural cells, followed by cells in the collagen scaffolds and then lower levels 
in cells from the alginate and peptide-alginate hydrogels, although none of these trends 
reached statistical significance (Fig 2-10). These early stage differences were also not 
present by Day 7 of differentiation where expression levels of Gap43 were comparable 
across all 2D and 3D differentiation conditions. 
 
Fig 2-11: Intra-scaffold quantitative PCR (qPCR) analysis of β-III-Tubulin, Gap43, Map2, 
Nf-l and Nf-h mRNA expression in PC12 cells during differentiation in two-dimensional 
culture (2D), alginate hydrogels (3D Alg), alginate and ECL protein mix composite 
hydrogels (3D Alg + ECL), collagen hydrogels (3D Coll), collagen and ECL protein mix 
composite hydrogels (3D Coll + ECL), and peptide-functionalised alginate hydrogels (Alg-
Pep). Data is shown as mean values ± standard error of the mean of three independent 
experiments. Statistical significance is denoted by * p≤0.05, ** p≤0.01, *** p≤0.001. 
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 Map2 expression showed a relative drop by Day 1 of differentiation in all 
differentiating culture conditions which then recovered back to Day 0 levels and above by 
Day 3 and 7 (Fig 2-10). The only increase that reached statistical significance was the 
increase in Map2 expression in two-dimensional culture between Day 1 and 3 of 
differentiation (Fig 2-11). Again, the fold changes seen over the course of differentiation in 
all culture conditions were minimal relative to the Day 0 constitutive expression and none 
of the differences between Map2 expression levels at each time point showed significant 
differences between each planar- or hydrogel-based culture.  
 The gene transcript expression of Nf-l however, displayed the strongest difference 
between PC12s differentiating in planar culture versus those in three-dimensional scaffolds 
(Fig 2-10). By Day 1 and Day 3 of differentiation the level of expression from cells in planar 
culture were in all cases higher than cells within hydrogel scaffolds. This effect was less 
pronounced by Day 7 of differentiation but remained significantly higher than expression 
from cells within collagen (±ECL) scaffolds. The peak fold change seen between Day 0 Nf-l 
expression and the level of expression on Day 3 in planar culture did reach statistical 
significance (~2.7 fold higher) (Fig 2-11). In each of the hydrogel scaffold samples, the level 
of Nf-l was relatively consistent over the course of differentiation, after an initial downward 
trend. Day 7 mRNA levels of Nf-l from alginate hydrogels reached a peak that was 
statistically significant from the Day 1 fold-change (Fig 2-11). 
 Nf-h mRNA expression across all two- and three-dimensional differentiation 
conditions showed a similar pattern of slight downregulation relative to Day 0 levels (Fig 2-
10, Fig 2-11), with the exception of the Alg-Pep scaffold encapsulated neural cells that 
showed a slight increase by Day 3 and Day 7. Overall no statistically significant differences 
were seen in gene expression levels of Nf-h either within a growth condition differentiation 







2.4 Discussion and Conclusions 
The techniques and challenges associated with in vitro neural cell culture have evolved 
dramatically since its inception (Millet and Gillette, 2012). Recent advances in biomaterial 
development and additive fabrication technologies (such as bioprinting) have put the onus 
on forming materials and cell growth environments that better recapitulate the 
cytoarchitecture and biophysical properties of native tissue. In vitro modelling of neural 
tissue forms the foundation of modern neurological research by creating a biomimetic 
environment to better understand human brain development, the pathology of 
neurological disease, to test and refine novel therapeutic agents, and eventually even form 
regenerative tissue applications. For this to be successful the selection and development of 
biological or non-biological scaffold materials that enable encapsulated cells to generate a 
more representative “brain-like” environment through enhanced cell-cell contact, dynamic 
cell-matrix interactions, and ultimately cell maturation and functionality are critical to this 
frontier.    
Although multiple individual studies of hydrogel scaffolds for neural tissue 
engineering applications are present in the literature, few of them directly compare 
multiple scaffold subtypes to one another or compare directly to planar 2D neural 
differentiation. This section of research aimed to directly compare, at a material and cell 
biological level, the effect of the biomaterial scaffold alone on encapsulated neural cell 
differentiation. 
 Alginate and collagen type I hydrogel scaffolds have been used in a variety of 
neural tissue modelling research, with varying degrees of success. Collagen hydrogels are a 
widely used scaffold biomaterial from which to generate 3D neural tissue constructs. These 
scaffolds are conducive to neuritogenesis (O’Connor et al., 2001; Swindle-Reilly et al., 
2012), show enhanced cell viability and activity when generated as composites with ECM-
derived proteins (Sood et al., 2016), and allow for the generation of synaptic connectivity 
and neural cell function (O’Connor et al., 2000; Ma et al., 2004; Xu et al., 2009; Odawara, 
Gotoh and Suzuki, 2013). Alginate-based hydrogel in vitro constructs however, show mixed 
effects on embedded neural cell morphology and activity that is heavily dependent on 
scaffold composition and crosslinking conditions (Banerjee et al., 2009; Meli et al., 2014; 
Palazzolo et al., 2015), but has shown promise in bioprinting methodologies (Chung et al., 
2013; Gu et al., 2017).  
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To overcome or ameliorate this steric hindrance of neuritogenesis we generated 
alginate scaffolds with double-ended functionalisation peptides containing MMP2/9-
cleavable motifs and laminin-derived cell binding moieties, which had shown promise in 
previous work with mesenchymal stem cell spreading in alginate hydrogels, and motor 
neurons in polyethylene glycol scaffolds (Fonseca et al., 2011; McKinnon, Kloxin and 
Anseth, 2013). Aqueous carbodiimide crosslinking chemistry was utilised to generate the 
peptide-functionalised alginate (Alg-Pep) through the reaction of native carboxylic acid 
groups within the alginate polymer chains and the terminal amine groups of each peptide 
derived from the amine-terminus and a C-terminus lysine side-chain. Reaction efficiencies 
of 40.5% and 46.8% were achieved for the crosslinking of the MMP-peptide and the 
laminin-peptide respectively, resulting in MMP-peptide levels of 4.05mg/g alginate and 
laminin-peptide levels of 4.68mg/g alginate. The efficiencies of these modification 
reactions are comparable to those previously reported under similar reaction conditions 
(Fonseca et al., 2011). This reaction chemistry generated peptide conjugates that were 
covalently bonded at both terminal ends of the peptides as opposed to the wider used 
pendant-style modification which grafts peptides using only a single terminus. The 
combination of both cell-binding and protease-cleavable motifs linking separate 
polysaccharide chains was developed in an attempt to enhance cellular interaction with a 
non-mammalian hydrogel scaffold whilst also limiting the steric hindrance of the alginate 
hydrogel on neuritogenesis, as seen in previous research (Banerjee et al., 2009). 
The stiffness of substrates used for in vitro cell culture has a strong impact on cell 
attachment, stem cell differentiation and cell morphology in both 2D and 3D (Engler et al., 
2006; Banerjee et al., 2009). To optimise neural cell differentiation, the moduli of hydrogel 
scaffolds should be comparable to that of native brain tissue. To this end, the candidate 
neural tissue construct biomaterials in this work were assayed under rheological 
measurement to directly compare their suitability to replicate 3D brain-like soft growth 
conditions. The concentrations of collagen used within these hydrogels (0.4mg/ml) mirror 
previously reported positive results of collagen hydrogel formation for neural culture 
(O’Connor et al., 2001). The alginate concentration used (0.5% w/v) was selected as it was 
the lowest concentration of polysaccharide that could generate a stable hydrogel under 
these culture conditions. This was an effort to engineer the lowest possible hydrogel 
modulus in an attempt to maximise positive neural differentiation (Banerjee et al., 2009).  
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All crosslinked hydrogels tested displayed storage moduli below 60Pa which is well 
within the softness equivalent range of neural tissue (<1kPa). We observed the softest gels 
were generated from collagen matrices (3.1Pa) and that composite scaffolds of collagen 
with a Matrigel equivalent (ECL) demonstrated slightly higher moduli (4Pa). Conversely, 
alginate scaffolds displayed a higher storage moduli reading of 58.1Pa, which was lower in 
composite scaffolds containing ECL (43.2Pa). This drop may be due to the nature of the 
ionic crosslinking between alginate polymer chains, which may be inhibited through the 
presence of ECM-derived structural proteins not allowing for adequate proximity of 
crosslinking regions. Alg-Pep scaffolds displayed lower moduli measurements than the base 
and ECL-doped hydrogels (15.4Pa) owing to the fact that the carboxyl-groups utilised within 
ionic crosslinking become the attachment points for the peptide reactions. The double-
ended nature of the peptide binding itself may also interfere on a steric level with how the 
alginate chains crosslink with each other and therefore lower the stiffness of the formed 
hydrogel during sol-gel transition. The level of peptide-crosslinking chemistry may 
therefore not only be used to functionalise scaffolds with biomimetic moieties, but also as 
a mechanism by which to tailor hydrogel moduli.  
Another key criterion for the applicability of biomaterials for use in neural tissue 
engineering applications is the ability to maintain cell viability both during the crosslinking 
process and over the course of neural differentiation. The five hydrogel compositions 
within this study showed comparable levels of PC12 neural cell viability, both after the 
crosslinking process and after 7 days of differentiation. This indicates that neither 
crosslinking process was detrimental to cell survival and that the metabolic activity of the 
differentiating cells was preserved over the time course of differentiation. Only at Day 1 
and 3 post-differentiation did a slight trend of lower viability in the collagen and Alg-Pep 
based scaffolds in comparison to the alginate (±ECL) hydrogels emerge. The fact that these 
differences are quite minimal, and that in all samples tested cell viability increases during 
the time course of differentiation, leads to the conclusion that strictly from a basis of cell 
survival within these constructs: all tested hydrogels show comparable cell biocompatibility 
profiles during neural differentiation.  
Large differences were seen between the neural tissue scaffolds however, when 
assays of neuritogenesis and neural cell morphology were undertaken. PC12 cells show 
rounded cell morphologies under proliferative conditions, but quickly undergo 
neuritogenesis under neurotrophic treatment and display extensive morphological changes 
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over 7 days of differentiation [(Fig 2-4) and (Das, Freudenrich and Mundy, 2004)]. PC12s 
when differentiated in collagen ± ECL hydrogels also underwent neuritogenesis over a 
similar time frame and with neurites extending in all directions within the scaffold. No 
discernible positive effect on neuritogenesis was seen in collagen scaffolds containing the 
ECL protein mix. These morphological changes were however not seen in the alginate or 
ECL composite alginate scaffolds; which contained aggregates of PC12s with a rounded cell 
morphology. This mirrors the rounded morphology of NSCs embedded in alginate scaffolds 
of equivalent and higher storage moduli (Banerjee et al., 2009), and the lack of dorsal root 
ganglia neuritogenesis also within alginate hydrogels (Novikova et al., 2006). The addition 
of ECL as a component of the alginate hydrogel did not elicit any positive neuronal 
morphology changes of the PC12s in this study, although the addition of fibronectin into 
alginate scaffolds in previous studies has been shown to ameliorate the inhibition of 
neuritogenesis to a degree (Novikova et al., 2006).  
Strong positive neurite outgrowth of primary rat cortical neurons within 
unmodified but “ultrasoft” alginate hydrogels of 0.1% - 0.4% (w/v), and with sub-
stoichiometric concentrations of crosslinking calcium ions, has been reported (Palazzolo et 
al., 2015), although we were unable to generate hydrogel structures from the alginate 
sources used in this study at the low concentrations the authors reported (data not shown). 
Even at comparable storage moduli (<100Pa) we do not observe comparable levels of 
neurite outgrowth, suggesting that modulus alone is an incomplete marker of whether 
neurite outgrowth will take place. In this instance it may be that sub-stoichiometric 
crosslinking of alginate scaffolds, rather than low dry-mass biomaterial concentrations, 
elicit positive neuritogenesis through limited steric inhibition of cell movement through 
incompletion of the gelation process. This system of incomplete crosslinking however, 
would be difficult to control and would be impossible to monitor and maintain partial sol-
gel transition during extended neural cell culture. 
It is possible that different neural cell types respond differently to the same 
hydrogel environment and that PC12s and primary neurons would show different 
morphological trends due to intrinsic cell-line and native-neuron differences, however 
preliminary data showed that embryonic primary rat cortical neurons were also unable to 
undergo neuritogenesis within alginate scaffolds, but rapidly do so in collagen hydrogels 
(Appendix 2.5.2), matching the effect seen on embedded PC12s. This reinforces the 
concept of utilising neural cell lines as a proxy for true neuronal responses. 
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The differences in conduciveness to neuritogenesis between alginate and collagen-
based scaffolds may be linked to the difference in storage moduli between the biomaterials 
(where collagen showed a much softer profile), but the recorded moduli for alginate 
hydrogels recorded in this study is still well within the degree of softness expected of native 
tissue and of equivalent successful neural tissue modelling studies (McKinnon, Kloxin and 
Anseth, 2013; Palazzolo et al., 2015). Therefore, the apparent inhibition or enhancement of 
neuritogenesis may hinge on biophysical and biomimetic factors beyond simple modulus 
testing. This could include crosslinking fibre formation and structural elements such as 
porosity and polymer chain alignment and assembly, which may differ greatly between 
alginate and collagen hydrogels. 
This lack of observable neuritogenesis seen within alginate and ECL composite 
alginate hydrogels is also reflected in the MMP- and laminin-peptide functionalised alginate 
scaffolds. Previous functionalisation of alginate scaffolds with laminin-derived binding 
epitopes allowed for a more in vivo-like glial and neuronal morphology in equivalent 
alginate (w/v) scaffolds (Frampton et al., 2011), although in constructs of a much smaller 
volume and with cell densities much higher than those used in this study. It is plausible that 
higher cell densities may impact the gelation process and minimise the effective 
crosslinking of alginate chains due to the steric hindrance of the cells themselves, in a 
fashion similar to sub-stoichiometric crosslinking methodologies. Similar double-ended 
MMP-sensitive peptide functionalisation of both alginate and PEG scaffolds did show 
promise for embedded mesenchymal stem cell spreading and motor neuron axonogenesis 
(Fonseca et al., 2011; McKinnon, Kloxin and Anseth, 2013). The different outcomes 
following peptide functionalisation of inert alginate scaffolds shown in this study may be 
due to multiple factors. The degree of functionalisation itself may not be at a level high 
enough to elicit a dense enough network of cleavable or cell-adhesive moieties for 
neuritogenesis and cell spreading to take place. Although reaction efficiencies were 
equivalent to those previously reported, the type and source of alginate used in each study 
(such as the content and ratio of β-D-mannuronic acid and α-L-guluronic acid monomers) 
have profound effects on viscosity and gelation properties that may enhance or inhibit the 
effects of peptide modification. Furthermore, the MMP-cleavable motif used in this study 
was designed to be sensitive to MMP-2 and MMP-9 secreted proteases, although a whole 
raft of protease-sensitive sequences can be generated, therefore it is possible that multiple 
sequences may enhance neuritogenesis of encapsulated differentiating neural cells 
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depending on their source. All of these elements could be modified in future work to try 
and tailor the use of alginate scaffolds for neural-tissue engineering. 
The gene and protein expression profiles of PC12s within each scaffold subtype also 
showed stark differences over the course of neural differentiation and also when compared 
to standard 2D planar culture. The protein expression levels of both β-III-Tubulin and 
GAP43 increase during PC12 differentiation in 2D planar culture in accordance with 
previous studies (Ohuchi et al., 2002; Das, Freudenrich and Mundy, 2004). This pattern of 
upregulation over 7 days of differentiation was seen across all 3D PC12 hydrogel cultures, 
even within the alginate (±ECL) and peptide-functionalised alginate cultures which showed 
no evidence of neuritogenesis. Intriguingly, this result suggests that even in matrices that 
restrict neural morphological development, the embedded neural cells still positively 
respond to signalling factors triggering differentiation-related protein expression. Equally 
as fascinating is the finding that at early time points (Day 1 and 3) β-III-Tubulin protein 
levels are significantly higher in neural cells differentiating in 3D alginate (±ECL) hydrogels 
than those seen at the same time points in 2D culture. This upregulation at each time point 
in 3D alginate scaffolds remains significantly higher than 3D collagen (±ECL) encapsulated 
neural cells until Day 7, and which themselves tend to match with 2D differentiation levels 
and the peptide-functionalised alginate hydrogels. This increase in canonical neuronal 
proteins from cells in 3D alginate scaffolds relative to 3D collagen scaffolds is also true of 
GAP43 protein expression. This finding may seem counterintuitive as higher levels of neural 
differentiation markers may be expected from culture conditions that allow for 
neuritogenesis and mature neural morphology formation. In this case however, it does 
appear that these particular neuronal markers although upregulated during the course of 
induced differentiation are unreliable markers of neuronal morphology development. The 
gene expression profiles of β-III-tubulin and Gap43 follow a similar pattern to protein 
expression and are upregulated during differentiation. However, the relative increase of 
each gene is slight, and no upregulation in any scaffold reaches statistical significance, and 
the differences seen between gene expression at each time point is not statistically 
different from PC12s in other hydrogel scaffold types, unlike those seen for protein 
expression levels.  
The dendritic marker MAP2 and its phosphorylated forms interact with the 
microtubule network within neural cells and may have a role in processes regulating 
cellular morphology (Sánchez, Díaz-Nido and Avila, 2000). In 2D planar differentiation, 
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MAP2 (C/D isoform) and the serine-136 phosphorylated form (P-MAP2) show 
downregulation over the course of PC12 differentiation. Robust differences are seen in 
MAP2 and P-MAP2 levels between PC12s differentiating in alginate and collagen scaffolds, 
whereby both markers are absent from PC12s in 3D alginate (±ECL) constructs but show a 
slower downregulation pattern mimicking the 2D differentiation samples in collagen (±ECL) 
constructs. Unlike the neuronal markers β-III-Tubulin and GAP43 whereby upregulation is 
discrete from morphological development, MAP2 and P-MAP2 show large differences 
between the same cell type differentiating in distinct biomaterial scaffolds. Even more 
surprising is the finding that the MAP2 and P-MAP2 protein expression pattern in the 
peptide-modified alginate scaffolds follows a similar pattern to 3D collagen and 2D planar 
differentiation rather than the 3D base alginate scaffolds. When looking at Map2 gene 
expression however, this pattern of downregulation is not seen. Instead a high constitutive 
expression with an initial trend of downregulation and then upregulation over 7 days of 
differentiation is comparable across PC12s differentiated in all scaffold subtypes. This is an 
interesting disconnect between the final protein marker product and the underlying gene 
expression profile which suggests strong post-transcriptional regulation of the Map2 gene 
depending on the cell-biomaterial interactions encountered during differentiation.  
Distinct differences are also seen in the expression of the neurofilament proteins 
NF-L and NF-H which have been shown previously to be upregulated slightly during PC12 
differentiation (Ohuchi et al., 2002). In 2D planar PC12 differentiation in this study, NF-L 
levels decrease over time, whereas NF-H protein levels increase. This difference in 
expression profiles may be due to a recapitulation of developmental timings of each 
neurofilament with early expression of NF-L followed by a later expression pattern of NF-H 
(Liu et al., 2004). However, within alginate hydrogels (±ECL), NF-L levels increase over time, 
whereas NF-H was not detected, suggesting a link between the lack of biomaterial 
interaction and the morphological changes within the encapsulated PC12s. The reverse of 
this pattern is seen in collagen hydrogels (±ECL) which do not show detectable levels of NF-
L but do show positive NF-H banding, but with a different pattern to that seen from 2D 
planar differentiation. Interestingly, PC12s differentiated within peptide-modified alginate 
scaffolds show NF banding patterns indicative of both collagen and alginate hydrogel 
samples; with NF-L expression measurable at all time points and an upregulation of NF-H 
that follows the same pattern as 2D differentiation. Some NF-L probes displayed double 
banding within samples from the 3D alginate (±ECL) and peptide-alginate samples not seen 
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in 2D planar culture, which may demonstrate an effect of post-translational modification 
such as glycosylation and/or phosphorylation (Liu et al., 2004). It has been seen in previous 
studies that Nf-l gene expression increases over the course of PC12 differentiation (Won et 
al., 2015), which is also seen in this study in 2D planar differentiation, but to a much more 
static degree in PC12s within all 3D hydrogel scaffolds. This static expression profile is again 
seen with Nf-h gene levels; that display high constitutive expression that remains relatively 
stable over the time course of differentiation. As was the case with MAP2 gene and protein 
expression, these disparate patterns do not reflect the final protein patterns seen 
experimentally. Again, it can be concluded that strict post-transcriptional regulation of 
these genes must be taking place and that constant gene expression levels of these 
markers may be a factor of the PC12s themselves, and must be factored into any analysis 
involving other neural cell types.  
The differing protein expression patterns of MAP2, P-MAP2, NF-L and NF-H 
between the hydrogel compositions and those derived from 2D differentiation highlight the 
complex interplay of these neural markers as PC12s undergo differentiation in 
environments that display different biophysical properties, that may or may not support 
neuritogenesis, and those that contain native-ECM binding motifs or not. From these data 
it appears that these protein markers are a more effective measure of cell-matrix 
interactions and possible neurite elongation than the canonical neuronal markers β-III-
Tubulin and GAP43. It is worthy of note however, that the constitutive expression levels of 
many neuronal genes and proteins within PC12s in basal growth media results in a more 
subtle upregulation during differentiation as was discussed above, and has discounted 
certain markers for use in previous differentiation studies of PC12s (Das, Freudenrich and 
Mundy, 2004). It has also been noted that intermediate filament expression patterns (such 
as neurofilaments) within PC12s do diverge from patterns seen in native neural cultures 
(Franke, Grund and Achtstatter, 1986). This surprising gene expression disconnect from 
translated protein products may also be related to the reportedly high level of post-
transcriptional regulation of differentiation-associated genes in PC12s (Lindenbaum et al., 
1988; Perrone-Bizzozero, Cansino and Kohn, 1993).  
In conclusion, the striking differences between protein marker expression in PC12s 
within 3D hydrogels and 2D culture is a firm demonstration of cell-matrix interactions 
dictating cellular responses at the molecular level, even under identical differentiation 
inducing conditions. Even with comparable cell viability retention and scaffold stiffness 
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analogous to that of native brain tissue, differentiation within alginate-based hydrogels 
restricted neurite outgrowth and in vivo-like morphology, but elicited strong canonical 
neuronal marker expression, but differential patterns of MAP2/P-MAP2 and neurofilament 
protein expression than was seen in 2D planar differentiation. Conversely, collagen-based 
3D hydrogel scaffolds had almost the opposite effect on the embedded neural cells; by 
allowing for extensive neuritogenesis together with gene and protein expression patterns 
more equivalent to 2D planar culture. Strikingly, peptide-modified alginate hydrogels 
(containing MMP-sensitive and laminin-binding motifs) although not conducive to 
neuritogenesis, showed protein expression patterns reflective of both alginate-embedded 
and collagen-embedded PC12s. This demonstrates that not only are encapsulated neural 
cells responding to the biophysical properties of the hydrogels themselves, but must be 
interacting at a biochemical level with the moieties presented within the hydrogels to 
regulate and modulate molecular pathways of neural cell differentiation.   
 
2.4.1 Summary of Chapter Findings 
 Using aqueous carbodiimide chemistry; double-ended MMP-cleavable and laminin-
binding peptide motifs can be covalently bonded to alginate polymers with high 
efficiency. 
 Collagen type I, alginate and peptide-modified alginate hydrogels all allow for high 
retention of cell viability of encapsulated neural cells during scaffold gelation, as well as 
over the time course of neural differentiation. 
 Rheological analysis of hydrogels reveals all candidate scaffolds have storage moduli 
below 100Pa. Collagen hydrogels show the lowest degree of stiffness, with alginate 
hydrogels the highest. Peptide-modified alginate hydrogels show intermediate stiffness 
measurements between collagen and basal alginate scaffolds. 
 Collagen type I hydrogels (both with and without ECM protein components) allow for 
neurite extension of encapsulated PC12 neural cells over the same time course as 2D 
planar differentiation.  
 Low concentration alginate hydrogels are non-conducive to neuritogenesis of 
encapsulated differentiating PC12 neural-like cells. This effect is not ameliorated by the 
addition of extracellular matrix proteins.  
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 Peptide-modified alginate hydrogels also do not allow for neuritogenesis of 
encapsulated neural cells, but do show a tendency for visible “halo-like” structures 
around cellular aggregates, suggesting cell-scaffold molecular interactions. 
 The canonical neuronal protein markers β-III-Tubulin and GAP43 increase in expression 
over the time course of neural differentiation in 2D and 3D culture. These increases do 
not reflect the neuritogenic potential of the hydrogel scaffolds and are highly 
expressed in alginate and alginate-peptide scaffolds which restrict neurite formation. 
 Other neuronal protein markers MAP2, P-MAP2, NF-H, and NF-L do show stark 
differences in expression profiles during neural differentiation in the various 
biomaterial scaffolds. These markers therefore represent more reliable measures of 
neuritogenic potential of candidate biomaterials. 
 Gene expression levels of the above markers in PC12s display a high constitutive 
expression level that show low levels of fluctuation during differentiation. These low 
relative changes in gene expression do not directly reflect the large differences seen 
with protein expression analysis. This is suggestive of a harsh post-transcriptional 
regulation of these genes at least within the PC12-based model. 
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2.5.1 Peptide Functionalisation Mass Spectrometry Data 
Following reversed-phase HPLC chromatography, peptide-containing aliquots were purity 
tested through mass spectrometry analysis. Double-charged peptide component peaks 
were used to determine the purest aliquots for down-stream alginate crosslinking 
chemistry. Some example spectra are shown below. 
 
 
2.5.2 Primary Rat Cortical Neural Cells within Alginate and Collagen 
Scaffolds 
Although PC12s, a rat-derived neural-like cell line, were used as a proxy for primary or stem 
cell derived neuron behaviour in 3D environments, it was necessary that gross 
morphological changes witnessed from the PC12 3D hydrogel tissue constructs should 
reflect those of primary neural cultures. Embryonic (E18) rat cortical cells (kindly supplied 
by Dr. Justin Bourke, St. Vincent’s Hospital Melbourne) were embedded in equivalent 
hydrogel matrices and differentiated over 7 days to ensure the inhibition or enhancement 
of neuritogenesis seen with PC12s in each scaffold type was recapitulated. E18 
Differentiation media was composed of Neurobasal (Gibco), B27 (Thermo Fisher Scientific), 
N2 (Thermo Fisher Scientific), GlutaMAX (Thermo Fisher Scientific), 100U/ml Penicillin and 
Appendix Fig 2-12: Mass spectrometry readings of aliquots of MMP- and laminin-
peptide following HPLC purification. The strong peaks of the double charged 
peptides allowed for selection and lyophilization of pure full-length peptides. 
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Appendix Fig 2-13: Bright field (top) and immunofluorescent (bottom) images of 
embryonic E18 rat cortical neurons differentiated within alginate and collagen 3D 
hydrogel scaffolds. β-III-Tubulin immunostaining is shown in green. As with PC12s no 
neuritogenesis was observed in alginate scaffolds, whereas extensive neurite branching 
and extension was seen from the same cells in collagen scaffolds (black arrow heads). 
Scale bars represent 50μm. 
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Chapter 3: Subtype Specific Neural 
Differentiation of Human Induced 
Pluripotent Stem Cells 
 
3.1 Introduction 
The advent of induced pluripotent stem cell (iPSC) technology has incredible potential to 
drive the next generation of human neurological research. Human iPSCs (hiPSCs) 
differentiated into neural lineages in vitro do so following the same developmental timings 
and maturation profiles as is seen in utero, and even more remarkably have the capacity to 
self-organise into multicellular substructures that are representative of early brain 
cytoarchitecture (Petros, Tyson and Anderson, 2011; Anderson and Vanderhaeghen, 2014; 
Kelava and Lancaster, 2016). This retention of in vivo-like properties of differentiation in 
the dish, combined with the fact that they can be reliably generated on a patient-specific 
basis, makes hiPSCs an attractive foundation for in vitro modelling of genetically linked 
neurodevelopmental and neurodegenerative pathologies (Park et al., 2008; Mattis and 
Svendsen, 2011; Okano and Yamanaka, 2014). By differentiating human pluripotent stem 
cells into particular neural subtypes in vitro that carry mutations implicated in disease 
pathologies, many researchers have already begun to recapitulate and better understand 
such conditions as Parkinson’s Disease (Soldner et al., 2009; Kriks et al., 2011; Miller et al., 
2013; Schwab and Ebert, 2015), Alzheimer’s Disease (Israel et al., 2012; Choi et al., 2014; D. 
Zhang et al., 2014; Duan et al., 2014; Kim et al., 2015; Nieweg et al., 2015; Mungenast, 
Siegert and Tsai, 2016), Huntington’s Disease (Juopperi et al., 2012), Amyotrophic Lateral 
Sclerosis (Motor Neurone Disease) (Di Giorgio et al., 2008), Spinal Muscular Atrophy (Ebert 
et al., 2009; Corti et al., 2012), Autism Spectrum Disorders (Mariani et al., 2015; Marchetto 
et al., 2017), and syndromic genetic Epilepsies such as Dravet Syndrome and Rett 
Syndrome (Marchetto et al., 2010; Ananiev et al., 2011; Cheung et al., 2011; Kim, Hysolli 
and Park, 2011; Farra et al., 2012; Yu Liu et al., 2013; Dajani et al., 2013; Higurashi et al., 
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2013; Jiao et al., 2013; Chen et al., 2014; Williams et al., 2014; Parent and Anderson, 2015; 
Du and Parent, 2015; Z.-N. Zhang et al., 2016; Maeda et al., 2016).  
 The strength of both in vitro neurological developmental- and disease-modelling is 
underpinned through the accurate generation of specific neural subtypes that are 
differentiated and matured to a level comparable to in vivo neural networks. Forebrain 
neural development in utero is derived from the anterior-dorsal region of the neural tube 
(the embryological precursor of the central nervous system). Interestingly, neural cells from 
this brain region represent the outcome of the default differentiation lineage of 
neuroectodermally induced cells from hiPSCs (Zeng et al., 2010; J.-E. Kim et al., 2011; Shi et 
al., 2012), rather than stochastic differentiation of multiple neuronal subtypes from 
multiple neural tube regions.  
However, as well as this predominantly excitatory pool of cells that form forebrain 
structures (such as the cortex) from this lineage pathway: approximately 20% of neocortical 
cell numbers are comprised of GABAergic inhibitory neural cell types (Arber and Li, 2013). 
These neural cell subtypes are generated from anterior-ventral regions of the neural tube 
and migrate tangentially into cortical regions from structures termed ganglionic eminences 
(Danjo et al., 2011; Arber and Li, 2013). The temporo-spatial patterning of the neural tube 
in utero is derived from gradients of morphogens that define dorsal-ventral and rostral-
caudal axes (Briscoe and Ericson, 2001; Le Dréau and Martí, 2012). One such morphogen is 
Sonic Hedgehog (SHH) which is a ventralising ligand secreted from the neural tube 
floorplate and notochord (Jessell, 2000). By replicating this exposure to SHH, or small-
molecule agonists of the SHH-signalling pathway, many in vitro pluripotent stem cell-
derived neural precursor cells (NPCs) can be patterned to a ventral and therefore 
GABAergic interneuron cell identity (Maroof et al., 2010; Danjo et al., 2011; Goulburn et al., 
2012; Ma et al., 2012; Arber and Li, 2013; Yan Liu et al., 2013; DeRosa et al., 2015). 
Therefore, to fully model human forebrain cortical development in a dish, the 
cellular components of the in vitro model must contain both dorsally-derived excitatory 
cells and ventrally-derived inhibitory interneurons in the appropriate ratios and combined 
in a developmentally relevant time frame. This will be especially important within studies 
of some genetic epilepsies, of which many carry mutations that specifically affect 
GABAergic neuronal migration and function (Noebels, 2015). Although multiple studies are 
present in the literature that look at single neural cell subtype differentiation and end-point 
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analysis, very few engage in parallel neural induction strategies that directly compare the 
molecular markers of differentiation, maturation and network formation.  
The purpose of this chapter will be to focus on the derivation of forebrain 
excitatory (dorsal) neural cell types in direct timeline comparison to deriving forebrain 
inhibitory (ventral) GABAergic interneurons. This will shed light on the molecular processes 
of forebrain neural cell development and maturation, and the intrinsic differences of the 
process from neural cells from distinct neural tube regions triggered through morphogen 
patterning. As well as biomolecular markers of differentiation such as gene and protein 
expression, the acquisition of neuronal cell activity and function will also be studied. 
All of these elements combined will help inform future models of complete 
forebrain development in vitro and will be an integral foundation stone on which to derive 
comparable developmental and disease-state neural tissue models. It is the processes and 














3.2 Materials and Methods 
3.2.1 iPSC Culture 
All work in this chapter utilised the commercial human iPSC lines; ATCC-BXS0116 Human 
Induced Pluripotent Stem (IPS) Cells (ATCC® ACS-1030™) derived from CD34+ bone marrow 
cells and ATCC-DYS0100 Human Induced Pluripotent Stem (IPS) Cells (ATCC® ACS-1019™) 
derived from foreskin fibroblasts. iPSCs were grown in feeder-free culture conditions on 
Vitronectin XF (Stem Cell Technologies) coated 6-well tissue culture plates in TeSR-E8 
media (Stem Cell Technologies). iPSC colonies were passaged every 6-7 days with Gentle 
Cell Dissociation Reagent (GCDR) (Stem Cell Technologies) and were re-plated with TeSR-E8 
media containing the RHO/ROCK pathway inhibitor Y-27632 (10μM, Stem Cell 
Technologies). Media was changed daily, except for the first day after a passage. Areas of 
random differentiation within colonies were removed manually. All iPSC and neural 
differentiation experiments used iPSCs below passage number 20.  
 
3.2.2 Neural Differentiation 
Dorsal neural induction of iPSCs was triggered using the monolayer dual SMAD-inhibition 
protocol using commercially available STEMdiff Neural Induction Media (NIM) (Stem Cell 
Technologies). Briefly, iPSCs were dissociated into single cells using GCDR (Stem Cell 
Technologies) and plated at densities of 1 x 106 cells/well of a 6-well tissue culture plate 
coated with poly-L-lysine (0.01%, Sigma) & laminin (20μg/ml, Sigma) (PLL) in 2ml NIM per 
well. Media was changed daily for the first 7 days of induction, also containing RHO/ROCK 
pathway inhibitor Y-27632 (10μM, Stem Cell Technologies).  
After 7 days of induction, media was changed to STEMdiff Neural Proliferation 
Media (NPM) (Stem Cell Technologies) for another 7 days to trigger neural precursor cell 
(NPC) maturation. NPCs were passaged at Day 10 to allow for continued expansion and 
differentiation under final plating conditions onto PLL coated tissue culture plates. At Day 
14 post-induction, media was changed to a final neural maturation media (NMM) which 
consisted of a 1:1 mix of “N2 media” and “B27 Media”. N2 media consisting of DMEM/F12 
(Lonza), N-2 Supplement (1x, Thermo Fisher Scientific), GlutaMAX (1x, Gibco), Non-
essential amino acid mixture (1x, Lonza), 100U/ml Penicillin and 100μg/ml Streptomycin 
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(Gibco). B-27 media consisting of Neurobasal (Gibco), B27 Supplement (1x, Thermo Fisher 
Scientific), and GlutaMAX (1x, Thermo Fisher Scientific). The combined maturation media 
was then supplemented with BDNF (20ng/ml, PeproTech), GDNF (20ng/ml, PeproTech), 
and DAPT (2μM, Stem Cell Technologies) to enhance neuronal differentiation and cell cycle 
synchronisation of differentiating NPCs (Crawford and Roelink, 2007; Borghese et al., 
2010). Maturation media was changed every 2-3 days over the course of differentiation. 
Ventral neural induction of hiPSCs followed the same protocol and media formulations as 
above but with the addition of Purmorphamine (1.5μM, Stem Cell Technologies) from Day 
2 to 14 post-induction. 
 
3.2.3 Immunofluorescence Microscopy 
Samples for immunocytochemistry were fixed for 15 minutes at room temperature in 10% 
neutral-buffered formalin solution (Sigma) and permeabilised for 15 minutes at room 
temperature in 0.1% Triton-X-100 (Sigma) in phosphate buffered saline (PBS) (137mM 
NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4). Samples were blocked for 1 hour in 5% goat 
or donkey serum (Millipore) in PBS before incubation with primary antibodies (also in block 
solution) overnight at 4⁰C; anti-Oct4 (Stem Cell Technologies 60093, 1:1000); anti-Pax6 
(Stem Cell Technologies 60094, 1:1000); anti-Nanog (Cell Signaling Technology 4903, 
1:1000); anti-Sox2 (Stem Cell Technologies 60055, 1;1000); anti-Tra-1-60 (Stem Cell 
Technologies 60064, 1:1000); anti-TUJ1 (Covance MMS-435P, 1:2000); anti-Nestin (Stem 
Cell Technologies 60091, 1:1000); anti-MAP2 (Cell Signaling Technology 4542, 1:1000); anti-
GAP43 (Millipore AB5220, 1:1000); anti-Synapsin I (Abcam ab64581, 1:1000); anti-Reelin 
(Abcam ab138370, 1:1000); anti-TBR1 (Abcam ab31940, 1:1000); anti-CTIP2 (Abcam 
ab18465, 1:1000); anti-BRN2 (DSHB PCRP-POU3F2-1A3, 1:500); anti-vGLUT1 (Sigma 
AMAb91041, 1:1000); anti-vGLUT2 (Abcam ab101760, 1:1000); anti-GAD65+67 (Abcam 
ab11070, 1:1000); anti-GABAAR1 (Synaptic Systems 224204, 1:1000); anti-GABABR1 (Abcam 
ab55051, 1:1000); anti-S100β (Sigma S2532, 1:1000); anti-GFAP (Stem Cell Technologies 
01415, 1:2000). Samples were washed three times in PBS before addition of secondary 
antibodies in block solution for 1 hour at room temperature: goat-anti-mouse IgG AF488 
(Invitrogen A11029, 1:2000); goat-anti-mouse IgG AF594 (Life Technologies A11032, 
1:2000); donkey-anti-rabbit IgG AF488 (Invitrogen A21206, 1:2000); donkey-anti-rabbit IgG 
AF594 (Invitrogen A21207, 1:2000); donkey-anti-rat IgG AF594 (Invitrogen A12109, 1:2000); 
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donkey-anti-goat IgG AF488 (Abcam ab150129, 1:2000); goat-anti-guinea pig IgG AF488 
(Abcam ab150185, 1:2000). Samples were washed three more times in PBS before addition 
of DAPI (Sigma) for 10minutes, for cell nuclei visualisation. Fluorescent images were 
acquired on an Olympus IX70 wide field microscope with Spot RT Slider digital camera and 
Spot Advanced software, version 4.8 (Diagnostic Instruments). 
 
3.2.4 Flow Cytometry 
For iPSC-based flow cytometry analysis, colonies were dissociated to single cells using 
GCDR (37⁰C, 10 minutes) and trituration, prior to centrifugation (500xg, 5 minutes). Cells 
were resuspended in 10% neutral-buffered formalin solution (Sigma) for fixation for 15 
minutes under mild-shaking conditions. iPSC-derived NPC cultures were dissociated with 
Accutase (Stem Cell Technologies) (37⁰C, 10 minutes) and gentle trituration. The fixation 
procedure was the same as for dissociated iPSCs. Cell suspensions were passed through a 
40μm filter (BD Falcon) to ensure the removal of large cell aggregates. All washes were 
preceded by a centrifugation step to pellet cells from suspension. Cells were permeabilised 
through 0.1% Triton-X-100 in PBS (137mM NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4) for 
15 minutes at room temperature under gentle mixing. Cell suspensions were blocked in 1% 
Bovine Serum Albumin (BSA) (Sigma) in PBS for 1 hour at room temperature prior to the 
addition of primary antibodies or fluorescently labelled primary antibodies in block solution 
for 1 hour at room temperature: anti-Oct4 (Stem Cell Technologies 60093, 1:1000); anti-
Nanog (Cell Signaling Technology 4903, 1:1000); anti-Pax6 (Stem Cell Technologies 60094, 
1:1000); anti-Sox2-PerCp-Cy5.5 (BD Stemflow 561562 kit); anti-SSEA4-AF647 (BD Stemflow 
562626 kit); anti-Tra-1-60-PE (BD Stemflow 562626 kit); anti-Nestin-AF647 (BD Stemflow 
561562 kit); and anti-DCX-PE (BD Stemflow 561562 kit). Samples were centrifuged and 
washed three times with block solution. For non-fluorescently labelled primary antibody 
probes, a second incubation with secondary antibodies was done for 1 hour at room 
temperature: goat-anti-mouse IgG AF488 (Invitrogen A11029, 1:2000); donkey-anti-rabbit 
IgG AF488 (Invitrogen A21206, 1:2000); goat-anti-mouse IgG AF647 (Invitrogen A21236, 
1:2000); goat-anti-rabbit IgG AF647 (Invitrogen A21245, 1:2000). Data acquisition and 
analysis was performed on the CytoFLEX Flow Cytometer with CytExpert software, version 




3.2.5 Western Blot Assay 
For protein concentration and Western blot assays, cells were harvested with Accutase 
(Stem Cell Technologies) for 10 minutes at 37⁰C and gentle trituration. Cells were pelleted 
under centrifugation at 500xg for 5 minutes and the supernatant removed. Pellets were 
snap frozen at -80⁰C and stored until protein extraction. 
Cell pellets were resuspended in 100-200μl of M-PER Mammalian Protein 
Extraction Reagent (Thermo Fisher Scientific) and mixed gently at room temperature for 10 
minutes. After centrifugation at 10,000xg for 15 minutes the supernatants were 
transferred to new 1.7ml microfuge tubes and stored at -80⁰C until needed for 
downstream assays.  
A colourmetric Bradford assay was used for total protein quantification, calibrated 
against a Bovine Serum Albumin (BSA) (Sigma) standard curve. 1μl of each protein sample 
was utilised for protein quantification together with 200μl of 1:5 diluted Bradford Reagent 
(Bio-Rad). Absorbance readings at 590nm were measured on a FLUOstar Galaxy plate 
reader (BMG).  
For SDS-PAGE: protein samples were denatured at 70⁰C for 10mins in the presence 
of NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) and NuPAGE Sample Reducing 
Agent (Thermo Fisher Scientific). Protein samples were separated on BOLT 4-12% Bis-Tris 
Gels (Thermo Fisher Scientific) at 150V for 45 minutes. Molecular weight estimation was 
achieved with parallel loading of Precision Plus Protein Kaleidoscope Prestained Protein 
Standards (Bio-Rad). Protein lanes were transferred on to nitrocellulose membranes (GE 
Healthcare Life Sciences) using a Semi-Dry Transfer Cassette (Bio-Rad) at 20V for 70 
minutes in Bjerrum Schafer-Nielsen buffer (48mM Tris, 39mM glycine, 1.3mM SDS, 20% 
Methanol, pH 9). Successful protein transfer was confirmed with Ponceau S stain (0.1% 
w/v) in acetic acid, and de-stained through washing in Tris buffered saline (TBS) with 0.05% 
Tween-20 (TBST) (50mM Tris, 150mM NaCl, pH 7.6). Membranes were blocked for 1 hour 
at room temperature in 5% (w/v) low fat milk powder in TBST. Membranes were incubated 
with primary antibodies overnight in the block solution at 4⁰C on a plate rocker: anti-Nanog 
(Cell Signaling Technology 4903, 1:2000); anti-Nestin (Stem Cell Technologies 60091, 
1:2000); anti-TUJ1 (Covance MMS-435P, 1:2000); anti-neurofilament-H (Cell Signaling 
Technology #2836, 1:2000), anti-neurofilament-L (Cell Signaling Technology #2837, 1:2000); 
anti-Tau (Neuromics CH23018, 1:1000); anti-FOXG1 (Abcam ab18259, 1:2000); anti-Reelin 
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(Abcam ab138370, 1:1000); anti-BRN2 (DSHB, 1:750); anti-PSD95 (Abcam ab2723, 1:2000); 
anti-Synaptophysin (Abcam ab14692, 1:2000); anti-vGLUT1 (Sigma AMAb91041, 1:1000); 
anti-vGLUT2 (Abcam ab101760, 1:1000); anti-GAD65+67 (Abcam ab11070, 1:1000); anti-
GABAAR1 (Synaptic Systems 224204, 1:1000); anti-GABABR1 (Abcam ab55051, 1:1000); anti-
NMDAR1 (Millipore AB9864R, 1:1000); anti-AMPAR1 (Abcam ab31232, 1:1000); anti-S100β 
(Sigma S2532, 1:2000); anti-GalC (Millipore MAB342, 1:1000) & anti-GAPDH (Cell Signaling 
Technology #5174, 1:5000). Membranes were washed three times in TBST prior to addition 
of secondary antibodies. Membranes were incubated with secondary antibodies in block 
solution for 1 hour at room temperature on a plate rocker: Goat-anti-Mouse-HRP 
(Millipore, 1:10,000); Goat-anti-Rabbit-HRP (Millipore, 1:10,000); Donkey-anti-Chicken-HRP 
(Millipore, 1:10,000); Goat-anti-Guinea Pig-HRP (Invitrogen, 1:10,000) Membranes were 
washed a further three times in TBST and once in TBS prior to chemiluminescent detection. 
Imaging of protein bands on membranes was achieved on a ChemiDoc MP system (Bio-Rad) 
after incubation with Western Lightning® Ultra chemiluminescence substrate (Perkin 
Elmer). 
 
3.2.6 Gene Expression 
Relative gene expression analysis was performed using quantitative polymerase chain 
reaction (qPCR) methodology. Cells were harvested with Accutase (Stem Cell Technologies) 
for 10 minutes at 37⁰C and gentle trituration. Cells were pelleted under centrifugation at 
500xg for 5 minutes and the supernatant removed. Pellets were snap frozen at -80⁰C and 
stored until RNA extraction. 
RNA was purified from frozen cell pellet samples using the RNeasy Plus Mini Kit 
(Qiagen) as per the manufacturer’s instructions into a total elution volume of 50μl nuclease 
free water. RNA concentration was determined using an Ultraspec 2200 Pro 
Spectrophotometer (GE Healthcare Life Sciences) and RNA integrity was confirmed by 
running samples on a 1% Agarose (w/v)-EtBR Tris-acetate (TAE) buffered gel under 
electrophoretic conditions for 40 minutes at 80V followed by imaging on a ChemiDoc MP 
(Bio-Rad) to confirm sharp ribosomal RNA banding. 
 cDNA was generated from 1μg of each RNA using the Omniscript Reverse 
Transcription Kit (Qiagen) with 1μM oligo dTs (Thermo Fisher Scientific) and 1U/ml RNase 
Inhibitor (Qiagen). Reverse transcription reactions took place at 37⁰C for 80 minutes in a 
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20μl reaction volume. On completion of the reaction, samples were further diluted with 
20μl of nuclease free water. cDNA samples were stored at -20⁰C until used in qPCR 
reactions.  
 qPCR reactions were performed with SYBR Green PCR Master Mix (Qiagen) in 10μl 
reaction volumes with 1μM of each primer set. All primer pairs were designed using 
Primer-BLAST (NCBI) (Table 3-1). All amplicons were designed de novo to be between 50-
250bp in length and have equivalent primer annealing temperatures. 
 
 
Reactions were run on a RealPlex Mastercycler (Eppendorf) with the following 
parameters: 95⁰C for 2 minutes, then 40 cycles of 95⁰C for 5s and 60⁰C for 10s, followed by 
a melt curve recording. Amplicon specificity was determined via melt curve peak analysis. 




All relative expression data was normalised to HPRT1 housekeeping gene expression. Data 
were analysed by the ΔΔCt method in Microsoft Excel and statistical analyses performed in 
GraphPad Prism using multiple unpaired T-test analyses. Data is shown ± standard error of 
the mean with significance denoted when the p-value ≤0.05. Four biological repeats were 
completed for each differentiation type (dorsal/ventral) for each time point. Robust 
regression analysis of fold change expression data was performed in Stata statistical 
software (version 15.1). Regression coefficients were maintained between ordinary least 
squares (OLS) regression and those of the robust regression analysis. Raw output tables are 
displayed in Section 4.5.1. 
 
3.2.7 Electrophysiological Analyses 
For patch clamp-based electrophysiological recordings, NPCs were seeded on 13mm glass 
cover slips coated with poly-L-lysine (0.01%, Sigma) & laminin (20μg/ml, Sigma) and 
maintained in 12-well tissue culture plates. Cell-seeded coverslips were differentiated using 
the same protocol as for other molecular analyses (Section 3.2.2) before patch-clamp 
recordings. For electrophysiological recordings, coverslips were transferred to a recording 
chamber fitted to an AxioExaminer D1 microscope (Carl Zeiss) and cells were superfused at 
1–2 ml/min with a recording solution composed of 137mM NaCl, 5mM KCl, 10mM HEPES, 
1mM MgCl2, 2mM CaCl2, 10mM glucose (pH 7.35; 300–305 mOsmol/kg). Neurons were 
visually identified by a round-to-oval soma (diameter of ~ 10 μm) and patent bipolar 
processes. Whole-cell patch clamp recordings were made at room temperature using 
borosilicate microelectrodes (2–6 MΩ; 1.0 mm O.D.; 0.58 mm I.D., Sutter) filled with an 
internal solution containing 115mM K-gluconate, 10mM HEPES, 7mM KCl, 0.05mM EGTA, 
2mM Na2ATP, 2mM MgATP, 0.5mM Na2GTP (pH 7.3; 290–295 mOsmol/kg). All chemicals 
were purchased from Sigma unless otherwise indicated. Signals were recorded with a 
MultiClamp 700B amplifier (Molecular Devices), data acquisition system (Digidata 1440A, 
Molecular Devices), and AxoGraph X analysis software (AxoGraph Scientific). The above 
protocol was adapted from neurosensory cell patch clamp methodologies (Needham et al., 
2014). The data presented in Section 3.3.5 is representative of ventral-patterned neuronal 
cultures (n=9) and dorsal-patterned neurons (n=1) at Day 95 of differentiation. Preliminary 
data acquisition was attempted at Day 60 but limited success in patching of the cells 




3.3.1 Pluripotency Validation and Quantification 
To ensure robust and stable expansion and proliferation of hiPSCs prior to neural 
differentiation, protein markers of pluripotency such as OCT4, SOX2, NANOG and TRA-1-60 
were assayed via fluorescent immunocytochemistry (Fig 3-1). Each hiPSC colony showed 
strong nuclear-localised staining for the pluripotency-associated transcription factors OCT4, 
SOX2 and NANOG. The cell-surface pluripotency marker TRA-1-60 was also present 
throughout cells within each hiPSC colony.   
 
 
 To better quantify the quality of hiPSC colonies and to determine the number of 
differentiated cells within a stable culture that may have lost markers of pluripotency, 
hiPSCs underwent flow cytometric analysis. The same markers were chosen as for the 
immunocytochemical analysis above, together with another cell-surface pluripotency 
marker, SSEA4. Dual staining of both OCT4 and NANOG showed an OCT4-positive cell 
population of 96.41% and a NANOG-positive hiPSC population of 95.47% within a typical 
culture. Co-localisation of both OCT4 and NANOG was present in 95.08% of cells (Fig 3-2 A). 
Fig 3-1: Fluorescent immunocytochemistry of pluripotency-associated protein 
markers in hiPSC colonies. Pluripotency-associated transcription factors OCT4, 
NANOG and SOX2 show strong nuclear staining, as well as the cell-surface TRA-1-




This high proportion of pluripotent marker-positive cells was also observed when 
assaying for TRA-1-60 (95.25%), SOX2 (94.99%) and SSEA4 (99.40%) (Fig 3-2 B). Co-
localisation of these markers within the hiPSCs showed high correlation with each other: 
TRA-1-60 & SOX2 (92.98%), TRA-1-60 & SSEA4 (95.73%), and SOX2 & SSEA4 (95.18%). 
 
3.3.2 Generation of Neural Precursors from hiPSCs 
The first stage in neural differentiation of hiPSCs is the restriction of potency to that of a 
neuroectodermal or neuroepithelial lineage. In this study, initial germ layer restriction was 
achieved through dual-SMAD inhibition using a commercially available neural induction 
Fig 3-2: Flow cytometric analysis of undifferentiated hiPSC colonies for pluripotency-
associated protein markers. (A) NANOG and OCT4 dual staining. (B) Triple-staining of 
TRA-1-60, SOX2 and SSEA4. hiPSC samples (red), negative controls (green). 
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media (STEMdiff, Stem Cell Technologies) (NIM). Gene expression analysis of hiPSCs 
dissociated as single cells and grown in monolayer in NIM for 7 days showed strong down-
regulation of the pluripotency-associated gene OCT4 (~250-fold less seen at Day 7 than Day 
0), and robust upregulation of the neural precursor cell (NPC) marker PAX6 over 7 days of 
neural induction (Fig 3-3 A), with an approximate 128-fold increase from Day 3 to Day 7 of 
differentiation. All fold change differences in gene expression reached statistical 
significance, with PAX6 non-detectable in undifferentiated Day 0 hiPSCs.  
 
Fig 3-3: Gene and protein expression of pluripotency and neural precursor cell markers 
over 7 days of neural induction. (A) qPCR analysis of the pluripotency marker OCT4 
downregulation during differentiation, and the upregulation of the early neural 
precursor marker PAX6. Data is shown as mean values ± standard error of the mean. 
Statistical significance denoted by * p≤0.05, ** p≤0.01. ND; Not detected. (B) 
Upregulation of PAX6 protein expression over the same time course of neural 




Upregulation of this NPC marker transcript was also reflected at the protein level, 
with PAX6 protein being robustly upregulated in differentiating hiPSCs over 7 days of neural 
induction, as shown through fluorescent immunocytochemistry (Fig 3-3 B). 
 This upregulation of the early NPC marker PAX6 at both the gene and protein 
expression level is indicative of early forebrain neural differentiation events, together with 
the downregulation of OCT4 gene expression showing the loss of pluripotent cell identity.  
 To better quantify the efficiency of neural induction and to track the degree of 
forebrain precursor marker expression and concurrent loss of pluripotency markers, 
differentiating cells underwent quantitative flow cytometry. Over 10 days of neural 
differentiation, the percentage of cells expressing OCT4 dropped from 97.26% in 
undifferentiated (Day 0) hiPSCs to 2.52% after 10 days of neural induction (Fig 3-4 A). The 
loss of pluripotency-associated markers occurred very early on in the differentiation with 
OCT4-positive cells accounting for 52.40% of the cell population after 1 day of 
differentiation, and 45.63% of cells by Day 3. After 7 days of neural induction only 3.31% of 
assayed cells showed OCT4 marker expression.  
    At later stages within the neural induction time frame, PAX6-positive cells 
accounted for 74.57% of the population by Day 7 and 82.46% by Day 10 (Fig 3-4 B). This 
high degree of neural induction efficiency is mirrored when looking at another NPC marker: 
the intermediate filament protein NESTIN. After 7 days of neural induction NESTIN-positive 
cells were present at a level of 88.90%, which remained stable at 88.32% by Day 10. 
However, the NPC/early neuronal protein marker DOUBLECORTIN (DCX) showed no 
expression in NPC cultures by Day 7 or 10, demonstrating that more extensive 
differentiation timelines are necessary to derive more mature NPC and neuronal markers. 
 To further refine the induction protocol, a second proliferative media (also 
commercially available) termed neural proliferation media (NPM) was studied in parallel to 
NIM induction alone to assay any positive or negative effects on NPC induction and marker 
expression. After 14 days of NIM-alone differentiation of hiPSCs, a high prevalence of PAX6-
positive cells was maintained in the population, but the level of NESTIN-positive cells was 
more restricted in the NPC cultures and was predominantly localised to aggregated cell 
clusters in the monolayer induction culture (Fig 3-5). However, a stepwise neural 
differentiation of 7 days of NIM treatment followed by 7 days of NPM triggered NPC 




Fig 3-4: Flow cytometric analysis of pluripotency markers, neural precursor markers and 
early born neuronal markers in hiPSC cultures undergoing neural induction. (A) Levels of 
OCT4-positive cells during 10 days of neural differentiation. (B) PAX6 and NESTIN 
positive cells represent successful neural precursor induction by Day 7-10 of 
differentiation. Negative DOUBLECORTIN staining indicates no early-neuronal cells are 
present in the precursor pool. iPSCs/NPCs (red), negative controls (green). 
110 
 
widespread NESTIN signal throughout the culture. Interestingly, the size of cell nuclei also 
appeared to show differences under these differing culture conditions. NIM-alone treated 
NPCs retained smaller and more densely packed cell nuclei, whereas the NIM-NPM treated 
neural cultures showed bias to larger nuclei (Fig 3-5). This demonstrates that distinct 
differences within the differentiation pathway are occurring between these two methods 
resulting in higher degrees of NESTIN induction in cultures exposed to NPM following dual 
SMAD-inhibition methods of neural induction.  
 
 To fully differentiate the NPC cultures into mature neural cells displaying typical 
neuronal morphology and marker expression, media composition was changed to a neural 
maturation media (NMM) containing N2 and B27 primary neural culture supplements as 
well as brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor 
(GDNF) and the gamma-secretase inhibitor N-[N-(3,5-difluorophen- acetyl)-l-alanyl]-S-
phenylglycine t-butyl ester (DAPT) (See Methods Section 3.2.2). This procedure of neural 
induction of hiPSCs and consequent maturation resulted in neural cell cultures displaying 
extensive neuritogenesis and branching, together with mature neuronal marker expression 
of β-III-TUBULIN after 28 days of differentiation (Fig 3-6 B). This methodology therefore was 
adopted for all future hiPSC neural differentiation experimental setups, with the procedure 
outlined in Fig 3-6 A. To retain adequate levels of cell viability during differentiation, the 
RHO/ROCK pathway inhibitor Y-27632 was added as a component of the NIM media. 
Fig 3-5: Neural precursor marker expression in hiPSCs undergoing neural differentiation 
over 14 days with either neural induction media (NIM) alone, or in 7 days of NIM and 7 
days of neural proliferation media (NPM). Cell nuclei are visualised with DAPI stain. 
Scale bars represent 100μm. 
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It is interesting to note that even after 4 weeks of neural differentiation, the NPC 
marker PAX6 was still retained in a subset of cells, indicating the early-neuronal nature of 
the derived cells and the retention of NPC cell identity throughout differentiation. All of 





Fig 3-6: Schematic representation of neural differentiation protocol of hiPSCs and 
example images of derived neural cultures. (A) Timeline of the hiPSC-neural 
differentiation pathway involving stepwise treatment with neural induction media 
(NIM), neural proliferation media (NPM) and maturation media. The maturation media 
also contained the neurotrophic factors; brain-derived neurotrophic factor (BDNF), glial 
cell-derived neurotrophic factor (GDNF), and the Notch signalling inhibitor N-[N-(3,5-
difluorophen- acetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT). (B) Fluorescent 
immunocytochemistry of hiPSC-derived neural cultures after 4 weeks of differentiation 
showing the mature neuronal marker β-III-TUBULIN and NPC marker PAX6. Cell nuclei 
are shown through a DAPI stain. Scale bars represent 100μm. 
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3.3.3 Dorsal Forebrain Differentiation and Maturation 
Following the neural induction principles outlined above (Section 3.3.2), hiPSCs were 
differentiated towards a neural lineage for 60 days. No other patterning morphogens were 
added into any stage of the differentiation protocol in order to derive the default dorsal 
forebrain excitatory neuronal identity as is seen in other differentiation studies (Gaspard et 
al., 2008; Zeng et al., 2010; Shi et al., 2012; Shi, Kirwan and Livesey, 2012). Following this 
extended maturation period, extensive neurite outgrowths developed in the iPSC-derived 
neural cultures together with positive immunostaining of both neuronal and astroglial 
markers (Fig 3-7).  
A subpopulation of cells within the hiPSC-derived neural culture maintained NPC 
marker expression (PAX6 and NESTIN) even after 60 days of differentiation and maturation, 
showing retention of neural precursor characteristics. Widespread neural morphology in 
tandem with strong positive staining of the neuronal markers β-III-TUBULIN, MAP2 and 
GAP43 were seen throughout the iPSC-derived cultures at this time point: indicative of 
successful and highly efficient neural induction and maturation. Interestingly, the astroglial 
markers Glial Fibrillary Acidic Protein (GFAP) and S100β were also present in cells within 
the neural culture that did not show colocalisation with the β-III-TUBULIN neuronal marker, 
but robust colocalisation with each other (Fig 3-7). These cell types also had an immature 
cell morphology suggesting an early degree of astroglial differentiation, which does agree 
with in utero forebrain neurogenesis where glial cell differentiation follows chronologically 
that of neuronal differentiation (Hansen, Rubenstein and Kriegstein, 2011).  
This dorsal-forebrain default neural differentiation pathway gives rise to cortical-
associated structures in vivo and in vitro. To track the development of cortical generation 
and lamination events in vitro we observed markers known to localise to particular early-
born (deep layer) and late-born (upper layer) cortical neurons (Fig 3-8). Reelin is an 
extracellular glycoprotein secreted from Cajal-Retzius cells, which form the outermost layer 
(Layer I) of the developing cortex (Frotscher et al., 2009). REELIN immunostaining of iPSC-
derived dorsal neural cultures showed diffuse but positive staining suggestive of a small 
proportion of neural cells of the early outer cortical plate (Fig 3-8). The transcription factor 
TBR1 is highly expressed within cells of the cortical preplate and within layer VI early-born 





these in vitro neural cultures, suggestive of not only cortical plate identity but also more 
mature deep layer cortical generation events. This is mirrored by the protein expression of 
CTIP2, a zinc finger transcription factor, that localises to neural cells in layer V of the 
developing cortex. A subpopulation of CTIP2-positive cells in these in vitro neural cultures is 
suggestive of development beyond cortical preplate generation. Late-born neurons or 
Fig 3-7: Fluorescent immunocytochemistry of hiPSC-derived neural cultures after 60 days 
of differentiation. A subpopulation of cells retain the NPC markers PAX6 and NESTIN, 
while many display the canonical neuronal markers β-III-TUBULIN, MAP2, and GAP43. 
Astroglial markers (GFAP and S100β) are also seen colocalised in a subpopulation of cells. 
Nuclei shown through DAPI staining. Scale bars represent 100μm. 
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upper cortical layer neurons (layers II-IV) show different protein marker expression and a 
well-known marker of these cell types and layer identity is BRN2. BRN2 expression within 
the in vitro iPSC-derived neural cultures at this time point was less prevalent than was seen 
for TBR1 and CTIP2 (Fig 3-8). As BRN2-positive neurons and upper layer cortical identity 
follows a more protracted timeline of development than deep layer neurons, this further 
shows that these neural cultures are representative of developmental timings and 
cytoarchitecture formation events seen in utero.    
  
As well as localisation markers by which to describe the comparable in vivo-
location of the differentiating neural cultures, we also aimed to describe the neuronal 
Fig 3-8: Fluorescent immunocytochemistry of cortical-associated layer markers of 
hiPSC-derived neural cultures. REELIN staining indicative of outer-layer (layer I) cortical 
identity. TBR1 associated with early-born (layer VI) and preplate cortical regions. CTIP2-
positive staining representative of layer V cortical regions. BRN2 as a marker of late-




subtype specificity of the derived neural cells. Dorsal forebrain differentiation reportedly 
derives excitatory glutamatergic pools of neuronal cells. To this end we stained for the 
presence of the presynaptic glutamate re-uptake transporter vGLUT2 and the glutamate 
decarboxylase enzymes GAD65+GAD67, present within glutamatergic neurons and 
GABAergic inhibitory neuronal subtypes respectively (Fig 3-9). From these data it is clear 
that the vast majority of derived neural types using this differentiation protocol expressed 
markers of excitatory glutamatergic neurons, and not of inhibitory GABAergic cell types. 
This fits with the known patterning effects and down-stream neural-tube derived signalling 
events that predispose NPCs to differing lineage subtypes as outlined in Section 3.1.  
 
To better track protein markers of neural differentiation and maturation over time, 
Western blot analysis of a panel of neural markers was undertaken to investigate the 
timing and maturation events of the hiPSC-derived neural cultures (Fig 3-10). The 
pluripotency-associated marker NANOG was highly expressed in undifferentiated hiPSC 
cultures but was completely absent during extended neural induction from 14 days to 60 
days post induction, showing the expected loss of stem cell pluripotency after initiation of 
differentiation. The NPC marker NESTIN showed no expression within undifferentiated 
hiPSC cultures, but instead peaked at Day 14 post-neural induction following the expected 
timeline of NPC generation, and was also present but to a lesser degree after neural 
Fig 3-9: Fluorescent immunocytochemistry of excitatory and inhibitory neuronal 
markers of hiPSC-derived neural cultures. The excitatory glutamatergic marker VGLUT2 
shows high level expression throughout the culture, whereas the GABAergic markers 
GAD65+67 show no expression in the derived neuronal cells. Nuclei are shown through 
DAPI staining. Scale bars represent 100μm. 
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maturation following 60 days of differentiation. β-III-TUBULIN expression was seen at Day 
14 post-neural induction and continued to increase in intensity over the full time-course of 
differentiation, demonstrating the development and enrichment of neuronal cells within 
the culture. This early expression profile shows that canonical neuronal lineage markers are 
expressed early in the differentiation process, but other markers of neuronal 
differentiation, such as the axonal marker TAU and the neurofilament-light and -heavy 
chains (NF-L and NF-H), required more extended periods of maturation before detectable 
levels are seen in hiPSC-derived neural cultures in vitro (Fig 3-10). 
  
The early forebrain and telencephalic marker FOXG1, as well as the early- and late-
born cortical neuronal markers REELIN and BRN2 all showed protein expression by Day 60 
of neural differentiation. The presence of these temporo-spatial localisation markers 
reinforces the finding that neural cultures differentiated in this way are biased to lineages 
derived from dorsal-anterior neural tube regions.  
Fig 3-10: Western blot analysis for an array of neural markers present within 
undifferentiated hiPSCs, hiPSC-NPC cultures after 14 days of differentiation, and 
hiPSC-derived dorsal neural cultures after 60 days of differentiation. 
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For neural networks to form in vitro, as they do developmentally, it is important 
that they express and assemble molecular machinery that form functional synaptic 
connections. By observing the presence of proteins involved in pre- and post-synaptic 
pathways it is possible to infer that neural cells in culture have the capacity to form such 
connections with surrounding cells. To this end the pre-synaptic marker SYNAPTOPHYSIN 
(SYN) and post-synaptic density marker 95 (PSD95) protein expression were both 
investigated. By Day 60 of neural differentiation, both SYN and PSD95 displayed detectable 
levels of protein expression, showing that the differentiating neurons were expressing 
genes relevant to pre- and post-synaptic structure formation (Fig 3-10).  
 For neuronal subtype identification; the glutamatergic pre-synaptic markers 
vesicular glutamate transporters vGLUT1 and vGLUT2 showed robust expression after 60 
days of neural differentiation, with a lower expression of vGLUT2 after 14 days of 
differentiation. The GABAergic neuronal markers GAD65+67 were not detected in these 
neural cultures (Fig 3-10). Taken together, this suggests a prominent bias towards 
differentiation to excitatory neuronal subtypes.  
 Together with general synaptic machinery, the array and type of neurotransmitter 
receptors present within neural cultures are indicative of the maturity of the cells as well as 
displaying which neurotransmitters functional neural networks would respond to. The 
ionotropic glutamate receptors N-Methyl-D-Aspartate Receptor 1 subunit (NMDAR1, also 
designated as GluN1), and α-Amino-3-hydroxy-5-Methyl-4-isoxazole Propionic Acid 
Receptor 1 subunit (AMPAR1) both displayed protein expression by Day 60 of 
differentiation (Fig 3-10). The presence of both of these functional receptors would enable 
neuronal sensitivity and response to glutamate-based neurotransmission. The ionotropic 
GABA-A receptor (GABAAR1 subunit) and the G-protein coupled GABA receptor subunit 
GABABR1 were also highly expressed within the hiPSC-derived dorsal neural cultures at 
later time points (Fig 3-10). The presence of all four neurotransmitter receptors at the 
protein level after 60 days of differentiation suggests that mature neuronal cells may be 
sensitive to both excitatory and inhibitory neurotransmitter signalling.  
 The astroglial marker S100β, was also expressed by Day 60 of differentiation, which 
illustrates that astrocytic lineages were also a component of neural cultures at this level of 
maturation. However, galactosylceramidase (GALC) a marker of mature oligodendrocytes, 
and lineage restricted oligodendrocyte precursors, did not display any positive signal 
through Western blot analysis (Fig 3-10). This either suggests a longer maturation time may 
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be necessary by which to generate oligodendroglial lineages, or that this pathway of 
lineage differentiation is intrinsically low in dorsal forebrain neural induction.   
 
3.3.4 Molecular Comparisons of Dorsal and Ventral Forebrain Neural 
Lineage Differentiation 
In parallel with hiPSCs differentiated towards default forebrain “dorsal” lineages, we also 
wanted to investigate differentiation of NPCs to “ventral” neural tube lineages through 
morphogen patterning via the SHH pathway agonist Purmorphamine (Pur). For direct 
timeline comparisons to be made, the scheme of neural induction, proliferation and 
maturation was kept the same as outlined in Section 3.3.3, but with the addition of Pur 
from Day 2 to Day 14 of differentiation (Fig 3-11). 
Fig 3-11: Schematic representation of the protocols for parallel differentiation of dorsal 
(excitatory) forebrain lineages and ventral (inhibitory) forebrain lineages from hiPSCs. 
Both differentiation pathways include stepwise treatment with neural induction media 
(NIM), neural proliferation media (NPM) and maturation media. The maturation media 
also contained the neurotrophic factors; brain-derived neurotrophic factor (BDNF), glial 
cell-derived neurotrophic factor (GDNF), and the Notch signalling inhibitor N-[N-(3,5-
difluorophen- acetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT). In addition, the 
ventral differentiation pathway contained purmorphamine (Pur) a small molecule 
agonist of the sonic hedgehog signalling pathway. 
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After 60 days of differentiation following these protocols, protein marker 
expression was assayed through fluorescent immunocytochemistry. The early-cortical layer 
VI and preplate marker TBR1 showed extensive expression in dorsal neural cultures (as was 
seen in Section 3.3.3) but was lacking from neural cultures that underwent ventralising 
pathway signalling (Fig 3-12), despite having comparable levels of β-III-TUBULIN-positive 
neuronal cells.  
Fig 3-12: Fluorescent immunocytochemistry of early and late cortical plate markers in 
neural cultures differentiated from hiPSCs into dorsal and ventral forebrain lineages. All 
samples are stained with β-III-TUBULIN to highlight mature neuronal cell types and also 
markers of deep-layer and upper-layer cortical markers TBR1, CTIP2 and BRN2. Cell 
nuclei are imaged through DAPI staining. Scale bars represent 100μm. 
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As well as positive staining within nuclei of dispersed neural cells, TBR1 expression 
was also strongly localised to the outer layer of neural ganglia-like structures that formed 
within the differentiating cultures (Fig 3-12, white arrow heads). This pattern of staining is 
indicative of organoid-like cortical self-organisation within these cellular aggregates.  
Fig 3-13: Fluorescent immunocytochemistry of excitatory and inhibitory neuronal 
markers in neural cultures differentiated from hiPSCs into dorsal and ventral forebrain 
lineages. All samples are stained with β-III-TUBULIN to highlight mature neuronal cell 
types with glutamatergic markers vGLUT1/2 and GABAergic markers GAD65+67. Cell 
nuclei are imaged through DAPI staining. Scale bars represent 100μm. 
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A similar pattern was also observed in dorsal cultures that displayed CTIP2-positive 
expression, with strong staining in the outer layer of cellular aggregates within the cultures 
(Fig 3-12). Unlike TBR1 however, CTIP2 staining was prevalent throughout the ventralised 
neural culture which suggests a role for CTIP2 within ventral neural tube neural lineage 
generation. The upper-layer cortical marker BRN2 showed dense staining in dorsal neural 
cultures which were predominantly localised and prevalent in ganglion-like aggregates. It 
was however, also seen to a lesser degree within ventral-patterned neural lineages. 
Striking differences between markers of neuronal subtype specificity were also 
apparent between dorsal and ventral patterned cultures (Fig 3-13). The glutamatergic 
neuronal markers vGLUT1 and vGLUT2 both displayed higher degrees of staining within 
dorsal rather than ventral cultures. Conversely, the GABAergic markers GAD65+67 showed 
higher levels of expression from ventrally-patterned cell lineages. 
To better understand the potential neurotransmitter responsiveness of each neural 
lineage subtype, we investigated the presence of the ionotropic glutamate receptor subunit 
AMPAR1, and the ionotropic and metabotropic GABA receptor subunits GABAAR1 and 
GABABR1 respectively (Fig 3-14). Intriguingly, even though AMPAR1 protein expression was 
seen in both dorsal and ventral patterned cultures and did show colocalisation with cells 
expressing the neuronal marker β-III-TUBULIN, a strong presence of this glutamate 
receptor was also visualised in surrounding cell types, with weaker or absent mature 
neuronal staining. Conversely, the staining pattern for GABAAR1 showed near perfect 
overlap with post-mitotic neuronal cells in both dorsal and ventral neural cell pools, with 
no apparent staining in other cells of glial or immature lineage. The G-protein coupled 
receptor subunit GABABR1, in contrast, only showed prevalent staining in non-neuronal cell 
types. Suggesting a developmental effect of this metabotropic receptor at this stage of 










Fig 3-14: Fluorescent immunocytochemistry of neurotransmitter receptor subunit 
markers in neural cultures differentiated from hiPSCs into dorsal and ventral forebrain 
lineages. All samples are stained with β-III-TUBULIN to highlight mature neuronal cell 
types. Other staining displays the ionotropic glutamate receptor subunit AMPAR1, and 
the GABA-receptor subunits GABAAR1 and GABABR1. Cell nuclei are imaged through 
DAPI staining. Scale bars represent 100μm. 
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To more accurately compare neural marker expression levels between the dorsally- 
and ventrally-patterned neural cultures, we undertook Western blot analysis of a wide 
panel of proteins related to; post-mitotic neuron identity & axonogenesis, neuronal 
neurotransmitter subtype, developmentally related forebrain localisation, pre- and post-
synaptic machinery, and neurotransmitter receptor subunits (Fig 3-15).  
Neither neural culture derived through the dorsal or ventral differentiation 
protocol displayed any expression of the pluripotency marker NANOG, while it was highly 
expressed in undifferentiated hiPSCs. The neuronal structural protein β-III-TUBULIN and 
axonal marker TAU showed comparable levels of protein expression in both dorsal and 
ventral cultures after 60 days of maturation, with a slight elevation seen within the 
ventrally-patterned cultures. However, neurofilament-light chain (NF-L) was seen at a much 
lower level in ventral cultures than the default excitatory dorsal cell populations. None of 
the above markers were observed in undifferentiated hiPSC cultures (Fig 3-15).  
 Stark and robust differences were seen at the protein expression level for 
identifiers of excitatory neurons and inhibitory interneurons between dorsal and ventral 
cultures. The glutamatergic neuronal marker vGLUT1 was only detected within dorsally-
patterned neural cultures, whereas the GABAergic neuronal markers GAD65+67 were 
conversely only detected in ventrally-patterned differentiation cultures (Fig 3-15). 
 The early forebrain marker FOXG1 was strongly expressed in both dorsal and 
ventral cultures, indicating both retained anterior neural tube marker characteristics. 
However, divergence was observed when looking at the early-cortical marker REELIN and 
late-cortical marker BRN2, which were both expressed within dorsally-patterned neural 
cells but were either absent (in the case of REELIN) or reduced (in the case of BRN2) in 
ventrally-patterned cultures. These results highlight the dorsal-ventral cellular identity and 
brain regionalisation instigated respectively by these neural induction protocols. 
 The pre- and post-synaptic markers SYNAPTOPHYSIN and PSD95 mirror the 
expression of the neuronal and axonal markers, and were detected in both dorsal and 
ventral cultures, again with a slightly biased elevation in ventrally-patterned neural cells.  
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 The GABAergic neurotransmitter receptor subunits GABAAR1 and GABABR1, in 
contrast, were much more highly expressed in neural cultures undergoing ventral 
differentiation than dorsal patterned cultures, although they did still retain detectable 
levels of each receptor subunit (Fig 3-15). The glutamate receptor subunit NMDAR1 
showed much more comparable levels of expression between the two methods of neural 
induction, albeit again with a slight elevation within ventral-patterned neural cells.  
  
To develop a greater resolution of gene regulation timings and strengths between 
dorsal- and ventral-patterned neural cultures; quantitative polymerase chain reaction 
(qPCR) analysis was used to investigate the level of gene expression in each patterned 
culture over the time-course of differentiation (Fig 3-16 to Fig 3-21).  
The relative expression of the NPC marker NESTIN peaked by Day 20 in dorsal-
patterned cultures, and Day 30 in ventral cultures, before reduction to lower expression 
levels over the remaining time course of differentiation. At all the time points assayed, the 
pattern of early NESTIN upregulation and then downregulation was followed in both dorsal 
and ventral cultures with no significant differences in expression level. There was a slight 
Fig 3-15: Western blot analysis for an array of neural markers present within 
undifferentiated hiPSCs, and dorsal- & ventral-patterned hiPSC-neural cultures 
after 60 days of differentiation. 
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trend for ventral cultures to display higher levels of expression at the later time points 
assayed but this difference never reached statistical significance (Fig 3-16). The dorsal-NPC 
marker PAX6 followed a similar peak of expression in the early stages of neural 
differentiation (Day 20) before subsiding to a lower but stable level of expression. This 
pattern was restricted to dorsal-patterned cultures which show increased and statistically 
significant higher expression levels compared to PAX6 expression within ventral-patterned 
cultures on Day 20, 30 and 40 of differentiation. The reverse is true of the ventral-NPC 
marker NKX2.1, which is barely detectable in dorsal-patterned cultures, but shows robust 
and substantially higher relative expression in ventral-patterned neural cells at all time 
points assayed (all of which reached statistical significance). For all three of these NPC 
markers; a peak of expression around Day 20 of differentiation suggests the maximal 
generation of neural precursors after approximately three weeks of differentiation with a 
gradual decrease over the following 40 days of differentiation and maturation. 
  
Fig 3-16: Quantitative PCR analysis for NPC markers expressed within dorsal- and 
ventral-patterned hiPSC-derived neural cultures over 60 days of differentiation. Data is 
shown as mean values ± standard error of the mean of four independent experiments. 




Similar analyses were performed to observe changes in the canonical neuronal 
marker β-III-TUBULIN and axonal marker TAU, as well as the pre- and post-synaptic 
associated markers SYNAPTOPHYSIN and PSD95 (Fig 3-17). β-III-TUBULIN expression 
showed a strong early expression by Day 20 in dorsal cultures, which lowered by 
approximately half for the remainder of the differentiation period. In contrast, ventral 
cultures displayed a more delayed peak of β-III-TUBULIN expression (Day 30) which 
dropped over the next 30 days of differentiation. However, expression levels in ventral 
cultures were significantly higher than those seen in dorsally-patterned cultures from Day 
30 to 50 (~2.1-fold higher at Day 30). In addition, the axonal marker TAU, showed a pattern 
of continuous slight upregulation over the 60-day time-course of differentiation in both 
dorsal and ventral cultures, with a trend of higher levels of expression in ventral cultures at 
Day 50 and 60, however this difference did not reach statistical significance (Fig 3-17). 
 
 
Fig 3-17: Quantitative PCR analysis for neuronal and synaptic markers expressed within 
dorsal- and ventral-patterned hiPSC-derived neural cultures over 60 days of 
differentiation. Data is shown as mean values ± standard error of the mean of four 
independent experiments. Statistical significance denoted by * p≤0.05, ** p≤0.01 based 
on unpaired two-tailed t-tests. 
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The pre-synaptic marker SYNAPTOPHYSIN showed a distinct point of upregulation 
after 20 days of dorsal-patterned differentiation. This level of expression was maintained 
within dorsally-patterned cultures for the remainder of the assayed differentiation timeline 
with a slight drop by Day 60. Relative to dorsal cultures, ventral cultures showed a delayed 
peak of expression (at Day 30 - mirroring the temporal peak of β-III-TUBULIN expression) 
and maintained a similar level of expression until Day 60. A trend for higher expression 
levels of SYNAPTOPHYSIN within these later time points in ventral cultures was seen, 
although statistically significant increased expression was only recorded at Day 50 between 
the two differentiation strategies. A similar timing peak of PSD95 expression was also seen 
after 20 days of neural induction and maturation that was stable over the time course of 
dorsal differentiation but appeared to peak at Day 30 in ventral cultures (which 
represented a significant increase relative to the dorsal expression level), before lowering 
to dorsal-patterned equivalent expression levels (Fig 3-17).   
 To monitor excitatory and inhibitory neuronal maturation in either the dorsal or 
ventral neural patterning schemes, we also tracked gene expression levels of glutamatergic 
and GABAergic pre-synaptic neuronal markers (Fig 3-18). Dorsal-patterned differentiation 
of hiPSCs resulted in increased expression of the glutamatergic neuronal makers vGLUT1 
and vGLUT2 after 20 days of differentiation that remained steadily expressed until Day 60. 
However, the GABAergic markers GAD67 and GABA Transporter 1 (GAT1) displayed very 
low level basal expression without robust upregulation over the timeline of differentiation. 
In contrast to this, ventrally-patterned neural cultures showed steady upregulation of both 
GAD67 (from Day 14) and GAT1 (from Day 30) during differentiation, which by later 
timepoints showed statistically significant increases compared to the levels seen in dorsal 
cultures. In tandem with this, glutamatergic markers in ventral cultures were repressed 
under these patterning conditions, whereby vGLUT1 expression was far below that seen in 
dorsal neural culture (Day 20-50) (Fig 3-18). This repression of glutamatergic neuronal 
identity was less pronounced when looking at vGLUT2 expression, which although 
displayed a trend of lower expression in ventrally-patterned cultures than dorsal, these 
lower expression levels did not reach statistical significance. For both sets of these 
glutamatergic and GABAergic markers, it is apparent that there is much more robust 
upregulation of the non-default ventral lineage markers in the ventral-targeted 





After understanding the extent of neuronal subtype divergence triggered by the 
patterning protocols during differentiation, we examined how markers of forebrain cortical 
localisation differed between the differentiation pathways. Observing the expression of the 
early- to late-cortical formation markers REELIN, TBR1, CTIP2 and Special AT-rich sequence 
Binding protein 2 (SATB2) we were able to track the timing of markers relevant to deep-
layer and upper-layer cortical neuronal generation in vitro (Fig 3-19).  
Across all the cortical markers assayed, robust gene expression was seen only in 
dorsal-patterned cultures, with comparably lower levels seen in ventrally-induced cell 
populations. This is again not only suggestive of a neuronal subtype divergence triggered by 
each patterning methodology, but also one of brain region specification. However, it should 
be noted that the level of expression for the cortical localisation markers displayed high 
variation between biological repeats – resulting in a large spread of expression data. As 
each marker is suggestive of only a subset of excitatory neural types it is possible that a 
Fig 3-18: Quantitative PCR analysis for excitatory and inhibitory neuronal markers 
expressed within dorsal- and ventral-patterned hiPSC-derived neural cultures over 60 
days of differentiation. Data is shown as mean values ± standard error of the mean of 
four independent experiments. Statistical significance denoted by * p≤0.05, ** p≤0.01, 
*** p≤0.001 based on unpaired two-tailed t-tests. 
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stochastic generation of each subtype may strongly alter bulk mRNA expression from mixed 
cultures between biological repeats. Even so, strong upregulation of excitatory cortical 
markers was only recorded within dorsally-patterned cultures, albeit with high variance. A 
strong upregulation of the layer I marker REELIN by Day 20 and 30 post-differentiation 
dropped to a stable plateau for the remainder of the maturation timeline, and similar 
patterns are seen for both the cortical pre-plate and layer V/VI markers TBR1 and CTIP2 
expression (Fig 3-19).  
The upper-layer late-born cortical marker SATB2 also showed slight upregulation 
over the course of differentiation, however the relative expression only reached just over a 
two-fold increase at its peak, suggestive of a baseline expression that still shows heavy bias 
in dorsally-patterned lineages, but which does not show a dramatic increase within the 
timeframe of this assay.  
  
 
Fig 3-19: Quantitative PCR analysis for early and late cortical markers expressed within 
dorsal- and ventral-patterned hiPSC-derived neural cultures over 60 days of 
differentiation. Data is shown as mean values ± standard error of the mean of four 
independent experiments. Statistical significance denoted by * p≤0.05, ** p≤0.01, *** 
p≤0.001 based on unpaired two-tailed t-tests. 
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 In order to further visualise the extent of the efficacy of neuronal subtype 
patterning we undertook robust regression analysis to compare each subtype-specific 
marker expression profile over the full time course of differentiation. Rather than simple 
point-to-point statistical comparisons this methodology seeks to compare the difference in 
the overall strength and pattern of expression between dorsal- and ventral-patterned 
neural cultures for each gene. The markers analysed were those related to dorsal neuronal 
identity (vGLUT1 and vGLUT2), ventral neuronal identity (GAD67 and GAT1), and cortical 
(dorsal) localisation (REELIN, TBR1, CTIP2 and SATB2) (Table 3-2).  
 From this analysis it can be seen that a strong, statistically significant divergence is 
seen from both dorsal/excitatory neuronal markers when comparing dorsally-patterned 
and ventrally-patterned neural cultures across the 60 days of differentiation. Both vGLUT1 
and vGLUT2 show strong significant differences in expression between the dorsal and 
ventral cultures when analysed using regression methodologies. This is equally mirrored 
with the expression pattern of the ventral neuronal markers GAD67 and GAT1, which only 
maintain robust expression patterns within ventrally-patterned neural cultures (Table 3-2 
and Fig 3-18) 
  
 The forebrain cortical localisation markers are also shown by this analysis to be 
statistically biased to expression predominantly within dorsally-patterned neural cultures 
for all of the early to late cortical marker genes (REELIN, TBR1, CTIP2, and the modestly 
expressed SATB2) (Table 3-2). Taken altogether this analysis confirms the divergence in 
Table 3-2: Regression analysis table of dorsal and ventral neuronal identity gene 
markers for the time course of differentiation for dorsally versus ventrally patterned 
neural cultures. Statistical significance denoted by * p≤0.05, ** p≤0.01, *** p≤0.001. 
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neuronal subtype differentiation that is occurring during the dorsal and ventral patterning 
techniques used in this chapter. 
As another indicator of neuronal maturity and synaptic-associated development, 
we chose to observe the gene expression patterns of both the glutamatergic receptor 
subunits NMDAR1 and AMPAR1, as well as the ionotropic and metabotropic GABA receptor 
subunits GABAAR1 and GABABR1 (Fig 3-20). 
  
 
The GABAergic receptor subunit GABAAR1 showed a delayed upregulation 
expression profile in ventral-patterned cultures (Day 40-60) relative to dorsal neural cell 
types, which showed a trend for lower gene expression at these later time points but an 
earlier onset of receptor expression. Only at Day 40 of differentiation did ventral neural 
cultures show a statistically significant increase of GABAAR1 expression compared to dorsal-
Fig 3-20: Quantitative PCR analysis for glutamatergic (AMPAR1 and NMDAR1) and 
GABAergic (GABAAR1 and GABABR1) neurotransmitter receptor subunits expressed 
within dorsal- and ventral-patterned hiPSC-derived neural cultures over 60 days of 
differentiation. Data is shown as mean values ± standard error of the mean of four 
independent experiments. Statistical significance denoted by * p≤0.05 based on 
unpaired two-tailed t-tests. 
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patterned cell types (~4.6-fold higher). A more robust, early, and stable pattern of gene 
upregulation was seen in both dorsal and ventral-cultures for GABABR1 expression from 
Day 20 onwards. Again, there was a trend for higher relative expression in ventrally-
patterned neural cells at each time point (Fig 3-20).  
NMDAR1 subunit expression showed a steady expression profile in dorsal cultures 
from Day 20, but a gradually increasing pattern within ventral cultures, which reached a 
statistically significant difference at Day 60. A comparable expression profile over the 
timeline of differentiation was seen for AMPAR1 gene expression in both dorsal and ventral 
differentiation pathways, albeit with a slight increase in ventral cell types at later time 
points. A peak in expression at Day 30-40 post induction was seen in both dorsal- and 
ventral-patterned cultures that gradually lowered over the course of maturation (Fig 3-20). 
However, the expression of AMPAR1 in ventral cultures at Day 60 was significantly higher 
than that seen in dorsal-patterned cultures, mirroring the result of NMDAR1. 
 Finally, we wished to investigate the expression of genes related to glial cell 
identity over the time course of neural differentiation, and to observe whether there was a 
delay in the upregulation of glial-associated genes relative to neuronal markers. The 
astroglial marker gene GFAP and the oligodendroglial marker GALC were monitored over 
the same timeline of dorsal- and ventral-patterned neural differentiation (Fig 3-21). 
Following the same pattern of delayed generation of astroglial cell types in CNS 
development in utero (Hansen, Rubenstein and Kriegstein, 2011), both dorsal- and ventral-
patterned in vitro neural cultures only showed detectable levels of GFAP gene expression at 
later time points in differentiation: Day 40 in dorsally-induced cultures and Day 60 in 
ventrally-induced cultures. This does suggest that a more protracted timeline of 
differentiation and maturation would be necessary to generate an enriched population of 
mature astroglial cell types. Surprisingly however, GALC expression did show initial early 
upregulation and stable expression over the course of differentiation. Although GALC is not 
completely specific to oligodendroglial lineages it is highly enriched within them, and it is 
interesting that such robust gene expression is seen in these cultures that is not 
recapitulated by the protein expression from the same induction protocol (Figs 3-10, 3-21). 
It is possible that basal levels of GALC transcript are present in a subpopulation of cells 
within each directed neural culture, but that true oligodendroglial lineage formation and 




3.3.5 Electrophysiological Analyses 
Tracking the differentiation and maturation of hiPSC-derived neural cultures through the 
molecular assays outlined above, generates a wealth of information about morphological 
development as well as gene and protein expression during targeted differentiation. 
However, electrophysiological functionality of hiPSC-derived neurons may be essential for 
certain aspects of in vitro developmental- and disease-modelling. To this end, dorsally- and 
ventrally-patterned neural cultures were assayed through patch clamp analysis to 
determine the functional maturity of cells within each neural culture generated.  
 Current-clamp recordings of neuronal cells from each differentiation patterning 
methodology after 95 days of differentiation are shown in Fig 3-22. The mean resting 
membrane potential of all cells assayed was -46.6mV and a capacitance of 7.1pF. In 
response to intracellular current injection both ventral- and dorsal-patterned neuronal cells 
fired action potentials (Fig 3-22 B-C). The evoked action potentials were over 100mV in 
both neural cell types with sharp narrow peaks. Ventrally-patterned neurons fired in 
between one and four action potentials at threshold stimulation, with higher numbers of 
action potentials initiated under lower current stimulation than supra-threshold values (Fig 
3-22 B i-iii). Also, at supra-threshold stimulation levels a prolonged depolarisation was  
Fig 3-21: Quantitative PCR analysis for astroglial marker (GFAP) and oligodendroglial 
marker (GALC) expression within dorsal- and ventral-patterned hiPSC-derived neural 
cultures over 60 days of differentiation. Data is shown as mean values ± standard error 
of the mean of four independent experiments. Statistical significance denoted by * 




recorded after the initiation of the action potential (Fig 3-22 B ii, grey arrow). Neurons from 
dorsally-patterned cultures however, were only capable of firing one action potential 
regardless of the current stimulus (Fig 3-22 C), and after firing the action potential also 
Fig 3-22: Current-clamp recordings of dorsally- and ventrally-patterned hiPSC-derived 
neuronal cultures. (A) Bright field image of a patched cell. (B) Ventrally-patterned 
neurons fired 1-4 large brief action potentials in response to current injection. Lower 
stimulus levels (i-ii) evoked higher numbers of action potentials than supra-threshold 
stimulation (iii) which elicited a sustained depolarisation before restoring holding 
membrane potential (grey arrow). (C) Dorsally-patterned neurons fired only one action 
potential regardless of stimulation level 
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displayed sustained depolarisation before returning to resting membrane potential. The 
action potentials seen within triggered dorsally-patterned neurons were also slightly 
broader than those seen from ventral neuronal cultures. 
 Voltage-clamp recordings of the dorsally- and ventrally-patterned neuronal 
cultures also showed differences in the maturation of functionality between the two 
differentiation pathways (Fig 3-23).  
    
 
Fig 3-23: Voltage-clamp recordings of dorsally- and ventrally-patterned hiPSC-
derived neuronal cultures. Both Ventral (A) and Dorsal (B) neurons displayed 
fast transient inwards currents following stimulation (black arrows) followed by 
sustained outward currents (asterisks). Both inward (sodium) and outward 
(potassium) currents were larger in ventrally-patterned neurons. 
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Neurons from both neural differentiation pathways displayed strong, transient 
inward sodium currents after the onset of the stimulus. This inward current flux was 
greater in neurons derived from ventrally-patterned cultures. Outward potassium currents 
were also measured following sodium depolarisation, with larger currents being seen 
within ventral-patterned neurons. From these data it appears as if the level of functional 
maturity is delayed in the iPSC-derived forebrain dorsal neuronal cultures compared to 
ventrally-patterned neurons.  
  
3.4 Discussion and Conclusions 
Many neural induction protocols from pluripotent stem cells have been generated for 
obtaining neural subtypes of dorsal-forebrain & cortical lineages (Gaspard et al., 2008; Zeng 
et al., 2010; Shi et al., 2012; Espuny-Camacho et al., 2013), and ventrally-derived inhibitory 
GABAergic interneurons (Maroof et al., 2010; Danjo et al., 2011; Goulburn et al., 2012; Ma 
et al., 2012; Arber and Li, 2013; Yan Liu et al., 2013; DeRosa et al., 2015) using signalling 
morphogens derived from studying in vivo neural tube development (Jessell, 2000). 
However, few studies have attempted parallel induction protocols to interrogate the 
timings and mechanisms of in vitro neurological models from distinct brain regions. Mature 
cortical tissue in vivo is derived from dorsal-anterior excitatory neural cell types combined 
with migrating inhibitory interneurons generated in ventral-anterior regions of the neural 
tube. Therefore, to fully model mature neural forebrain tissue in vitro, both neural cell 
types must be generated and combined at developmentally relevant time frames to allow 
for true recapitulation of neural tissue development. 
 We aimed to generate developmentally representative pools of excitatory cortical 
neural cells and inhibitory GABAergic interneurons (displaying markers of the medial 
ganglionic eminence transitory brain structure) from human iPSCs, and to investigate the 
strength of neural induction, the molecular timings of genes and proteins involved in 
differentiation, and the development of electrophysiological activity within the derived 
cultures in vitro. 
 We used commercially available hiPSC cell lines that were shown to maintain high 
levels of pluripotency marker expression throughout culture and expansion in a stable 
fashion. The dual-SMAD inhibition mechanism of neural induction triggered a rapid 
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reduction in pluripotency-associated cell markers, while vastly upregulating the gene and 
protein expression of the forebrain neural precursor marker PAX6 over the course of 7 
days. Flow cytometric analysis of cells undergoing differentiation revealed induction 
efficiencies of >82% for PAX6-positive cells and >88% NESTIN-positive cells by Day 10. 
Further refinement of the differentiation protocol was investigated with the use of a neural 
proliferation media (NPM) and its effect on PAX6 and NESTIN expression. Stronger and 
more penetrant NESTIN staining was seen under NPM treatment than with dual-SMAD 
inhibition induction alone and was therefore adopted into the full long-term maturation 
protocol.  
 Prevalent neural morphology and post-mitotic neuronal protein expression was 
observed from Day 28 of the differentiation protocol. This was also studied after 60 days of 
neural maturation; whereby extensive neuronal and glial protein marker expression 
corresponded with widespread neuritogenesis. However, astroglial markers present at this 
time, were displayed in cells with an immature morphology. Interestingly, oligodendroglial 
lineage markers were not detected within neural cultures at this time point. This mirrors 
other findings on neurological  development, by which glial differentiation and maturation 
is delayed relative to neuronal generation (Hansen, Rubenstein and Kriegstein, 2011; 
Mallamaci, 2013; Anderson and Vanderhaeghen, 2014), such marker expression therefore 
may be present after more protracted periods of differentiation and maturation. This 
“default” neural differentiation pathway also upregulated proteins associated with cortical 
(and therefore dorsal neural tube) neuronal cell identity. With noticeable expression of the 
outermost layer I marker REELIN, the deep-layer neural markers TBR1 and CTIP2, and to a 
lesser extent the upper-layer (II-IV) marker BRN2 in neural cultures differentiated for 60 
days. This demonstrates that this level of differentiation and maturation of hiPSC-derived 
neural cultures display representative markers of early- and late-born markers of 
corticogenesis, and therefore recapitulation of neurodevelopmental processes in vitro.  
Excitatory glutamatergic protein markers were present throughout the non-
patterned differentiated neural cultures, whereas markers of GABAergic differentiation 
were not detected; again, suggestive of targeted dorsal-anterior cell populations. Other 
protein markers of neuronal maturity, pre- and post-synaptic machinery, and glutamate- 
and GABA-sensitive neurotransmitter receptor subunits showed high levels of protein 
expression after 60 days of neural differentiation but were not present during early NPC-
enriched cultures nor undifferentiated hiPSCs. These results indicate a robust maturation 
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process occurring within iPSC-derived neural cultures after 60 days of differentiation that 
encompasses gene expression relevant to neurotransmitter release and response, which 
are the foundation stones of functional network formation.  
 We then attempted to “pattern” the differentiating NPC cultures to one of ventral-
anterior lineages using the SHH signalling pathway agonist purmorphamine (Pur), in parallel 
to the default dorsal-excitatory pathway. A strong nuclear presence of the early-cortical 
marker TBR1 within cells in dorsal cultures, was in stark contrast to ventrally-patterned 
ones which showed no such positive immunostaining. The presence of TBR1 was not only 
localised to diffuse single cells throughout the dorsal culture, but also seen in the outer 
layer of neural ganglia-like structures that had formed during maturation. A similar pattern 
of staining was seen for the deep-layer cortical marker CTIP2 also within dorsal cultures, 
suggestive of a possible organoid-like self-organisation into simplified versions of early 
cortical structures (Kadoshima et al., 2013; Lancaster et al., 2013). However, CTIP2 
immunostaining was also observed within subpopulations of ventrally-patterned neural cell 
cultures. It is possible that this effect may be due to inefficient silencing of pathways 
denoting default dorsal neural differentiation, and that upregulation of CTIP2 is more 
sensitive to this. Another possibility is the inherent presence of CTIP2 in populations of 
GABAergic interneurons, as has been reported in vivo (Nikouei, Muñoz-Manchado and 
Hjerling-Leffler, 2016), and therefore the use of CTIP2 alone as a cortical localisation 
marker should be used with caution.  
Through Western blot analysis we report that the early and late cortical markers 
REELIN and BRN2 follow the same divergent pattern as is seen with TBR1 expression 
between dorsal- and ventral-patterned cultures; with the majority of protein expression of 
these cortical markers found within dorsal-patterned cultures. From gene expression data 
over the time-course of differentiation, early cortical markers peak to statistically 
significant elevations in dorsal-patterned neural cultures by Day 30 of differentiation, 
relative to ventrally-patterned cell populations. These upregulated genes continue to be 
expressed throughout the maturation timeline in dorsal cultures, indicating that molecular 
events driving early human corticogenesis can be detected as early as Day 20 of neural 
induction and differentiation in vitro. The lower relative expression levels of the upper-
layer cortical marker SATB2 over the full time-course however, does suggest that full 
maturation of all late-born cortical cell types has not by this time point reached 
completion, and that more protracted timelines of differentiation may be needed to obtain 
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neural cell populations representative of layers II-IV of the prenatal cortex. Interestingly, 
the gene expression level of CTIP2 in ventral cultures, although lower than dorsal-
patterning at all time points measured, does show a gradual increase by Day 60 in culture, 
which may explain the presence of the positive protein immunostaining at the end-point of 
differentiation seen in a subpopulation of ventrally-patterned neural cells.    
 For assays of neuronal subtype specificity, immunostaining and Western blot 
analysis of neural cultures after the full time-course of differentiation showed stark 
differences in expression of glutamatergic and GABAergic neuronal markers from dorsally- 
and ventrally-patterned cultures. vGLUT1 and vGLUT2 protein levels were far higher in 
dorsally-patterned cultures, whereas GAD65+67 expression showed exclusive upregulation 
within ventrally-patterned neural cell types. Gene expression data also displays this strong 
relationship to subtype marker expression and patterning methodology over the course of 
differentiation. However, it is worthy of note that the upregulation of non-default ventral 
GABAergic genes (GAT1 and GAD67) show far more striking and elevated levels within 
differentiating ventral cultures, but still display basal levels of glutamatergic marker 
expression (vGLUT1 and vGLUT2). This is suggestive of a system by which the upregulation 
of non-default ventral-associated genes shows more distinct expression profiles than the 
complete repression of genes of the default dorsal neural-lineage pathway. Hence the lack 
of ventral-associated gene expression within dorsal-patterned cultures, but a “leaky” 
expression of dorsal-associated genes within ventral-cultures. Even so, when the pattern 
and strength of expression for each of these genes is assessed through robust regression 
analysis over 60 days of differentiation: strong statistical divergence is seen between 
dorsal- and ventral-patterned cultures for all of the markers assayed. 
This segregation of neuronal subtype however did not disrupt comparable levels of 
β-III-TUBULIN and TAU neuronal protein markers between the differentiation pathways. 
This indicates that the timing of neuronal induction is maintained to equivalent levels 
between the two pathways by this timepoint in neural maturation, and that only the 
subtype of the neurons themselves show inherent differences. Interestingly, the 
intermediate filament protein NF-L did show robust upregulation within dorsal- rather than 
ventral-patterned neural cells, indicating a greater necessity of this gene within dorsal-
patterned neural development. A slight upregulation of the canonical neuronal markers β-
III-TUBULIN and TAU was seen within ventrally-patterned neuronal cultures at the 
transcript and protein level at most time points, which suggests a slightly more enriched 
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neuronal population of cells within these cultures. This pattern is also replicated when 
observing the expression levels of the synaptic markers SYNAPTOPHYSIN and PSD95, which 
again show slightly higher levels of protein expression in ventral-cultures, and a trend for 
upregulation at the gene transcript level at most measured time points during 
differentiation. These data could indicate a slightly higher proportion of mature neuronal 
populations within GABAergic ventral cultures, which may equate to higher degrees of glial 
differentiation within dorsal-patterned cell types or a higher retention of precursor cells 
with a slightly delayed timescale of differentiation compared to ventrally-patterned neural 
cells.   
This postulated higher level of retention of NPCs in dorsal cultures however, is not 
supported by the relative gene expression profile of the NPC marker NESTIN. No 
statistically significant differences were recorded between dorsally- and ventrally- 
patterned neural cell cultures over the full time-course of differentiation, although there 
was a slight trend of higher NPC marker expression within ventral-patterned cultures. As 
with mature neuronal subtype markers, almost exclusive dorsal-NPC marker expression 
(PAX6) and ventral-NPC marker expression (NKX2.1) was recorded that agreed with each 
separate differentiation pathway. The statistically lower levels of PAX6 seen within 
ventrally-patterned cultures may again be derived from the incomplete suppression of 
default differentiation, but may also be related to Pax6’s role in neuroectodermal fate 
determination and may be due to residual expression in early-NPC cell populations (Zhang 
et al., 2010; Goulburn et al., 2011). All the NPC gene markers observed here however, show 
the same pattern of early high relative expression before a decrease during neural 
maturation. This would follow with the expected outcome of the neural differentiation 
pathway by which high initial levels of NPCs would be generated from lineage restricted 
hiPSCs which would decrease as post-mitotic neuronal differentiation takes place. Basal 
retention of NPCs are indicative of the protracted neurological development of human 
brain tissue, and are maintained throughout the differentiation culture, following intrinsic 
developmental cellular timings (Espuny-Camacho et al., 2013).    
The transcript expression of the glutamate receptor subunit NMDAR1 showed 
comparable levels of expression throughout dorsal- and ventral-patterned differentiation 
pathways, but with increased expression in ventral cultures by Day 60 of differentiation. 
This increase is also reflected at the protein level. This pattern of gene upregulation in both 
differentiation pathways is also mimicked by the glutamate neurotransmitter receptor 
141 
 
subunit AMPAR1, which shows peak levels of expression in dorsal and ventral cultures at 
Day 40 and Day 30 of differentiation respectively.  Surprisingly, the cellular localisation of 
AMPAR1 is not only within neuronal-marker-positive cell types, but also a subpopulation of 
surrounding cells. This points to the conclusion that upregulation of AMPAR1 may precede 
true post-mitotic neuronal differentiation and neuritogenesis, or that it may have other 
developmentally relevant uses during early neural tissue generation.  
The presence of GABA-sensitive neurotransmitter subunits GABAAR1 and GABABR1 
did show protein level differences between dorsal- and ventral-cultures, with both of these 
receptor subunits showing stronger upregulation in ventrally-induced neural cells. These 
differences post-translationally are less pronounced when looking at gene expression levels 
during neural differentiation. Although relative expression levels of both subunits were 
consistently higher in ventrally-patterned cultures, they did not reach statistical significance 
over the majority of assay time-points. Intriguingly, the localisation pattern of GABAAR1 and 
GABABR1 show stark differences in neural cultures generated from both induction 
pathways. GABAAR1 expression was restricted to cells displaying neuronal markers and 
morphology, whereas GABABR1 showed strong expression within non-neuronal marker-
positive cell types, to an even greater degree than was seen with AMPAR1. These results 
indicate that the ionotropic GABA receptor subunit GABAAR1 shows a neuronal-specific 
expression pattern that may be indicative of maturing receptor complexes necessary for 
post-synaptic formation, whereas the metabotropic GABA receptor subunit GABABR1 may 
have a NPC-specific role in GABA sensing or in other non-neuronal cell types during neural 
induction and maturation.  
Markers of gliogenesis, such as those found in astroglial lineages (GFAP and S100β) 
and oligodendroglial lineages (GALC) were assayed over the time course of neural induction 
and differentiation. Both astroglial markers were observed by Day 60 in dorsally-patterned 
neural cultures in a subpopulation of cells. These markers co-localised with each other and 
were separate from neuronal-marker-positive cell types. However, they displayed 
morphology indicative of immaturity, which does follow the delayed gliogenesis seen 
developmentally in vivo (Barateiro and Fernandes, 2014) and also from PSC-derived neural 
cultures in vitro (Gaspard et al., 2008). This agrees well with the gene expression data of 
GFAP which only displays upregulation at late time points over the course of this 
differentiation. Oligodendroglial markers were not detected through protein analysis 
within Day 60 neural cultures, but gene expression data did reveal consistent expression 
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following NPC induction through both patterning pathways. This may be explained through 
the presence of GALC in non-oligodendroglial lineages (albeit in less enriched amounts) 
that were too low for detection through protein-based assays, or possibly indicate a strong 
post-transcriptional silencing effect before the triggered onset of gliogenesis.  
 Electrophysiological assays of the hiPSC-derived neural cultures also uncovered 
differences in functional maturation between the excitatory dorsal-patterned and 
inhibitory ventral-patterned neuronal subtypes. Both dorsal- and ventral-patterned neural 
cultures generated neuronal cells that were electrophysiologically active and could fire 
action potentials under current-clamp stimulation. However, dorsally-derived neurons only 
fired a single action potential after the onset of current stimulus whereas ventrally-derived 
neurons fired in between one and four action potentials depending on the level of current 
injection. This can be interpreted as a level of enhanced maturity of the ventrally-patterned 
neurons relative to dorsally-patterned neurons. This advanced level of maturation is also 
echoed in voltage-clamp recordings of each neuronal subtype. Larger sodium (inward) and 
potassium (outward) currents were seen in ventrally-derived neurons following stimulation 
than in the dorsally-derived counterparts. In both neuronal types however, extended 
periods of depolarisation after stimulus withdrawal and lower potassium currents may be 
indicative of a general immature neuronal phenotype relative to primary neurons. As 
normal human brain development takes place throughout the protracted timeline of 
gestation, it is plausible that true neuronal maturity and functionality of iPSC-derived 
neural cultures would also need to take place over the course of many months in vitro if 
the recapitulation of neurodevelopmental processes followed intrinsic timing mechanisms.  
 These preliminary findings show ventrally-patterned neural cultures display 
hallmarks of advanced maturity compared to excitatory dorsally-patterned neurons at the 
same time point. Although more research will be needed to verify this, it does reveal some 
intriguing questions about the independent developmental timings of ventrally-derived and 
dorsally-derived anterior neural cell types and how it would be best to combine them in in 
vitro models to develop representative models of mature forebrain. Indeed, the higher 
expression and protein profiles of neuronally-associated markers seen in ventrally-
patterned cultures may reflect an enhanced maturing population of post-mitotic neuronal 
cultures, that require extended timelines to be generated from dorsal-patterned cell pools. 
 In conclusion, we have demonstrated that efficient neural differentiation can be 
elicited from hiPSCs in vitro and targeted to generate specific neuronal subtypes derived 
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from dorsal-anterior and ventral-anterior regions of the neural tube. The maturity of these 
patterned neuronal pools is displayed through comparable molecular markers of neuronal 
cell identity, synaptic machinery, and appropriate dorsal/ventral identity markers. 
Ventrally-patterned cells however show increased tendency for higher expression profiles 
of many neural-associated markers and more mature electrophysiological properties, 
suggestive of an accelerated maturation timeline of neural cells patterned in this way. All of 
these data will inform future in vitro models of human forebrain cortical development.    
 
3.4.1 Summary of Chapter Findings 
 hiPSCs undergoing neural induction via dual-SMAD inhibition pathways generate NPCs 
with high efficiency over 7-14 days. 
 Further maturation of NPCs without exogenous signalling morphogens will derive 
neuronal cells with extensive neuritogenesis after 28 days of differentiation and both 
neuronal and glial-lineage cell types by Day 60 of maturation. 
 Neural cell cultures differentiated for 60 days will show markers of; cortical and 
forebrain localisation; excitatory glutamatergic neuronal subtype; pre- & post-synaptic 
components; and glutamate- & GABA-sensitive neurotransmitter subunits. 
 Ventral patterning of NPCs, through the use of a SHH-pathway agonist, generates 
mature neurons of a predominantly inhibitory GABAergic cell type after 60 days of 
differentiation and show heavily reduced cortical marker expression. 
 Robust regression analysis of neuronal subtype marker expression confirms the efficacy 
of the patterning techniques and divergence of neural subtype differentiation. 
 Both neural induction pathways show upregulation of canonical neuronal markers over 
the same timeline of differentiation. 
 Ventral-patterned neural cells show slight enrichment of neuronal associated markers 
at the gene and protein level in comparison to the default (dorsal) induction pathway. 
 Glutamate-receptor subunits show comparable expression within neural cells from 
both pathways of differentiation, but GABA-receptor subunits show elevated 
expression in ventral-patterned cultures. 
 Astroglial lineage markers show highly delayed patterns of upregulation. Whereas 
oligodendroglial protein markers were not detected in hiPSC-derived neural cultures 
after 60 days.  
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 Both dorsally- and ventrally-patterned matured neuronal cells can fire an action 
potential under intracellular current stimulation. Multiple action potentials can be 
evoked from ventrally-patterned neuronal cells depending on the current stimulus 
level, demonstrative of a more mature phenotype than is seen in dorsally-patterned 
neurons. 
 Transient sodium and potassium currents are both present after stimulation of 
dorsally- and ventrally-derived neurons. Both current levels are higher in ventrally-
patterned cultures, indicative of a more mature ion channel composition phenotype. 
However, potassium currents in neurons from both patterning methodologies are low, 
showing an overall immature phenotype for all neurons assayed.  
 
3.4.2 Acknowledgements 
We would like to thank Dr. Karina Needham (Dept of Otolaryngology, University of 
Melbourne) for her indispensable help with the patch-clamp recordings of neuronal 
cultures, as well as assistance with data analysis and figure generation. We are also 
indebted to Prof. Raymond Boston (Dept of Medicine, University of Melbourne) for his aid 
in generating the robust regression analysis pipeline for the gene expression data displayed 












3.5.1 Matrigel Surface-Coatings for NPC Induction 
Initial substrate testing for NPC induction and neural maturation also utilised Matrigel 
coating, which was reported to show high rates of neuronal marker induction in PSC-
derived neural cultures (Muratore et al., 2014). However, preliminary data from the hiPSCs 
used in this study showed high retention of NPC markers when cultivated on Matrigel 
substrates but with low levels of neuronal maturation and marker expression (Appendix Fig 
3-24). Therefore, we chose to complete all neural induction protocols using poly-L-lysine 
and laminin coated surfaces that were conducive to neural maturation. Low levels of 
neuronal morphology and marker development after 6 weeks of differentiation discounted 









Appendix Fig 3-24: hiPSCs undergoing neural differentiation on Matrigel coated 
surfaces displayed limited neuronal maturation but high rates of NPC marker retention 
even after 4-6 weeks of differentiation. Scale bars represent 100μm. 
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Chapter 4: Neural Differentiation of 




The generation of mature neural cultures from human iPSCs (as described in Chapter 1 and 
Chapter 3) follows that of embryological developmental timing and molecular signalling 
(Gaspard et al., 2008), and can result in functional network formation (Odawara et al., 
2016). For the most part, these neural differentiation protocols are achieved in two-
dimensional (2D) adherent cell culture environments. Even so, crude elements of self-
organised developmental structures can be seen within these 2D cultures that recapitulate 
in vivo-like tissue. For example, early neural precursor structures termed “neural rosettes” 
are self-formed multicellular patterns that were shown to be representative of a transverse 
plane of neural tube cytoarchitecture (Watanabe et al., 2005; Eiraku et al., 2008). Further 
development of more mature “brain-like” structures from hiPSCs has not been recorded 
from planar culture but has been reported extensively since the advent of three-
dimensional (3D) organoid culture. By culturing neural precursors as free-floating 
aggregates throughout differentiation and maturation, they generate histologically 
accurate representations of early brain structures beyond those seen in rosette formation 
(Kadoshima et al., 2013; Lancaster et al., 2013). The development of these 3D cerebral or 
brain organoid cultures has been an incredible step forward in the field of in vitro-based 
neuroscience as it illuminates not only the intrinsic timing of neural development that is 
preserved in hiPSC differentiation, but also an inherent ability to self-organise into region-
specific complex structures (Meinhardt et al., 2014; Mariani et al., 2015; Muguruma et al., 
2015; Jo et al., 2016; Qian et al., 2016).  
 Although the potential of organoid tissue models for neurological research is 
remarkable, there are limitations within this methodology that may impede specific aspects 
of the research being undertaken. Firstly, continuous generation of single brain-like 
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structures within the organoids (rather than multiple pseudo-structures within the same 
aggregate) are dependent on high degrees of oxygen and nutrient diffusion, and therefore 
require the use of spinning bioreactors to enable the generation of more representative 
cytoarchitecture (Lancaster et al., 2013; Qian et al., 2016). However, this can still not 
overcome the presence of necrotic cores within each organoid due to lack of vasculature 
formation (Lancaster et al., 2013; Kelava and Lancaster, 2016). Furthermore, the 
heterogeneity in the structure and cellular content of each organoid with high batch-to-
batch variability may have repercussions in the reproducibility of experiments with more 
subtle phenotypic outcomes (Brennand et al., 2015; Kelava and Lancaster, 2016).   
 Rather than free-floating organoid culture, 3D neural cultures from hiPSCs can also 
be generated through encapsulation of differentiating neural cells within hydrogel scaffolds 
that aim to mimic properties of the extracellular matrix microenvironment. The advantages 
of 3D neural culture over 2D planar culture are apparent, even without the use of free-
floating organoid formation. The enhanced degree of cell-cell interactions allowing for in 
vivo-like cytoarchitecture and networking potential, whilst cell-matrix interactions would 
allow for spontaneous cell migration throughout the scaffold, together with self-
organisation reminiscent of neural organoids. It is also telling that the most successful 
organoid culture protocols still embed cellular aggregates within droplets of hydrogel 
scaffolds to enhance organoid formation (Lancaster et al., 2013), showing the great effect 
that 3D neural cell encapsulation can generate. Although the same problems of nutrient 
and oxygen diffusion exist in the generation of 3D encapsulated neural constructs, albeit to 
a lesser degree compared to those found in organoid culture, these issues can be overcome 
through control of cell density and scaffold geometry creation; variables that cannot be 
controlled during organoid formation. An overview of some of the advantages and 
disadvantages of 2D and 3D neural cell culture is shown in Fig 4-1.  
 Neural differentiation from pluripotent stem cells within 3D hydrogel environments 
have shown promise throughout previous studies (Li et al., 2011; Lu et al., 2012; Kim, 
Sachdev and Sidhu, 2013; Bozza et al., 2014) and in some instances have been shown to 
enhance the efficiency and speed of neural maturation (Lu et al., 2012; Z.-N. Zhang et al., 
2016). However, little has been shown of this effect on the biomolecular process of 
differentiation and maturation itself, and its effect on patterned neural subtypes that 
undergo differential brain-region specific pathways of differentiation and development (as 
outlined in Chapter 3). We have already shown the basis of generating both dorsal- and 
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ventral-patterned neural subtypes from hiPSCs in planar culture with time-course analyses 
of markers denoting post-mitotic neuronal generation, synaptic maturation, forebrain 
localisation, neurotransmitter receptor generation, and gliogenesis. The downstream 
neural maturation events of this hiPSC-derived NPC differentiation within 3D hydrogel 
scaffolds however, remains largely unknown. 




Fig 4-1: Overview of advantages and disadvantages of neural cell culture in 
2D and 3D environments. 
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This chapter will therefore focus on the timing of the molecular processes of neural 
differentiation and maturation from hiPSCs in vitro and directly compare these markers 
from neural cultures grown in 2D planar culture to those grown within a neuritogenic-
conducive 3D collagen hydrogel scaffold environment (as developed and assayed in 
Chapter 2). The results of these assays will uncover any deviation in the efficiency of 
derivation of dorsal- and ventral-patterned neural cultures in 3D compared to 2D 
environments, as well as any effect of the 3D microenvironment on neural cell maturation 
or neural tube patterning factors. This data will help inform future neural culture protocols 
and elucidate the specific advantages (or otherwise) of neural differentiation from hiPSCs 
















4.2 Materials and Methods 
4.2.1 iPSC Culture 
All work in this chapter utilised the commercial human iPSC lines; ATCC-BXS0116 Human 
Induced Pluripotent Stem (IPS) Cells (ATCC® ACS-1030™) and ATCC-DYS0100 Human Induced 
Pluripotent Stem (IPS) Cells (ATCC® ACS-1019™). iPSCs were grown in feeder-free culture 
conditions on Vitronectin XF (Stem Cell Technologies) coated 6-well tissue culture plates in 
TeSR-E8 media (Stem Cell Technologies). iPSC colonies were passaged every 6-7 days with 
Gentle Cell Dissociation Reagent (Stem Cell Technologies) and were re-plated with TeSR-E8 
media containing the RHO/ROCK pathway inhibitor Y-27632 (10μM, Stem Cell 
Technologies). Media was changed daily, except for the first day after a passage. Areas of 
random differentiation within colonies were removed manually. All iPSC and neural 
differentiation experiments used iPSCs below passage number 20.  
 
4.2.2 Neural Differentiation 
Dorsal neural induction of iPSCs was triggered using a monolayer dual SMAD-inhibition 
protocol using commercially available STEMdiff Neural Induction Media (NIM) (Stem Cell 
Technologies). Briefly, iPSCs were dissociated into single cells using Gentle Cell Dissociation 
Reagent (GCDR) (Stem Cell Technologies) and plated at densities of 1 x 106 cells/well of a 6-
well tissue culture plate, coated with poly-L-lysine (0.01%, Sigma) & laminin (20μg/ml, 
Sigma) (PLL), in 2ml NIM per well. Media was changed daily for the first 7 days of induction, 
which also contained RHO/ROCK pathway inhibitor Y-27632 (10μM, Stem Cell 
Technologies).  
After 7 days of induction, media was changed to STEMdiff Neural Proliferation 
Media (NPM) (Stem Cell Technologies) for another 7 days to trigger NPC maturation. NPCs 
were passaged at Day 10 and seeded into Collagen Type I-based hydrogel scaffolds for 
further differentiation and maturation within a 3D environment (see Section 4.2.3). At Day 
14 post-induction, media was changed to a final neural maturation media (NMM) which 
consisted of a 1:1 mix of “N2 media” and “B27 Media”. N2 media consisting of DMEM/F12 
(Lonza), N2 Supplement (1x, Thermo Fisher Scientific), GlutaMAX (1x, Gibco), Non-essential 
amino acid mixture (1x, Lonza), 100U/ml Penicillin and 100μg/ml Streptomycin (Gibco). B27 
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media consisting of Neurobasal (Gibco), B27 Supplement (1x, Thermo Fisher Scientific), and 
GlutaMAX (1x, Thermo Fisher Scientific). The combined maturation media was then 
supplemented with BDNF (20ng/ml, PeproTech), GDNF (20ng/ml, PeproTech), and DAPT 
(2μM, Stem Cell Technologies) to enhance neuronal differentiation and cell cycle 
synchronisation of differentiating NPCs (Crawford and Roelink, 2007; Borghese et al., 
2010). Maturation media was changed every 2-3 days over the course of differentiation. 
Ventral neural induction of hiPSCs followed the same protocol and media formulations as 
above but with the addition of Purmorphamine (1.5μM, Stem Cell Technologies) from Day 




Fig 4-2: Schematic representation of the protocols for parallel differentiation of 
dorsal (excitatory) forebrain lineages and ventral (inhibitory) forebrain lineages 
from hiPSCs. Both differentiation pathways include stepwise treatment with neural 
induction media (NIM), neural proliferation media (NPM) and maturation media. 
The maturation media also contained the neurotrophic factors; brain-derived 
neurotrophic factor (BDNF), glial cell-derived neurotrophic factor (GDNF), and the 
Notch signalling inhibitor N-[N-(3,5-difluorophen- acetyl)-l-alanyl]-S-phenylglycine 
t-butyl ester (DAPT). In addition, the ventral differentiation pathway contained 




4.2.3 Three-Dimensional Hydrogel Encapsulation of NPCs 
At Day 10 post-induction, NPCs were harvested from 2D culture plates prior to 3D hydrogel 
encapsulation. NPCs were dissociated from the culture well surface with Accutase (Stem 
Cell Technologies) for 5 minutes at 37⁰C. Cells were pelleted by centrifugation at 500xg for 
5 minutes before resuspension in 1ml of media. Cell counts were performed using trypan 
blue (Thermo Fisher Scientific) staining and quantified using a haemocytometer. Final cell 
density for each cell-laden hydrogel was 1x105 cells/ml.  
Collagen hydrogel scaffolds were formed with final concentrations of 0.4mg/ml 
Collagen Type I from Rat Tail (Corning), 0.23x of the added collagen volume of 0.1M NaOH 
(Sigma), and 1x HEPES Buffer (20mM HEPES [Sigma], 150mM NaCl [Sigma] pH 7.4), and 
0.05mg/ml ECL Cell Attachment Matrix (Millipore). The working volume of the collagen 
hydrogels was made up in sterile de-ionised water. Collagen and NaOH working volumes 
were mixed (to trigger neutralisation) prior to addition to buffered cell suspensions. 250μl 
of the hydrogel solution was added per well of a 48-well tissue culture plate to form each 
scaffold for molecular analyses. 500μl of cell-laden hydrogel solution was added to a 60mm 
x 15mm IVF One Well Dish (Falcon, Corning) for downstream fluorescent 
immunocytochemical and confocal microscopy analyses. Scaffolds underwent gelation at 
37⁰C for 30 minutes before addition of 0.5ml differentiation media per well, or 1ml media 
per dish. Approximately 70% of media volume was changed every two days over the time 
course of differentiation.  
 
4.2.4 Fluorescent Immunocytochemistry and Epifluorescent/Confocal 
Microscopy 
Three-dimensional scaffolds for immunocytochemistry were fixed for 1 hour at room 
temperature in 10% neutral-buffered formalin solution (Sigma) and permeabilised for 1 
hour at room temperature in 0.5% Triton-X-100 in phosphate buffered saline (PBS) (137mM 
NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4). Samples were blocked overnight at 4⁰C in 5% 
goat or donkey serum (Millipore) in PBS before incubation with primary antibodies (also in 
block solution) overnight at room temperature; anti-TUJ1 (Covance MMS-435P, 1:1000); 
anti-MAP2 (Cell Signaling Technology 4542, 1:1000); anti-GAP43 (Millipore AB5220, 
1:1000); anti-Synapsin I (Abcam ab64581, 1:1000); and anti-TBR1 (Abcam ab31940, 
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1:1000). Constructs were washed three times for 1 hour each in PBS before addition of 
secondary antibodies; goat-anti-mouse IgG AF488 (Invitrogen A11029, 1:2000); donkey-
anti-rabbit IgG AF594 (Invitrogen A21207, 1:2000) in block solution overnight at room 
temperature. Constructs were washed three more times in PBS before addition of DAPI 
(Sigma) for 1 hour, for cell nuclei visualisation. 
Epifluorescent images were acquired on an Olympus IX70 wide field microscope 
with Spot RT Slider digital camera and Spot Advanced software, version 4.8 (Diagnostic 
Instruments). Confocal image acquisition was performed using a Nikon Ti Eclipse 
microscope equipped with a fully automated A1 confocal laser (A1R, Nikon) and processed 
with NIS-Elements software (Nikon). Prior to acquisition, 3D constructs were transferred to 
35mm Nunc Glass Bottom Dishes (Thermo Fisher Scientific). 
 
4.2.5 Gene Expression Analysis 
For cell extraction from collagen scaffolds, media was exchanged for 0.5ml maturation 
media containing 0.05mg/ml Collagenase Type 1 (>125U/mg, Worthington Biochemical 
Corporation) per well. Scaffold digestion took place at 37⁰C for 45 minutes prior to 
trituration and centrifugation of cell pellets. Cells from five scaffolds were pooled to form 
one pellet from each experimental setup. Cell pellets were stored at -80⁰C until RNA 
purification. 
Relative gene expression analysis was performed using quantitative polymerase 
chain reaction (qPCR) methodology. Firstly, RNA was purified from frozen cell pellet 
samples using the RNeasy Plus Mini Kit (Qiagen) as per the manufacturer’s instructions into 
a total elution volume of 50μl nuclease free water. RNA concentration was determined 
using an Ultraspec 2200 Pro Spectrophotometer (GE Healthcare Life Sciences) and RNA 
integrity was confirmed by running samples on a 1% Agarose (w/v)-EtBR Tris-acetate (TAE) 
buffered gel under electrophoretic conditions for 40 minutes at 80V followed by imaging 
on a ChemiDoc MP (Bio-Rad) to show sharp ribosomal RNA banding. 
 cDNA was generated from 1μg of each RNA using the Omniscript Reverse 
Transcription Kit (Qiagen) with 1μM oligo dTs (Thermo Fisher Scientific) and 1U/ml RNase 
Inhibitor (Qiagen). Reverse transcription reactions took place at 37⁰C for 80 minutes in a 
20μl reaction volume. On completion of the reaction, samples were further diluted with 
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20μl of nuclease free water. cDNA samples were stored at -20⁰C until used in qPCR 
reactions.  
 qPCR reactions were performed with SYBR Green PCR Master Mix (Qiagen) in 10μl 
reaction volumes with 1μM of each primer set. De novo primer pairs were designed using 
Primer-BLAST (NCBI) (Table 4-1). All amplicons were designed to be between 50-250bp in 
length and have equivalent primer annealing temperatures. 
 
 
Reactions were run on a RealPlex Mastercycler (Eppendorf) with the following 
parameters: 95⁰C for 2 minutes, then 40 cycles of 95⁰C for 5s and 60⁰C for 10s, followed by 
a melt curve recording. Amplicon specificity was determined via melt curve peak analysis. 
Table 4-1: Primer pair sequences used for qPCR analysis of human iPSC-derived 
neural cultures in 3D matrices. 
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All relative expression data was normalised to HPRT1 housekeeping gene expression. Data 
were analysed by the ΔΔCt method in Microsoft Excel and statistical analyses performed in 
GraphPad Prism using multiple unpaired T-test analysis. Data is shown ± standard error of 
the mean with significance denoted when the p-value ≤0.05. Four biological repeats were 
completed for each differentiation type (dorsal/ventral) for each time point from both 2D 
and 3D culture. Robust regression analysis of fold change expression data was performed in 
Stata statistical software (version 15.1). Regression coefficients were maintained between 
ordinary least squares (OLS) regression and those of the robust regression analysis. Raw 

















4.3.1 hiPSC-derived NPCs Differentiate and Undergo Neuritogenesis 
within Three-Dimensional Collagen Scaffolds 
We demonstrated in Chapter 2 that collagen (type I) hydrogel scaffolds allowed for 
extensive neuritogenesis of encapsulated neural-like cells, as well as primary rat cortical 
neurons (Appendix 2.5.2), in contrast to neural cells within alginate hydrogel scaffolds. 
Therefore, we wished to observe whether these desired morphological changes in the 3D 
collagen environment would also allow for neurite extensions during differentiation and 
maturation of hiPSC-derived neural cultures.  
Fig 4-3: Fluorescent immunocytochemistry of neuronal and synaptic markers of 
hiPSC-derived neural cultures within 3D collagen hydrogel scaffolds after 60 days 
of maturation. Cell nuclei are visualised through DAPI staining. Scale bars 
represent 200μm (top three rows) and 100μm (bottom row) 
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To this end, hiPSC-neural precursors were derived through adherent dual-SMAD 
inhibition before seeding into collagen hydrogels at Day 10 of differentiation (see Methods 
section 4.2.3). These 3D neural constructs were matured using the same maturation 
protocol as 2D planar neural cultures over 60 days. Fluorescent immunocytochemical 
staining of the neuronal markers β-III-TUBULIN, GAP43, and MAP2 reveal widespread 
neuritogenesis and neuron-marker positive cells throughout the constructs (Fig 4-3). The 
pre-synaptic marker SYNAPSIN I is also present throughout many of the derived neuronal 
cells, which is suggestive of a successfully maturing neuronal population generating the 
machinery necessary for functional synaptic formation. 
However, simple epifluorescent microscopy is unable to capture the fully 3D nature 
of the encapsulated cells and observed neuritogenesis. Therefore, confocal microscopy was 
used to acquire images to show the full range of multi-planar neuronal extension and 
prevalence throughout the scaffold (Fig 4-4). Dorsally-patterned neural differentiation of 
hiPSCs was undertaken to generate neural cultures with a high prevalence of β-III-TUBULIN-
positive neuronal cells and TBR1-positive nuclei staining to better visualise the placement 
of cell soma and neurites within the 3D scaffold (Fig 4-4 A). Robust neuronal cell 
morphology and neurite extensions were observed throughout the cell-laden hydrogel 
showing that this formulation of collagen hydrogel is conducive to neural tissue construct 
formation with hiPSC-derived NPCs. 
To better visualise the extent of neuritogenesis throughout the depth (Z-axis) of 
the hydrogel; Z-depth colour coding of the matured hiPSC-derived neural culture was 
generated to investigate the overall morphology of the neurite extensions and cell nuclei 
within 3D space (Fig 4-4 B). Image stacks of approximately 40μm in depth are sufficient to 
show that neurite growth occurs along all three-axes within the scaffold and that neuronal 
soma are also dispersed throughout the structure. 
It is also worthy of mention that although loose clusters of neural cells were 
observed within the 3D constructs; tightly-packed ganglia-like structures seen throughout 
planar culture of hiPSC-derived neural cells were not observed. Also, the pattern of 
rounded cell aggregate formation seen within alginate hydrogels with neural cell lines 
(Chapter 2), were not present within these scaffolds. Another indicator of the success of 





Fig 4-4: Confocal microscopy of dorsally-patterned hiPSC-derived neural cultures 
encapsulated in 3D collagen hydrogels. (A) Immunostaining with the neuronal 
marker β-III-TUBULIN (green) and the nuclei-localised early-cortical marker TBR1 
(red). (B) Z-depth colour coding of the cell-laden scaffolds; β-III-TUBULIN (top row) 
and TBR1 (bottom row) showing neurite extension and cell soma distribution along 
all three axes. All image fields of view approximately 200μm x 200μm x 40μm. 
159 
 
4.3.2 Neural Precursor Marker Expression in 2D and 3D Hydrogel 
Scaffolds 
To investigate whether hiPSC-derived NPCs within 3D collagen hydrogel scaffolds prompted 
any differences in the propagation or maturation of the precursor population over the 
time-course of differentiation, gene expression assays of NPC-specific markers were 
undertaken. These assays were done to directly compare both dorsal- and ventral-
patterned neural differentiation from hiPSCs in both 2D culture (from Chapter 3) and 3D 
collagen hydrogel scaffolds.  
 The NPC marker NESTIN showed an early peak of expression (Day 20-30 of 
differentiation) in all patterned neural cell populations in both 2D and 3D culture (Fig 4-5). 
The levels of expression were comparable at all time points between 2D Dorsal, 2D Ventral, 
and 3D Dorsal cultures. Only 3D Ventral cultures showed statistically significant increases in 
NESTIN expression at Day 14 and Day 20 post-neural induction compared to the other 
three culture conditions. This pattern indicates that in both 2D and 3D culture conditions, 
early NPC marker expression occurs prior to a decrease over the time course of neuronal 
maturation and post-mitotic differentiation. The initial induction or preservation of NESTIN 
marker expression however, is much higher under ventral-patterning conditions within a 
3D hydrogel environment. 
 The dorsal-forebrain precursor marker PAX6 displays robust upregulation in 2D 
dorsal-patterned differentiation. This peaks at Day 20 of differentiation before slightly 
lower but stable expression for the rest of the maturation time course. These levels of 
expression were consistently and significantly higher than was seen in the ventrally-
patterned neural cultures from both 2D and 3D differentiation. Interestingly, the level of 
PAX6 expression within 3D Dorsal cultures did show the same early peak of upregulation, 
but to a much lower level than was maintained within 2D dorsal inductions. Also, this burst 
of PAX6 expression was not maintained throughout maturation, suggesting that a drop in 
the number of dorsal-forebrain precursors may be taking place within 3D scaffolds (Fig 4-
5). 
 The ventral-forebrain precursor marker NKX2.1 displayed almost exclusive 
upregulation within ventrally-patterned neural cultures, and this ventralisation signal was 
unaffected through differentiation within 3D scaffolds compared to planar culture. The 





Fig 4-5: Quantitative gene expression analyses of neural precursor markers in dorsally- 
and ventrally-patterned hiPSC-derived neural cultures differentiated in 2D planar 
cultures and 3D hydrogel scaffolds over 60 days of differentiation. ND; Not Detected. 
Data is shown as means ± S.E.M of four independent experiments. Statistical 
significance is displayed relative to; 2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α 
p≤0.05, **,##,αα p≤0.01, ***,###,ααα p≤0.001 based on unpaired two-tailed t-tests. 
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Ventral cultures at Day 14 post neural induction (~8-fold higher), which mirrored the 
concurrent significant upregulation of NESTIN at the same point (Fig 4-5). Ventral 
patterning and propagation of ventral-forebrain precursors over the time course of neural 
differentiation for the most part was unaffected and certainly not inhibited by maturation 
within 3D culture environments. 
 
4.3.3 Comparison of Neuronal and Synaptic Marker Expression 
Profiles in 2D and 3D Scaffolds 
To further investigate and understand the effect of neural differentiation and maturation 
within 3D scaffold environments we next sought to observe the expression profiles of 
canonical neuronal and axonal markers as well as pre- and post-synaptic functional 
components (Fig 4-6).  
  
Fig 4-6: Quantitative gene expression analyses of neuronal and synaptic markers in 
dorsally- and ventrally-patterned hiPSC-derived neural cultures differentiated in 2D 
planar cultures and 3D hydrogel scaffolds over 60 days of differentiation. Data is shown 
as means ± S.E.M of four independent experiments. Statistical significance is displayed 
relative to; 2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01, 
***,###,ααα p≤0.001 based on unpaired two-tailed t-tests.  
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The neuronal structural marker β-III-TUBULIN displayed robust expression after 20 days of 
neural differentiation, in both 2D ventrally- and dorsally-patterned neural cultures. At later 
time-points this level of expression was significantly enhanced within ventral cell 
populations. This pattern of increased expression under ventral-patterning was also seen 
within the 3D encapsulated cultures, however, the overall level of expression was 
significantly lower in cells within hydrogel scaffolds than in planar culture by later time-
points of differentiation (Day 30-60) (~3.3- to 7-fold lower) (Fig 4-6).  
This difference between expression levels within 2D and 3D differentiation 
strategies was less pronounced at earlier time points, suggesting that the onset of post-
mitotic neuronal maturation was not inhibited within 3D cultures, although further 
maturation or development of increased neuronal cell numbers may be negatively 
affected.  
The axonal marker TAU displayed consistent upregulation over the course of 
differentiation in both 2D Dorsal and 2D Ventral neural cell cultures, but again with a trend 
for higher upregulation in ventral-patterned cultures. In contrast to the expression profiles 
of β-III-TUBULIN in 3D Dorsal cultures, which showed restricted expression compared to 2D 
Dorsal cultures; the level of TAU in 3D Dorsal culture showed a trend for constant increase 
over the course of differentiation. At later time points this level of expression exceeded 
that seen within 2D Dorsal differentiation (~1.7-fold higher at Day 60) but did not reach 
statistical significance. Conversely, the level of TAU expression within 3D Ventral 
differentiation displayed its highest peak of expression by Day 20 (significantly above dorsal 
culture conditions) before showing a gradual decreasing pattern of expression until Day 60 
when it became significantly lower (~3.5-fold lower than 3D Dorsal conditions), breaking 
the pattern of gradual upregulation seen in other experimental conditions. This low level of 
TAU expression in 3D Ventral cultures was also significantly lower than the level of 
transcript obtained from 2D Ventral cultures. These data suggest that markers of 
axonogenesis follow a comparable pattern and level of gene expression in 2D Dorsal, 2D 
Ventral and 3D Dorsal neural cultures, but show divergently lower levels within 3D Ventral 
setups, possibly indicating an inhibitory effect of axonal generation within these cultures or 
retention of NPC characteristics.  
The pre-synaptic marker SYNAPTOPHYSIN (SYN) from Day 30 of differentiation 
onwards showed stable expression within 2D Dorsal and 2D Ventral neural cell cultures, 
with a trend for higher expression under ventral-patterning. Overall expression levels of 
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SYN in 3D Dorsal cultures however, were lower than their 2D counterparts at the majority 
of later time points, and significantly lower at Day 30 of differentiation. From Day 30 of 
differentiation onwards SYN levels in 3D Dorsal cultures were significantly lower than those 
seen within 2D Ventral differentiations. After a very high peak of SYN expression at the 
early Day 20 time point in 3D Ventral cultures, that was significantly higher than that seen 
in any of the other experimental conditions, this too reduced to a low basal level 
comparable to that seen within 3D Dorsal cultures. By Day 40-60 post neural induction, SYN 
levels in both dorsal- and ventral- patterning methodologies in 3D scaffolds were 
significantly lower than those seen from 2D Ventral culture (Fig 4-6). 
A very similar pattern was seen when assaying the post-synaptic marker PSD95 
across all 2D and 3D experimental conditions. 2D Dorsal expression levels were robustly 
present after Day 20 of differentiation and remained stable over the course of 
differentiation. This was also true of PSD95 gene expression levels within 3D Dorsal 
cultures but with a relative expression level approximately half of that seen within 2D 
Dorsal cultures, although not to a statistically significant degree. 3D Ventral cultures 
showed an early expression peak of PSD95 (Day 14-20) as was seen with SYN expression, 
but which lowered after 30 days of differentiation to levels comparable to those seen in 3D 
Dorsal inductions. This peak of synaptic machinery transcript expression was also seen 
within 2D ventrally-patterned cultures (Day 30), which may indicate a conserved 
upregulation of such genes in ventralised cultures compared to those undergoing dorsal 
patterning. Again however, significantly lower levels of relative PSD95 expression were 
seen within 3D neural cultures than in 2D ventral cultures at more mature time points (Fig 
4-6).  
 
4.3.4 Preservation of Neuronal Subtype Patterning within 3D Hydrogel 
Scaffolds 
It is possible that cell-matrix interactions occurring within 3D cell-laden hydrogel 
environments may have an impact on the efficacy of neural subtype patterning utilised in 
this study. To observe whether the 3D cellular microenvironment influenced the 
development of mature excitatory or inhibitory neuronal subtype markers (from dorsal- 
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and ventral- patterning respectively) we assayed the expression profiles of markers 
indicative of glutamatergic and GABAergic neuronal cell fates (Fig 4-7). 
 The glutamatergic marker vGLUT1 was strongly expressed from Day 20 post neural 
induction in 2D Dorsal cultures demonstrating the presence of excitatory neuronal cell 
populations. Expression was also seen within 3D Dorsal cultures from Day 20 of neural 
induction although with a trend for lower expression levels than was seen from the default 
2D induction pathway, but still significantly higher than both 2D and 3D ventral 
differentiations at Day 40-50 of maturation. Basal low-level expression of vGLUT1 was 
observed within both 2D and 3D Ventral cultures showing an incomplete inhibition of the 
excitatory neuronal differentiation pathway, but still with significantly lower excitatory 
neuronal marker expression than dorsally patterned cultures. This excitatory neuronal 




Fig 4-7: Quantitative gene expression analyses of excitatory (vGLUT1 and vGLUT2) and 
inhibitory (GAD67 and GAT1) neuronal markers in dorsally- and ventrally-patterned 
hiPSC-derived neural cultures differentiated in 2D planar cultures and 3D hydrogel 
scaffolds over 60 days of differentiation.  ND; Not Detected. Data is shown as means ± 
S.E.M. of four independent experiments. Statistical significance is displayed relative to; 
2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01, ***,###,ααα 
p≤0.001 based on unpaired two-tailed t-tests.  
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However, adherence to this divergent pattern of expression is exhibited less in the 
expression level of the excitatory marker vGLUT2. The upregulation of this marker showed 
more robust segregation between 2D Dorsal-patterned and 2D Ventral-patterned cultures, 
with higher expression found within the former experimental condition. However, 
expression levels within 3D Dorsal cell populations were lower than their 2D counterparts 
and were more comparable to levels seen within ventrally-patterned cultures, although 
these lower levels of expression did not reach statistical significance. Intriguingly, the Day 
20 level of expression seen within 3D Ventral cultures, was comparable to that seen within 
both dorsally-patterned differentiation pathways and significantly higher than the level 
seen within 2D ventrally-patterned cultures. However, this high spike of vGLUT2 
glutamatergic marker expression in 3D ventral cultures is not paired with an equivalent 
upregulation of vGLUT1 expression (which was not detected at the same time point) (Fig 4-
7). This is suggestive of either a transient upregulation of vGLUT2 expression in ventral 
cultures that does not denote intrinsic pathway divergence or possibly the generation of an 
early glutamatergic neural subset that is not maintained throughout the culture. Overall 
the divergent nature of ventral- and dorsal-patterning is more apparent through vGLUT1 
expression patterns than was seen with vGLUT2 expression.  
 The inhibitory GABAergic neuronal marker GAD67 within 2D Ventral cultures 
displayed a steady upregulation during neural differentiation and maturation over 60 days. 
Upregulation was also seen within the 3D Ventral-patterned cultures, albeit to a 
significantly lower level than was observed in 2D (~13-fold relative expression versus ~3-
fold relative expression at Day 60 of differentiation). Within both 2D and 3D Dorsal cultures 
the level of GAD67 was at a consistently low basal level that was significantly lower than 
the expression level within the ventrally-patterned cultures throughout the latter half of 
the neural differentiation pathway (Fig 4-7).  
 GAT1 (a GABA re-uptake transporter and GABAergic marker) expression levels 
showed robust upregulation from Day 30 onwards of 2D ventrally-patterned neural 
differentiation that was not observed in either the 2D Dorsal nor 3D Dorsal differentiation 
pathway cultures. Unlike GAD67 expression however, 3D Ventral cultures showed almost 
no GAT1 gene expression at any time-point during the differentiation process. This more 
mature marker of GABAergic neuronal function may therefore be inhibited within the 3D 
growth conditions of this experiment. 
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 As in the previous chapter, regression analysis of marker gene expression pattern 
and strength can be used to determine overall comparisons between divergent growth 
conditions for each marker. In this case when comparing the neuronal subtype specific 
markers vGLUT1, vGLUT2 and GAD67 it can be seen that between 3D Dorsal and 3D Ventral 
cultures a significantly divergent pattern of expression is recorded for both the dorsal 
marker vGLUT1 and the ventral marker GAD67 (Table 4-2). However, this is not true of the 
vGLUT2 regression data which shows a similar pattern between 3D Dorsal and 3D Ventral 
cultures (mirroring the point-by-point t-test data above).  
 
 
These data reinforce the conclusion that although patterning bias is preserved 
within dorsal and ventral 3D neural culture, the overall expression of mature neuronal 
subtype markers are lower in 3D growth cultures compared to 2D differentiation. This drop 
in overall neuronal maturation is reflected in the lower degrees of significance seen in the 
regression tables of 3D patterned cultures (Table 4-2) than is seen in 2D patterned cultures 
(Fig 4-7, Table 3-2). 
 To better visualise the effect of the 3D growth environment on the extent of 
neuronal subtype marker expression (and therefore patterned differentiation) within each 
neural culture; robust regression analysis was also performed on the 2D/3D Dorsal 
expression data (Table 4-3) and 2D/3D Ventral expression data (Table 4-4). 
 For dorsally-patterned differentiations there is no upregulation in ventrally 
associated gene expression (GAD67) when growth occurs within the 3D hydrogel 
environment compared to 2D planar culture (Table 4-3). This confirms that the hydrogel 
Table 4-2: Table of full time-course robust regression analysis of dorsal and ventral 
markers for 3D Dorsal vs 3D Ventral neural cultures. Statistical significance denoted 
by * p≤0.05, ** p≤0.01, *** p≤0.001. 
3D Dorsal vs 3D Ventral 
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scaffold itself does not impose any ventralising factors to the embedded cells and thereby 
triggering inhibitory neuronal subtype development.  
 
However, the strength of induction of dorsal-specific neuronal gene expression is 
inhibited within 3D Dorsal environments (Table 4-3), as is seen with the difference in 
expression patterns of the dorsal markers vGLUT1 and vGLUT2. This difference is not 
derived from a breakdown in the patterning events per say, but instead is reflective of 
lower overall neural maturation/differentiation within this 3D environment, of which these 
subtype markers are also indicative (see section 4.3.3). 
This is also true when comparing the patterned 2D Ventral and 3D Ventral 
expression data, which also preserve the same extent of dorsal-gene inhibition (i.e. the 
same efficacy of neural patterning) but combined with an overall significantly lower 
expression of ventral associated markers GAD67 and GAT1 (Table 4-4). 
 
Table 4-3: Table of full time-course robust regression analysis of dorsal and ventral 
markers for 2D Dorsal vs 3D Dorsal neural cultures. Statistical significance denoted 
by * p≤0.05, ** p≤0.01, *** p≤0.001. 
2D Dorsal vs 3D Dorsal 
Table 4-4: Table of full time-course robust regression analysis of dorsal and ventral 
markers for 2D Ventral vs 3D Ventral neural cultures. Statistical significance 
denoted by * p≤0.05, ** p≤0.01, *** p≤0.001. 
2D Ventral vs 3D Ventral 
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 Taken altogether this regression analysis confirms the preservation of patterning 
methodologies during differentiation within the hydrogel scaffolds, and that the scaffold 
itself does not elicit any patterning influence over the embedded cells. However, there is a 
strong consistent repression of neuronal subtype marker expression within both dorsal and 
ventral 3D cultures, which is also reflected in canonical neuronal marker expression. 
Therefore, under these 3D conditions; neuronal patterning is preserved but tied to 
inhibition of neural maturation. 
 
4.3.5 Cortical Marker Expression Profiles in 2D versus 3D Culture 
Neural morphogen patterning of hiPSC-derived NPCs does not generate specific neuronal 
subtypes in isolation, but instead does so by recapitulating temporo-spatial coordinates of 
neural tube localisation. Therefore it is necessary to uncover whether the maturation 
events of dorsal-forebrain identity (corticogenesis) are preserved, accelerated or altered 
under maturation in 3D hydrogel scaffolds. To this end, gene expression profiles of the 
early-to-late born cortical markers REELIN, TBR1, CTIP2 and SATB2 were analysed in all four 
neural differentiation conditions (Fig 4-8). 
 REELIN expression is a marker of the pioneer outer layer I of the cortex and an early 
marker of cortical development. The greatest upregulation of this gene was seen within 2D 
Dorsal cultures with peak expression after 30 days of neural differentiation but with 
maintenance of expression up until Day 60. It also showed upregulation within 3D Dorsal 
cultures although to a much lower extent. At Day 30 the relative expression in 2D was 8-
fold higher than expression in 3D Dorsal cultures, but by Day 40 to 50 of differentiation this 
difference in expression dropped to below 2-fold. Expression of REELIN in both 2D and 3D 
ventral-patterned cultures was consistently lower than is seen in the dorsal inductions, 
especially after protracted periods of neural maturation, but expression was not 
suppressed entirely. Even within positively expressing dorsal cultures, high variability of 
expression between biological repeats was prevalent.  
 This overall pattern was repeated when observing the expression of cortical pre-
plate and layer VI cortical marker TBR1 over the course of differentiation (Fig 4-8). Robust 
gene expression was limited to 2D Dorsal cultures with a significant peak around 30 days of 
differentiation followed by a steady decrease until Day 60. Recorded expression of TBR1 in 
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3D Dorsal culture was consistently lower than in 2D, ranging from approximately 8.5-fold to 
5.4-fold reduced relative expression across the course of differentiation. As with REELIN, 
ventrally-induced neural cultures (both 2D and 3D) showed the lowest expression levels of 
TBR1, although did maintain a minimal expression level. 
  
 
Intriguingly, the expression profiles of the layer V cortical marker CTIP2 and the 
late-born upper layer II-IV cortical marker SATB2 break from the pattern described above 
and showed enhanced levels of expression within 3D Dorsal cultures compared to the 2D 
Dorsal inductions (Fig 4-8). 
CTIP2 expression in 2D and 3D Dorsal cultures were at approximately equivalent 
levels over Days 20-40 of differentiation, but increased by Day 60 within the 3D Dorsal 
populations to a level over 7-fold higher than that seen in 2D Dorsal cultures at the same 
time point. Levels of CTIP2 gene expression within either of the ventrally-patterned culture 
conditions remained lower than those seen within dorsal cultures at every measured time 
Fig 4-8: Quantitative gene expression analyses of early and late cortical-specific markers 
in dorsally- and ventrally-patterned hiPSC-derived neural cultures differentiated in 2D 
planar cultures and 3D hydrogel scaffolds over 60 days of differentiation.  ND; Not 
Detected. Data is shown as means ± S.E.M. of four independent experiments. Statistical 
significance is displayed relative to; 2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α 
p≤0.05, **,##,αα p≤0.01, ***,###,ααα p≤0.001 based on unpaired two-tailed t-tests.  
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point. However, the low relative transcript expression increases only reached significance 
after 60 days of differentiation relative to 3D Dorsal cultures (Fig 4-8).  
At all assayed time points the upper-layer late-born neuronal cortical marker SATB2 
displayed a trend for higher relative expression levels in 3D Dorsal rather than 2D Dorsal 
cultures (~2 to 4-fold higher) (Fig 4-8). No noticeable upward trend of expression level was 
discernible along this timeline of neural maturation that would follow with the expected 
timeline of late-born cortical neuron generation. As with the majority of dorsal-anterior 
cortical markers, the expression level of SATB2 within both 2D and 3D Ventral cultures 
were barely detectable at any of the time-points assayed. The high variability of expression 
levels within dorsally patterned biological repeats hints at the possible stochastic nature of 
the development of these subpopulations of cortical cell types between differentiations. 
However, regardless of this spread of cortical marker strength, for all four markers 
analysed, all showed stronger expression profiles in the dorsally-patterned neural cultures. 
 To confirm the separation of cortical localisation markers between the 3D Dorsal 
and 3D Ventral growth environments, we once again used regression analysis of the gene 
expression data to compare overall pattern divergence (Table 4-5). 
 
 For all of the early-to-late cortical markers analysed, strong significant differences 
in expression pattern are maintained between 3D Dorsal and 3D Ventral cultures. All of 
these markers are indicative of cortical or pre-cortical neuronal localisation and dorsal 
forebrain development. Therefore the strong presence of these cortical markers in 
dorsally-patterned, but not ventrally-patterned, 2D and 3D neural cultures (Fig 4-8, Table 4-
5) confirm the preservation of dorsal identity within the hydrogel environment, and that 
Table 4-5: Table of full time-course robust regression analysis of cortical localisation 
markers for 3D Dorsal vs 3D Ventral neural cultures. Statistical significance denoted 
by * p≤0.05, ** p≤0.01, *** p≤0.001. 
3D Dorsal vs 3D Ventral 
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the 3D scaffold itself does not infer any localisation specification onto the encapsulated 
cells. 
 To observe whether the 3D environment itself has a negative impact on cortical 
marker expression (as was seen with neuronal subtype genes in Section 4.3.4) we repeated 
the robust regression analysis of cortical localisation gene markers between 2D Dorsal and 








 Intriguingly, the “early” cortical markers REELIN and TBR1 do show significant 
differences in the magnitude and pattern of expression between 2D and 3D Dorsal 
differentiation. This is also seen with the “late” cortical marker SATB2. No significant 
difference was observed in the expression pattern of the “mid”-onset cortical marker 
CTIP2. These differences in expression pattern between 2D and 3D Dorsal inductions are 
not simply a reduction in each overall gene transcription, as was seen for the neuronal 
subtype markers. Instead the expression of the “early” markers are lower in the 3D 
cultures, whereas the “late” cortical marker is significantly enhanced. 
 To ascertain whether the repression of anterior-dorsal cortical markers is 
maintained in 3D encapsulated ventrally-patterned cultures, we reproduced the regression 
analysis above for 2D Ventral and 3D Ventral neural cultures (Table 4-7). For all of the 
cortical regionalisation genes, with the exception of TBR1, no significant differences in 
cortical marker upregulation is seen in the 3D Ventral cultures. The differences flagged by 
this analysis for TBR1 expression denotes higher expression within 2D Ventral cultures than 
3D, which still confirms the conclusion that the hydrogel scaffold does not enhance dorsal 
gene expression patterns or limit the ventral patterning efficacy. Instead this difference, 
Table 4-6: Table of full time-course robust regression analysis of cortical localisation 
markers for 2D Dorsal vs 3D Dorsal neural cultures. Statistical significance denoted by 
* p≤0.05, ** p≤0.01, *** p≤0.001. 
2D Dorsal vs 3D Dorsal 
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although significant, is still based on expression levels far below those seen within planar 
dorsally-patterned cultures (Fig 4-8). 
 
 The combination of all cortical marker regression data does reinforce the 
conclusion that dorso-ventral regionalisation is strongly maintained within the 3D 
patterning differentiation methods utilised here. In addition to this, no evidence of 
repressed ventralisation within the hydrogel scaffold was observed in the pattern of 
cortical-specific genes. There were however differences in the magnitude of cortical gene 
expression from planar dorsal cultures and 3D Dorsal cultures showing that hydrogel 
embedding may elicit an effect on cortical cell maturation rates. 
 
4.3.6 Effect of 3D Culture on Neurotransmitter Receptor Expression 
Another aspect of neural cell maturation that may differ between planar and 3D 
encapsulated neural inductions is the prevalence of neurotransmitter receptor 
development, as a precursor to excitatory and inhibitory synaptic function.  
 The ionotropic GABA receptor subunit GABAAR1 showed a late-onset upregulation 
of expression in both 2D Dorsal and 2D Ventral neural cultures, with a bias of elevated 
expression within the latter (Fig 4-9). However, this pattern was not preserved with 3D 
Dorsal and Ventral neural inductions which displayed reduced expression in 3D Dorsal 
cultures relative to both 2D culture types with a 4-fold and 7.5-fold decrease in expression 
compared to 2D Dorsal and 2D Ventral cultures respectively. The upregulation of this 
receptor subunit was seen strongly within 2D Ventral inductions but were barely 
Table 4-7: Table of full time-course robust regression analysis of cortical localisation 
markers for 2D Ventral vs 3D Ventral neural cultures. Statistical significance denoted 
by * p≤0.05, ** p≤0.01, *** p≤0.001. 
2D Ventral vs 3D Ventral 
173 
 
detectable in 3D Ventral cell populations at any time point during differentiation (Fig 4-9). 
At Days 40-60 of differentiation, the GABAAR1 expression level in 3D Ventral cultures was 
significantly lower than that observed in 2D Ventral cultures at equivalent timepoints.    
 In contrast, the metabotropic GABA receptor subunit GABABR1 displayed 
upregulation earlier in the time-course of neural differentiation than GABAAR1. Consistent 
and robust expression of GABABR1 was observed in both 2D Dorsal and 2D Ventral cultures 
with a trend for approximately double the expression within ventrally-patterned cultures 
than in dorsal ones from Day 30 onwards (Fig 4-9). Spikes of GABABR1 expression at Day 14 
and 20 of differentiation were seen within 3D Ventral cultures that at the latter time point 
were 3- to 5-fold higher than in the other three culture conditions (p≤0.01 to p≤0.001). This 
early increase, at the time-point indicative of initial neuronal formation, then lowered to 
comparable levels seen within 2D induction conditions (and even lower by Day 60). 
Following the same pattern of 2D Ventral and Dorsal cultures, 3D Dorsal expression of 
GABABR1 was consistently lower than that seen in 3D Ventral cell populations.  
Fig 4-9: Quantitative gene expression analyses of GABA and glutamate neurotransmitter 
receptor subunit markers in dorsally- and ventrally-patterned hiPSC-derived neural 
cultures differentiated in 2D planar cultures and 3D hydrogel scaffolds over 60 days of 
differentiation. ND; Not Detected. Data is shown as means ± S.E.M. of four independent 
experiments. Statistical significance is displayed relative to; 2D Dorsal (*), 2D Ventral 
(#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01, ***,###,ααα p≤0.001 based on unpaired 
two-tailed t-tests.  
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The overall relative expression level observed within 3D Dorsal cultures did remain steady 
over the course of differentiation, but at a level constantly lower than the other three 
neural induction conditions (Fig 4-9).  
When assaying the gene upregulation of the ionotropic glutamate receptor 
subunits NMDAR1 and AMPAR1, the same spike of high expression within 3D Ventral 
cultures after 20 days of differentiation is observed, similar to that seen with GABABR1 
expression. For both AMPAR1 and NMDAR1 expression this early spike rapidly dropped 
over the time-line of differentiation to levels significantly below that seen in 2D culture 
conditions for NMDAR1 expression, or comparable to 2D culture conditions in the case of 
AMPAR1 (Fig 4-9). NMDAR1 expression levels within 2D Dorsal cultures remained stable 
over every time-point from Day 20 of neural maturation, while a gradual upregulation over 
time was observed with 2D Ventral cultures (from 4-fold less than 2D Dorsal expression at 
Day 20 up to a 2-fold significantly higher expression by Day 60). 3D Dorsal expression levels 
of NMDAR1 followed a similar pattern to that seen with GABABR1 expression, with gene 
expression levels 2- to 10-fold less than those recorded in 2D Dorsal cell populations. By 
Day 60 of differentiation, both 3D patterned neural cell cultures showed significantly lower 
expression of NMDAR1 than 2D Ventral cultures (Fig 4-9). 
 This same pattern was seen with AMPAR1 expression but less starkly than was 
observed in NMDAR1 expression analyses. By Day 50-60 of differentiation, similar levels of 
AMPAR1 expression was observed in 2D Dorsal, 3D Dorsal and 3D Ventral cultures, with an 
approximate 2-fold elevation in 2D Ventral cell populations. Earlier in the differentiation 
timeline (Day 20-30), the level of 3D Dorsal expression again remained stable but lower 
than that recorded in 2D Dorsal populations. Both 2D and 3D Ventral patterned cultures 
displayed slight trends for elevated AMPAR1 glutamate receptor expression than neural 
populations undergoing dorsal-patterning.   
 
4.3.7 Gliogenesis within 3D Scaffolds 
Gliogenesis in utero is delayed relative to neuronal differentiation, and this pattern is 
recapitulated in neural differentiation pathways from pluripotent stem cells in vitro. To 
study whether neural differentiation of hiPSCs within 3D hydrogel environments affects the 
induction strength of astroglial and oligodendroglial cell lineages, or the timing of such 
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molecular events relative to 2D, we studied the gene expression profiles of the astrocytic 
marker GFAP and oligodendroglial lineage marker GALC (Fig 4-10). 
 The astrocytic marker GFAP did indeed display a robust delay of upregulation in 
comparison to the neuronal-specific markers analysed above, with detectable expression 
levels only later in the maturation timeline (Day 50 to 60 of differentiation). The level of 
GFAP expression was increased within both 3D Dorsal and 3D Ventral cultures relative to 
both 2D neural induction cell populations, with statistically significant higher levels of 
expression in 3D Ventral cultures. By Day 60, 3D Dorsal neural populations displayed 
significantly higher levels of GFAP expression compared to 2D dorsally-patterned cell types. 
  
 
Interestingly, the expression of the oligodendroglial lineage marker GALC did not 
appear to be affected by neural differentiation strategies in either 2D or 3D environments 
and showed relatively stable expression levels over the full time-course of differentiation 
(Fig 4-10). Only in 3D Ventral cultures did the level of GALC expression show maintenance 
at significantly lower levels than 2D differentiation pathways. This is surprising, as the 
development of oligodendrocytes would logically follow the same pattern as astroglial 
generation, with a protracted (and intrinsic) delay following neuronal differentiation. 
However, this stable expression profile may represent basal levels of GALC within non-
oligodendroglial cell types (including neurons), and extended maturation times may be 
Fig 4-10: Quantitative gene expression analyses of astroglial (GFAP) and 
oligodendroglial (GALC) markers in dorsally- and ventrally-patterned hiPSC-derived 
neural cultures differentiated in 2D planar cultures and 3D hydrogel scaffolds over 
60 days of differentiation. ND; Not Detected. Data is shown as means ± S.E.M. of 
four independent experiments. Statistical significance is displayed relative to; 2D 
Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01, ***,###,ααα 
p≤0.001 based on unpaired two-tailed t-tests. 
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necessary to show strong gene upregulation indicating true oligodendrocyte formation. The 
trend of overall lower levels of expression in 3D Ventral cultures may indicate an increased 
population of neuronal rather than glial subtypes compared to other differentiation 
strategies, or an inhibition of oligodendroglial precursor identity within the 3D culture. 
 
4.4 Discussion and Conclusions 
To fully model neurological development and in vivo-like cytoarchitecture in vitro, many 
studies have focused on the generation of various 3D environments for neural cell 
encapsulation. These aim to mimic the biophysical and biochemical properties of native 
neural tissue. The reported advantages of such 3D neural cell culture systems would allow 
for enhanced cell-cell contacts ( e.g. synapse formation) along all three axes, as well as 
greater degrees of cell-matrix interaction allowing for cell migration and possible self-
organisation (LaPlaca et al., 2010). Differentiation of iPSCs into neural lineages in various 
3D hydrogel environments has been linked with enhanced markers of differentiation, and 
has been successfully used for migration-defect modelling of neurons from neurological 
pathologies (Z.-N. Zhang et al., 2016; Gu et al., 2017). However, direct comparisons of 
neural differentiation between 3D and 2D planar culture, and the effect of 3D hydrogel 
environments on dorsal- and ventral-patterned encapsulated NPCs in parallel, has not been 
explored.  
 In this chapter we have shown that hiPSC-derived NPCs differentiated in 3D 
collagen hydrogel scaffolds undergo extensive neuritogenesis. This is consistent with the 
finding detailed in Chapter 2; with neurite formation from neural-like cells encapsulated 
within collagen scaffolds. These neurites extend in all three-axes of the hydrogel 
environment and display markers of post-mitotic neuronal identity and pre-synaptic 
molecular machinery. Previous studies have shown that neural cell electrophysiological 
activity is preserved within collagen hydrogel matrices (O’Connor et al., 2000; Ma et al., 
2004), so such neuritogenesis as described here is integral for the maturation of functional 
synapses between neuronal cells in this microenvironment.  
 The NPC marker NESTIN, shows comparable levels of expression when hiPSC-
derived neural cultures are differentiated in 2D Dorsal, 2D Ventral and 3D Dorsal 
environments over 60 days. However, NESTIN expression early in differentiation (Day 14-
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20) within 3D Ventral cultures is significantly higher than is observed in all other 
experimental conditions (~3.6-fold higher at Day 14 and ~2.4-fold higher at Day 20). This 
suggests a higher level of NPC induction within 3D encapsulated ventrally-patterned neural 
cultures. This early spike of NPC induction is reflected by higher levels of the ventral 
forebrain precursor marker NKX2.1 at early time points within 3D Ventral cultures relative 
to 2D Ventral conditions. This pattern is not seen for dorsal-patterned cultures, in which 
PAX6 levels are not enhanced within cells cultured in a 3D environment. This suggests that 
this 3D environment enhances ventral NPC generation, but does not enhance default 
dorsal precursor cell pools. Importantly, the effect of 3D collagen encapsulation did not 
appear to alter the patterning of encapsulated cells. That is to say, the effect of the 
patterning molecule purmorphamine is not inhibited through cell growth and 
differentiation in hydrogels. Also, the biophysical composition of the hydrogel itself does 
not appear to adversely affect the dorsal/ventral NPC developmental pathway. This is in 
opposition to primarily Matrigel-based hydrogel scaffolds that can alter downstream 
neuronal subtype composition through inherent signalling molecule content (Shimada et 
al., 2012; Ni et al., 2013). 
 When observing markers of neuronal maturation such as β-III-TUBULIN; 2D and 3D 
growth environments appear to elicit comparable levels of this marker at early time points 
of neural differentiation (Day 14-20). However, this level drops to significantly lower levels 
in both 3D Dorsal and Ventral cultures relative to 2D inductions for the remainder of neural 
maturation. This may be due to either an inhibition of maturation of post-mitotic neuronal 
cells within the 3D environments or a possible inhibition of the NPC-to-neuronal transition 
event, leading to a retention of immature NPC characteristics. This 2D and 3D segregation 
is less defined when looking at the axonal marker TAU, in which only 3D Ventral cultures 
show lower expression levels by later timepoints of maturation. Interestingly, the pre- and 
post-synaptic markers SYN and PSD95 display early peaks within 3D Ventral cultures (Day 
14-20) that dissipate over the remainder of neural maturation to levels below those 
recorded in 2D culture. This may be indicative of an initial acceleration of ventral neural 
differentiation in 3D culture that is not maintained for the time course of differentiation 
and maturation. This effect, however, is limited to ventrally-patterned 3D cultures as no 
such early peak (or indeed elevation) of neuronal or synaptic markers is observed in 3D 
Dorsal neural cultures at any assayed time point. It may then be possible that these 3D 
hydrogel environments may elicit both enhancing and diminishing effects on hiPSC-derived 
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neural maturation dependant on the early patterning and neural tube regionalisation of the 
starting NPC pool. 
 As with NPC patterning specificity, dorsal- and ventral-derived forebrain 
localisation markers are also preserved within 3D hydrogel environments. The early- and 
late-born cortical markers REELIN, TBR1, CTIP2 and SATB2 are all present in 2D and 3D 
Dorsal cultures. REELIN and TBR1 expression levels however, were lower in 3D Dorsal 
cultures compared to 2D differentiation, whereas CTIP2 and SATB2 (late born cortical 
markers) showed higher expression profiles. Limited expression of these dorsal markers 
was seen in either 2D or 3D Ventral neural cultures. The segregation of these dorsal-
associated cortical markers between the dorsal and ventral patterned cultures is also 
confirmed through regression analysis of each pattern of marker expression for the whole 
time-course of differentiation. It is interesting to note that the raw patterning segregation 
of these dorsal regionalisation markers is preserved within 3D dorsally-patterned cultures, 
but that differences in early- and late-born cortical markers are apparent. It is possible that 
the enhanced upregulation of CTIP2 and SATB2 within 3D microenvironments may be due 
to biophysical interactions with the hydrogel itself, or a possible acceleration of late-born 
cortical neurogenesis at the expense of prolonged early-born cortical cell identity (REELIN 
and TBR1). In either case, the patterning of dorsal and ventral neural cell localisation 
identity appears preserved within this 3D hydrogel system.  
Excitatory and inhibitory neuronal subtype patterning was also shown to be 
unaffected by differentiation within the hydrogel environment through robust regression 
analysis of marker gene expression patterns between all of the growth conditions. The 
excitatory neuronal subtype marker vGLUT1 is highly expressed in 2D Dorsal neural culture 
but shows more restricted expression within neural cells in 3D Dorsal culture. Even so, the 
level of expression in dorsally-patterned neural cultures is still higher than that observed 
under ventral patterning, showing the preservation of excitatory/dorsal neuronal identity. 
This is also reflected in the upregulation of the GABAergic ventral neuronal marker GAD67, 
which shows steady upregulation in 2D Ventral cultures during maturation. GAD67 
expression is also observed within 3D Ventral neural cultures although, as with vGLUT1, to 
a lower level than is recorded from 2D planar culture. This is much more apparent with the 
GABAergic marker GAT1 which shows significantly lower levels of expression in 3D Ventral 
cultures compared to 2D. A possible explanation of this finding may be related to ideas 
discussed above, by which the 3D environment appears to be having an inhibitory effect on 
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the rate of neural maturation. This may be due to an interaction with the biomaterial itself, 
or possibly an issue related to relative cell densities between 2D and 3D environments. Cell 
seeding densities within this study were selected on the basis of maximising construct size 
without generating scaffolds that would have a negative impact on cell viability through 
restrictive diffusion of oxygen and nutrients. However, a truer in vivo-like developmental 
environment would require higher cell densities to be more neural tissue-like, which may 
positively impact neural cell differentiation. To overcome this, other studies have utilised 
restricted construct size to counterbalance cell death from high cell densities (Frampton et 
al., 2011), cultured 3D constructs within perfusion devices to keep pace with the metabolic 
demands of encapsulated cells (Cullen et al., 2007), and generated 3D bioprinted 
constructs that enable higher surface area exchange of oxygen and nutrients (Gu et al., 
2017).   
 This restriction of maturation within 3D environments was also observed when 
looking at molecular markers of neurotransmitter sensitivity. By later time points of neural 
differentiation and maturation, cells cultured within both 3D environments displayed 
generally lower levels of the neurotransmitter receptor markers GABAAR1, GABABR1, 
NMDAR1, and AMPAR1. Although this restriction was most pronounced in the expression 
profiles of GABAAR1 and NMDAR1. Interestingly, after 20 days of differentiation, 3D Ventral 
cultures displayed the same strong peak of expression for NMDAR1, GABABR1 and AMPAR1 
as was seen for SYN and PSD95 expression. It is surprising that both pre- and post-synaptic 
machinery transcripts seem to be preferentially upregulated in 3D Ventral environments 
rather than 3D Dorsal ones early in neural differentiation. This initial burst of expression 
may be related to an accelerated differentiation profile, before cessation during more 
protracted timelines of differentiation, and one that appears specific to ventrally-patterned 
NPCs within 3D hydrogels. However, this does not hold true for markers of 
neurotransmitter generation and uptake (GAD67 and GAT1) which conversely show more 
restricted expression in 3D Ventral environments than 2D Ventral counterparts. It may be 
concluded therefore that 3D encapsulation in biomaterial scaffolds can have differential 
effects on separate elements of neural differentiation and maturation, rather than 
complete enhancement of all neural differentiation markers. This effect also appears 
dependent on the type of patterned NPC pool, as ventrally- and dorsally-patterned 
precursors responded differently to the same 3D environment.   
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 Finally, the generation of astrocytic glial lineages does appear to be influenced 
through 3D hydrogel encapsulation compared to planar culture. Both 3D Dorsal and Ventral 
neural cell types displayed higher levels of the astrocyte marker GFAP by Day 60 of 
differentiation than is seen in either 2D culture. It is also possible that the 3D environment 
elicits a pro-glial environment for NPC differentiation, or may even accelerate intrinsic 
developmental timings that regulate the gliogenesis in vivo. 
 In conclusion, we have shown that 3D collagen hydrogel environments are 
conducive to neural cell neuritogenesis of encapsulated hiPSC-derived NPCs. Neural 
differentiation and maturation markers are expressed during this 3D differentiation, but in 
many cases, are directly comparable or reduced relative to 2D planar differentiation. 3D 
Ventral differentiation did appear to show accelerated markers of neural maturation 
through early expression spikes of canonical neuronal and synaptic markers, that were not 
seen in 3D Dorsal culture. From these data, it appears as though differentially patterned 
pools of NPCs demonstrate differing effects on gene expression from growth in the same 
3D environment. This would impact the formation of neural tissue constructs derived from 
dorsal and ventral lineages within these 3D scaffolds, with such discrepancies influencing 
the formation of any representative native tissue cellular composition. 
The lack of sustained expression of maturation markers observed may be due in 
part to lower cell densities within the 3D culture system resulting in reduced overall cell-
cell contact number than when compared to dense 2D neural cultures. Thus, high cell 
densities may be key to recapitulate and enhance neural differentiation in 3D but must 
overcome limitations in maintaining cell viability through restricted diffusion of oxygen and 
nutrients. Therefore, methods of generating bioprinted neural-tissue constructs (using 
biomaterials utilised in Chapters 2 and 4) that can maintain high neural cell densities, will 
be the focus of the next chapter. 
 
4.4.1 Summary of Chapter Findings 
 hiPSC-derived NPCs differentiating within 3D collagen type I scaffolds undergo 




 3D encapsulated neural cultures express protein markers of post-mitotic neuronal 
generation as well as pre-synaptic machinery. 
 Neural differentiation in 3D collagen hydrogel scaffolds does not affect the efficacy of 
patterning morphogens to generate dorsal- and ventral-derived neural lineages.  
 Enhanced NPC marker expression was seen within ventrally-patterned neural cells but 
not with dorsally-patterned neural cultures when encapsulated in 3D hydrogel 
environments. 
 3D Ventral cultures show early peak expression of neuronal and synaptic markers 
significantly above the levels of 2D cultures and 3D Dorsal neural cultures. 
 By later time points of differentiation: neuronal, axonal and synaptic marker expression 
are lower in 3D microenvironments than in 2D planar culture, suggesting an inhibition 
of maturation. 
 Excitatory and inhibitory neuronal subtype marker expression are preserved in 
dorsal/ventral patterning in 3D environments, but with lower levels of expression than 
is seen in planar differentiation. 
 Dorsal cortical localisation markers are observed in both 2D and 3D Dorsal neural 
cultures. In 3D scaffolds however, early-cortical markers (REELIN, TBR1) display 
expression profiles lower than in 2D differentiation, and late-cortical markers (CTIP2, 
SATB2) show enhanced expression relative to 2D Dorsal cultures. 
 The ionotropic GABA-receptor GABAAR1 shows limited expression in both 3D Dorsal 
and 3D Ventral neural cultures. 
 3D Ventral neural cultures show significantly high expression spikes of GABABR1, 
NMDAR1 and AMPAR1 neurotransmitter receptor subunits, not seen in 3D Dorsal 
differentiation. By later time points of maturation, these markers tend to show lower 
expression in 3D cultures compared to 2D differentiation. 
 Neuronal generation is not limited within 3D hydrogel scaffolds, but functional 
maturation does appear to be restricted under these experimental conditions.  
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4.5.1 Robust Regression Analysis Output Tables 
To further statistically verify the segregation of neural subtype patterning markers between 
dorsally-patterned and ventrally-patterned cultures (in both 2D and 3D) we undertook 
robust regression analysis for the pattern and magnitude of each subtype marker gene 
(Sections 3.3.4, 4.3.4, and 4.3.5). The raw output statistical tables for each pair-wise 




Appendix Fig 4-11: Robust regression analysis output tables for glutamatergic (dorsal) 
neuronal cell identity genes vGLUT1 and vGLUT2. Data set being compared to in each 
table is displayed on the left-hand side. Highlighted rows contain outputs used in 










Appendix Fig 4-12: Robust regression analysis output tables for GABA-ergic (ventral) 
neuronal cell identity genes GAD67 and GAT1. Data set being compared to in each table 
is displayed on the left-hand side. Highlighted rows contain outputs used in compiled 








Appendix Fig 4-13: Robust regression analysis output tables for early cortical-specific 
regionalisation (dorsal) neuronal cell identity genes REELIN and TBR1. Data set being 
compared to in each table is displayed on the left-hand side. Highlighted rows contain 








Appendix Fig 4-14: Robust regression analysis output tables for late-born cortical-
specific regionalisation (dorsal) neuronal cell identity genes CTIP2 and SATB2. Data set 
being compared to in each table is displayed on the left-hand side. Highlighted rows 
contain outputs used in compiled results tables in Chapters 3 and 4. 
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Chapter 5: Development of Bioinks for 
Neural Tissue Bioprinting 
 
5.1 Introduction 
Many potential advantages of in vitro neural tissue development within 3D culture systems 
have been outlined above (Chapter 4) and are well documented across other sources 
(LaPlaca et al., 2010). The construction of natural or synthetic cellular microenvironments, 
such as those within hydrogel scaffolds, allow for the recapitulation of in vivo-like spatial 
geometry, cell-cell communication and cell-matrix interactions. However, the use of simple 
hydrogel encapsulation of neural cells has implicit limitations. Cell densities within the 
constructs must not exceed the rate of oxygen and nutrient diffusion available, and 
therefore the more “tissue-representative” the cellular content, the smaller the size of the 
construct must be to avoid cell death. As is seen in Chapter 4, this critical cell density may 
be necessary for adequate neural cell maturation and development of function. Certain 
techniques have been utilised to overcome this limiting factor through the use of perfusion 
devices (or so-called “brain-on-a-chip” devices) by which to maximise the available 
concentrations of nutrients and the removal of metabolic waste products (Cullen et al., 
2007; Pamies, Hartung and Hogberg, 2014; Moreno et al., 2015). 
As well as issues with controlling nutrient diffusion, the cytoarchitecture within 
hydrogel scaffolds is difficult to modify manually, with the cells, in many cases, distributed 
evenly throughout the construct prior to gelation. Therefore, controlled deposition or 
assembly of different cellular pools is extremely difficult in basic encapsulation methods. 
Neural organoid culture can show incredible recapitulation of early-neurological structures 
derived from intrinsic self-organisation, and do so strongly when embedded within 
hydrogel scaffolds (Lancaster et al., 2013; Kelava and Lancaster, 2016), however, the same 
issue of low diffusion rates of nutrients (even within bioreactors) leads to the formation of 
necrotic cores and inherent size limitations of each organoid.  
To retain the intrinsic advantages of 3D neural cell culture, but to overcome the 
disadvantages of limited nutrient diffusion (or small construct size) and tighter control over 
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cell subtype segregation and placement, many research projects are now focused on the 
development of additive fabrication technologies to generate neural tissue in vitro (Thomas 
and Willerth, 2017; Knowlton et al., 2018). This process, termed “bioprinting”, is based 
around the use of 3D-printing technology by which to accurately generate 3D 
cytocompatible tissue-like structures in a controlled temporo-spatial manner.  
The scaffolds used for such bioprinting techniques are termed “bioinks”, which may 
also be a class of hydrogels, but are distinguished through the bioink’s ability to form and 
retain a filamentous morphology during the printing process. The ability to retain such 
shape fidelity allows for the design of custom topologies and complex structural elements. 
Unlike simple hydrogel encapsulation, which may only form a solid block of tissue-like 
scaffold, bioprinting can generate complicated geometries, may be formed from multiple 
bioinks, and contain structural elements to enhance the construct’s tissue-like properties 
(Kang et al., 2016). Certain aspects of cell positioning and placement within simple hydrogel 
in vitro neurological models, such as the layering of the cortex using hydrogel moulds and 
microfluidic devices, have been elegantly accomplished (Kunze et al., 2011; Odawara, 
Gotoh and Suzuki, 2013). However, the level of tailoring of construct parameters through 
these methods suffers from low resolution and require long periods of development. 
Scaffold designs for bioprinting, on the other hand, can be developed in silico and re-
designed extremely quickly. An example of an in silico designed output and a 3D-printed 










Fig 5-1: An example of an in silico 3D-printable design (left) that can generate 
complex structures from hydrogels through 3D printing technology (right).  
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 By creating specific geometries within the bioprinted construct, it is also possible to 
generate patterns of pseudovasculature that not only allow for improved access of 
encapsulated cells to oxygen and nutrients, but by doing so, allow for the scaling-up of 
hydrogel scaffolds into sizes relevant for human tissue research or regenerative therapy 
(Kang et al., 2016). The use of bioprinting therefore combines the advantages of basic 3D 
hydrogel culture with the ability to generate larger and more cell-dense in vitro models.  
 A critical aspect of any bioprinting methodology is the selection (and potential 
modification) of bioinks to make them amenable to the 3D-printing extrusion process as 
well as being tolerated by encapsulated neural cells. Cytocompatibility is of paramount 
importance when generating 3D cell-laden constructs and so not only in the base state 
must a bioink be non-cytotoxic to cells, but any associated cross-linking gelation processes 
must also be non-damaging (Knowlton et al., 2018).   
Methacrylate groups are a common additive to polymer backbones as a way of 
inducing controlled covalent crosslinking and gelation of hydrogels. This process 
predominantly utilises photoinitiator compounds that generate free radicals under 
exposure to ultraviolet (UV) light that consequently react and chemically-bond adjacent 
methacrylate moieties. Such crosslinking has been used extensively with the biomaterials 
methacrylated gelatin (GelMA) (Thomas and Willerth, 2017) and hyaluronic acid (HAMA) 
(Z.-N. Zhang et al., 2016).  Hydroxyphenylpropionic acid (HPA) conjugated gelatin (GelHPA) 
also crosslinks in the presence of free radicals, but rather than UV-activated 
photoinitiators, can be catalysed through the reaction products of hydrogen peroxide and 
horse radish peroxidase (M. Hu et al., 2009). Care must be taken however when optimising 
the exposure of cell-laden bioinks to UV irradiation and free radical generation as both are 
known to have pronounced cytotoxic effects (Williams et al., 2005; Mironi-Harpaz et al., 
2012). Bioinks derived from non-mammalian polysaccharides also have precedent as 
scaffolds for bioprinted neural tissue engineering, with ionic crosslinking either following or 
as a continuous process during bioprinting (Lozano et al., 2015; Gu et al., 2017), with no 
discernible negative effect on encapsulated cell types.  
 As well as the cytocompatibility of biomaterials for 3D tissue-engineering, bioinks 
should display an array of physical characteristics, that in broad terms, combine to define 
the “printability” of the material. Multiple methodologies of biomaterial printing have 
shown promise in generating cell-laden biomaterial scaffolds, although the main three 
techniques are inkjet-based printing, laser-assisted printing, and extrusion printing 
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(Knowlton et al., 2018). By far the most common however, is extrusion-based printing. This 
involves the mixing of cells and bioink prior to deposition through pressurised nozzles or 
needles. This fabrication technique allows for the rapid and large-volume deposition of cell-
laden and/or acellular biomaterial scaffolds. For extrusion-based bioprinting to be 
successful, the printability of bioinks is dependent on various material characteristics. The 
physical traits necessary for the generation of extrudable bioink formulations include; 
appropriate viscosity; non-Newtonian shear-thinning or thixotropic qualities; and retention 
of filament fidelity prior to crosslinking.  
 The viscosity of bioinks allows for the retention of design fidelity following 
extrusion from the nozzle. Therefore, extrudable bioinks must have viscosities that are high 
enough to maintain a free-standing shape, as well as being necessary for multiple layers to 
be printed and stacked on top of each other to generate 3D topographies. Candidate 
bioinks with too low a viscosity will lose shape resolution and be unable to form true 3D 
scaffolds. Another desired trait of extrudable-bioinks is for the biomaterial to display shear-
thinning or thixotropic qualities. This is a non-Newtonian pseudoplastic behaviour by which 
viscosity decreases under shear strain. In essence, this can be seen as transitioning the 
bioink to a more liquid-like state during the pressure-driven extrusion process, but after 
deposition, rapidly regains highly viscous characteristics. A bioink with high degrees of 
shear-thinning will result in lower levels of shear stress being generated under extrusion, 
which is advantageous for cell-laden bioinks, where high degrees of shear stress can have 
negative effects on cell survivability (Blaeser et al., 2016). Bioink compositions can also be 
modified to alter properties of viscosity; such as the addition of glycerol to modify the 
extrusion characteristics (Kang et al., 2016); as well as controlling the temperature of 
extrusion apparatus which can directly affect bioink printability (Chung et al., 2013).   
 This Chapter will focus on the development of bioinks and bioprinting techniques 
that allow for extrusion-based bioprinting of neural cells. The biomaterials used as a basis 
for these bioinks will be those assayed previously in Chapters 2 and 4, namely alginate and 
collagen type I. From Chapter 2 we demonstrated that neural cells encapsulated in alginate 
scaffolds retain high cell viability, but restricted neuritogenesis, whereas collagen type I 
hydrogels were conducive to neuritogenesis and hiPSC-derived neural differentiation 
(Chapter 2 and 4). This section of research will explore methods of utilising alginate within 
acellular components of a neural construct, with collagen forming the cell-laden and 
neuritogenic-conducive elements of the bioprinted scaffolds. After preliminary 
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development of biomaterial formulations, we also investigate the use of coaxial bioprinting 
as a mechanism of segregating structural and cell-laden components of the bioink scaffold. 
This mechanism of coaxial bioprinting is based on previously reported hand-held 
bioprinting of precursor cartilage tissue (Duchi et al., 2017).  
 This Chapter therefore aims to combine the findings from all previous chapters and 
to derive a usable neural-conducive bio-printable scaffold system by which to generate 



















5.2 Materials and Methods 
5.2.1 Preparation of Bioinks 
The biomaterials used in this chapter are; Sodium alginate (Sigma); Collagen Type I 
(Millipore); Hyaluronic acid (HA, Xi’an Rongsheng Biotechnology); Gelatin from bovine skin 
(Sigma); and CELLINK Start (CELLINK) as a “gold standard” extrusion printable material. For 
acellular extrusion assays, all dry-mass biomaterials were reconstituted in distilled water 
with percentages denoting w/v measurements. Samples were kept at 37⁰C until fully 
dissolved and mixed through trituration to ensure even dispersal. Fully dissolved materials 
were stored at 4⁰C until used. Acellular collagen bioinks were composed of a 0.4mg/ml final 
concentration derived from a commercially available stock solution, working 
concentrations were generated through dilution in distilled water.  
 
5.2.2 Bioprinting 
Bioprinting design G-Code was written de novo in a basic word processing software and 
visualised using an online G-Code simulator (https://nraynaud.github.io/webgcode). All 
bioprinting utilised the INKREDIBLE+ printer system from CELLINK (Fig 5-2). Bioinks were 
loaded into 3cc dispensing cartridges and extruded through a 25-gauge (0.25mm internal 










Fig 5-2: Image of the INKREDIBLE+ Bioprinter utilised for 




 Extrusion pressure for each bioink formulation was adjusted to maximise a smooth 
extrusion of material. Extrusion pressures varied from 5kPa for low viscosity materials up to 
140kPa for highly viscous bioinks. All materials were printed at room temperature, with the 
bioinks allowed to equilibrate to room temperature prior to printing. The printing substrate 
surfaces used were 25mm x 75mm standard microscope slides, as a simple way to handle 
and image the printed structures. All macroscopic images were captured with a Nikon 
D3400 DSLR camera and processed in ImageJ software (NIH).  
Shape fidelity assays were qualitative assessments of each bioink to recapitulate an 
in silico spiral design (20mm x 16mm) and therefore a measure of the viscosity and bio-
printable qualities of each bioink. String test assays were used as an indirect measure of 
printability by examining not only the base bioink viscosity, but also the cohesive nature of 
the material relating to shape fidelity (Schuurman et al., 2013). Biomaterials that formed a 
droplet under extrusion were said to have failed the test, whereas materials that formed 
strings over 10mm long during extrusion were more likely to generate better formed 
printed constructs. The layer stacking test is another measure of a biomaterial’s ability to 
stack upon itself following extrusion, as a precursor to fully realised multi-layer 3D scaffold 
printing. Bioinks that failed to adequately stack layered filaments of a 15mm x 15mm 
square were discounted from further testing.  
 
5.2.3 Coaxial Bioprinting 
For coaxial bioprinting, a specialised coaxial extrusion nozzle, previously developed for 
cartilage tissue engineering (Cornock et al., 2014; O’Connell et al., 2016; Duchi et al., 2017) 
was utilised. This nozzle was attached to two of the 3cc bioink cartridges used above, and 
was then fastened to the INKREDIBLE+ print stage. An image of the coaxial system used is 
seen in Fig 5-8.  
 For the shell material, a mixture of alginate (3%): gelatin (5%) was found in mono-
axial tests to generate a bioink with acceptable shape fidelity, string printability and 
filament stacking attributes under acceptable extrusion pressures. Both components were 
mixed together vigorously within a 5ml syringe (BD Biosciences) attached to the 3cc bioink 
cartridge, after warming to 37⁰C to minimise viscosity. The cell laden core material was 
composed of final concentrations of 0.4mg/ml collagen type I (neutralised with 0.23x of the 
added collagen volume of 0.1M NaOH, Sigma), 1% (w/v) HA, and 1x HEPES (20mM HEPES 
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[Sigma], 150mM NaCl [Sigma] pH 7.4). The remaining volume was composed of growth 
media containing neural cells. Final cell density within the core bioink was 2x106 cells/ml. 
For acellular core/shell testing, the cells were replaced with fluorescent red latex beads 
(0.5μm) (Sigma) used at 10μl per ml of core material, and with DMEM (Gibco) used in place 
of growth media. All manipulation of materials was done under aseptic conditions in tissue-
culture facilities and sterile laminar flow hoods. Extrusion pressures for core and shell 
material components were 12kPa and 50kPa respectively. 
 The crosslinking of alginate components of the shell material was done post-print 
with a sterile 200mM CaCl2 solution (Sigma). Scaffolds were left to crosslink at room 
temperature for 3 minutes, prior to scaffold transfer to 6-well tissue culture plates with 3ml 
of growth media per well. Cells were then cultured at 37⁰C and 5% CO2 in standard cell 
culture incubators. Differentiation within the printed scaffolds was monitored over 7 days, 
with differentiation media changed every 2 days. 
 
5.2.4 Cell Culture 
The murine NSC-34 neural cell line (obtained courtesy of the Intelligent Polymer Research 
Institute) was used for the assessment of cell survival and neural differentiation within 
bioprinted structures generated in this chapter. The short time-frame of induced 
differentiation enabled rapid assessment of the cell-laden bioprinted structures. Briefly, 
cells were cultured in a proliferation media composed of DMEM (Gibco), 10% FBS (Gibco), 
2mM L-Glutamine (Gibco), 100U/ml Penicillin and 100μg/ml Streptomycin (Gibco). Cells 
were cultured in 75cm2 tissue culture coated flasks and were passaged using a 0.025% 
Trypsin Dissociation Buffer for 5 minutes at 37⁰C. Differentiation of NSC-34s was triggered 
using a differentiation media composed of DMEM (Gibco), 2% Horse Serum (Gibco), 2mM 
L-Glutamine (Gibco), 100U/ml Penicillin and 100μg/ml Streptomycin (Gibco), 
 For cell harvesting prior to addition to the core bioink, cells were harvested 
through trypsin dissociation (as above) and pelleted at 400xg centrifugation for 5 minutes. 
Cells were resuspended in 1ml proliferation media, with an aliquot utilised for manual cell 





5.2.5 Viability Assay 
For assays of cell viability, the fluorescent dyes Calcein-AM (Life Technologies) and 
Ethidium Homodimer (Life Technologies) were used to establish the proportion of living 
and dead cells respectively, within printed cell-laden scaffolds. Briefly, media around the 
constructs was exchanged for DMEM containing 1μM Calcein-AM and 1μM Ethidium 
Homodimer. The constructs were left to incubate at 37⁰C and 5% CO2 for 1 hour. The dye-
laden media was then exchanged for differentiation media prior to imaging.   
 
5.2.6 Fluorescent and Live Cell Imaging 
Live cell imaging was achieved through visualisation on an EVOS XL Cell Imaging System 
(Thermo Fisher Scientific), with images processed with ImageJ software (NIH). 
 Imaging acquisition of fluorescent bead-loaded core constructs and fluorescently-
labelled cell viability assays was performed on an Olympus IX70 wide field microscope with 














5.3.1 Assessment of Unmodified Alginate and Collagen Hydrogels as 
Bioinks 
Previous work has shown that neural cells encapsulated within collagen hydrogels of low 
mass content, will undergo extensive neuritogenesis during differentiation (Chapters 2 and 
4). Cell-laden alginate hydrogel scaffolds retain many cytocompatible characteristics, 
display storage moduli comparable to native neural tissue, but are non-conducive to 
neurite extensions under assayed conditions (Chapter 2). However, the generation of a 
multimodal neural tissue construct whereby the support structure is supplied by one 
biomaterial and the cell-laden component by another, would allow for more complex 
scaffolds to be formed. 
 Using unmodified alginate and collagen in the concentrations known to be 
cytocompatible with encapsulated neural differentiation in cast-gel scaffolds, these 
biomaterial formulations were assayed for their printability in comparison to a 
commercially available 3D printable water-soluble ink.  
 Compared to the programmed print design, both alginate and collagen candidate 
bioinks at these formulations failed to maintain any filament integrity during the printing 
process (Fig 5-3). Each biomaterial displayed a viscosity similar to that of water, and as 
such, after printing were unable to maintain a filamentous shape, and instead combined 
into an amorphous pool of biomaterial. When compared to the Cellink Start material, 
which demonstrated high pattern fidelity and retention of filament shape, these basic 
alginate and collagen formulations would be unsuitable for the generation of free-standing 
neural tissue scaffolds.  
 Under extrusion from the bioprinting nozzle, both the alginate and collagen 
hydrogels formed only droplets, whereas the viscous cohesive nature of the Cellink Start 
generated a flowing “string” that reached over 10mm in length. This string test has been 
used previously as a qualitative measure of a bioink’s propensity to form free-standing 
filamentous structures (Schuurman et al., 2013). Under these assay conditions, again the 
alginate and collagen formulations evaluated here would fail to demonstrate appropriate 




As well as shape fidelity and string formation, another useful assay is the 
demonstration of multi-layer stacking properties of bioinks.  
An in silico designed 15mm x 15mm four-layered square was used as a basic assay 
of filament stacking properties. The Cellink Start ink formed a strong recapitulation of the 
programmed design shape, and demonstrated the ability to stack filaments in ordered 
layers (Fig 5-4). However, as with the pattern fidelity assays, both collagen and alginate 
hydrogels at these concentrations failed to form not only the basic shape pattern, but could 





Fig 5-3: Pattern fidelity and string test assays of collagen and alginate bioinks at low 
concentrations. When compared to the Cellink Start material, both alginate and 
collagen hydrogels fail to retain the printed filamentous design or generate flowing 




5.3.2 Modification of Alginate and Collagen Bioinks to Improve 
Printability 
We have shown above that collagen and alginate bioinks in the formulations necessary for 
in vitro neural tissue formation in solid cast-gel formats, are unsuitable for bioprinting 
purposes. However, certain concentrations and formulations of these inks may have 
positive effects on printability characteristics without negatively impacting 
cytocompatibility and permissiveness to neural tissue generation. 
 Using alginate as simply a structural support hydrogel in downstream neural tissue 
construct fabrication would utilise its strengths of cytocompatibility and inert cellular 
interactions, but not rely on encapsulated neural cell differentiation and neuritogenesis. 
For this reason, multiple alginate concentrations were assayed for the printability assays 
outlined in the previous section. Alginate hydrogels at 2% (w/v) displayed higher viscosities 
than the lower 0.5% (w/v) concentrations and as such maintained a better, although still 
poor, filamentous pattern fidelity after extrusion printing (Fig 5-5). However, this 
concentration of alginate still failed to generate a “string” under free-standing extrusion. 
Fig 5-4: Layer stacking assay of collagen and alginate bioinks at low concentrations. 
Cellink Start-based inks form a faithful recapitulation of input design (top panel) and 
allow for true 3D stacking of multiple printed layers. Collagen and alginate hydrogels 




When concentrations of alginate were increased to 8% (w/v) the recapitulation of the 
printed pattern design was far greater than was seen with lower concentrations. However, 
even at this very high alginate hydrogel solution, an incomplete string formation was 
observed and layer stacking tests tended to collapse shortly after printing has completed 
(Fig 5-5). It is also worth noting that manipulations of this high concentration alginate 
hydrogel were difficult due to its high level of viscosity as a solution, hence increasing 
alginate concentrations beyond 8% (w/v) was not possible.   
 
 
Collagen scaffold production with increased levels of collagen concentration may 
allow for enhanced bioprinting characteristics, however, these higher concentrations may 
have detrimental effects on neural differentiation and neuritogenesis within the scaffolds, 
as reported previously (O’Connor et al., 2001). Composite hydrogels formed from other 
soluble mammalian polymers however, may allow for the formation of a bioprinted 
construct but elicit a non-damaging effect on encapsulated neural cells and the gelation of 
the collagen fibrous network.  
Fig 5-5: Pattern fidelity, string test, and layer stacking assays of multiple 
alginate hydrogel concentrations. Increasing concentrations of alginate have 
positive effects on pattern fidelity, but are unable to form continuous strings 




The addition of the mammalian anionic glycosaminoglycan hyaluronic acid (HA) to collagen 
hydrogels did dramatically increase all measures of printability (Fig 5-6). Composite 
hydrogels of 2% (w/v) HA and collagen showed much stronger pattern fidelity than was 
seen with collagen hydrogels alone, although such a blend did not generate an extruded 
string of over 10mm and retained droplet-like morphology during extrusion. When the 
Fig 5-6: Pattern fidelity, string test and layer stacking assays of hyaluronic acid (HA) 
and collagen composite hydrogels. (A) Increasing the concentration of HA 
generates greater shape fidelity and string formation compared to base collagen 
hydrogels. (B) Layer stacking even with higher concentrations of HA shows limited 
height and compression of printed layers. Scale bars represent 10mm. 
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concentration of HA was increased to 4% (w/v), a noticeable increase in the sharpness of 
the printed pattern was seen and the extruded bioink did form a free-standing string (Fig 5-
6 A). 
 Layer-stacking of multiple filament layers was also improved by the addition of 
higher concentrations of HA (Fig 5-6 B), although neither of these formulations generated 
stacked structures to the same degree as was seen with Cellink Start ink (Fig 5-4). Printed 
structures derived from HA and collagen hydrogel composites are a promising source of 
modifying collagen bioinks to make them more amenable to bioprinting technologies. 
However, the non-crosslinked and soluble nature of the HA component of the ink, together 
with low stacking characteristics would necessitate the use of a secondary structural 
element by which to contain and protect and collagen scaffold undergoing gelation in an 
aqueous environment.  
 As base alginate bioinks, even at high concentrations, have poor string formation 
and layer stacking qualities, other strategies must be developed to generate printable 
forms of this biomaterial. As HA was used to modify the viscosity and printing 
characteristics of collagen hydrogels, we next demonstrated the use of gelatin composites 
within alginate hydrogels to modify bioink traits (Fig 5-7). Gelatin is a hydrolysed form of 
collagen type I, and the use of gelatin as a component of bioinks, has widespread 
precedent throughout the literature (Chung et al., 2013). Even small amounts of gelatin 
were shown to have profound effects on bioink printability and the extrusion pressure 
necessary to print the bioinks. 2% alginate and 2% gelatin composite inks showed low 
pattern fidelity and droplet formation during extrusion, but both parameters were slightly 
improved when alginate concentration was increased to 4% (Fig 5-7 A). The pressures 
necessary to extrude these materials increased only slightly from 8kPa to 13kPa. A vast 
improvement in print fidelity and string formation was seen with bioinks composed of 4% 
alginate and 4% gelatin, although with considerable lag in the extrusion deposition of the 
material and lag after the ceasing of the extrusion pressure. This was seen by the absence 
of bioink filament in the lower left point of the spiral design (the print origin point) and the 
slight pooling of material in the centre of the spiral design (the print endpoint) (Fig 5-7 A). 
This increase in bio-printable characteristics with increased gelatin concentration was also 
accompanied with an increased necessary extrusion pressure (56kPa).  
Further increasing the gelatin concentration to 6% with 2% alginate did increase 
the resolution of the printed design, and demonstrated string formation during extrusion. 
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However, this bioink lost characteristics of smooth filament formation and demonstrated 
traits of over-gelation that required high extrusion pressures to print (~140kPa). This stiff 
gel-like bioink did perform very well in the layer stacking assay (Fig 5-7 B), but its inability to 
print smoothly and consistently would be disadvantageous in downstream neural tissue 
engineering applications. A composite blend of 3% alginate and 5% gelatin bioink 
demonstrated high print pattern fidelity, string formation and relatively good layer stacking 
properties, and as such was chosen as the candidate structural alginate bioink formulation 





Fig 5-7: Bioprinting characteristics of alginate and gelatin composite bioinks. 
(A) Pattern fidelity and string test assays of each blended material. (B) Layer 
stacking assays of each biomaterial composition. Scale bars represent 10mm. 
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5.3.3 Formation of Neural Tissue Constructs Using Coaxial Bioprinting 
As well as mono-axial bioprinting techniques, where a single material is deposited in a 
single filament; coaxial printing methodologies can combine two separate bioink 
formulations into a single extruded strand. Its applicability to neural tissue engineering 
relates to the generally low viscosity, low modulus hydrogels conducive to neural cell 
differentiation being unsuitable for the majority of free-standing extrusion bioprinting 
processes shown above. However, by separating a neural cell-laden “core” material that 
maintains the appropriate modulus and biophysical interactions to allow for neural 
differentiation to take place, and surrounding it concentrically with a “shell” material that 
maintains the structural support and pattern fidelity of the bioprinted scaffold, then de 
novo neural tissue scaffolds can be designed.  
 To accomplish this, we utilised a coaxial printing nozzle that was generated through 
selective laser melting of titanium 6Al4V alloy. This coaxial system was developed internally 
and has been utilised for precursor cartilage bioprinting (O’Connell et al., 2016; Duchi et al., 
2017). The “shell” material chosen for coaxial printing tests was a 3% alginate and 5% 
gelatin composite bioink (A3G5), as determined by the positive printability characteristics 
displayed in Section 5.3.2. Initial “core” material tests for bioprinting capabilities used a 
coloured water solution in place of a bioink to assess the stability and sealed nature of the 
core/shell structure. However, the low viscosity core continuity was easily disturbed 
through the printing process (data not shown) and so future experiments utilised a collagen 
(0.4mg/ml) and 1% HA core material in order to represent the true printing format of 
neural cells and increase the viscosity of the core to a level that would not be disrupted 
through the bioprinting process (Fig 5-8).   
 These bioink formulations extruded through the coaxial nozzle maintained 
segregation of core and shell components and could generate free standing string 
formations (Fig 5-8 A). Furthermore, this process could derive coaxial printed scaffolds to a 
pre-determined two-layer print design and maintained the core/shell separation (Fig 5-8 B). 
Following in situ crosslinking, the printed scaffold could be handled easily. This was also 
seen after 24 hours in cell culture conditions at 37⁰C. This retention of integrity was due to 
the alginate component of the shell bioink which retained ionic crosslinking properties in 
cell culture media, whereas the non-crosslinked nature of the gelatin component would 
undergo gel-sol transition at physiological temperatures. Steric entanglement of gelatin 
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molecules within the alginate scaffold however, may act to retain some gelatin 
composition. 
 
 To further demonstrate the segregated nature of the core and shell elements after 
the printing process, the core material was combined with fluorescently-labelled beads 
while the shell material was left “empty”. Fig 5-9 shows that 24 hours after printing and 
maintenance in cell culture conditions, fluorescent beads were present only in the core of 
Fig 5-8: Coaxial bioprinting of 3% alginate/5% gelatin shell materials and collagen/HA 
core materials. (A) Coaxial separation of core and shell is maintained throughout the 
printing process together with string formation. The geometry of the coaxial nozzle is 
also shown.  (B) Bioprinting of the coaxial bioink formulations can be made to specific 
design patterns that maintain structural integrity. Scale bars represent 10mm. 
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each coaxial filament. The total filament size ranged from 1-2mm in diameter with the core 
representing approximately 500-750μm of this width. This process has therefore generated 
a construct in which the core biomaterial composition could not ostensibly be generated 
into a multi-layer bioprinted construct using conventional mono-axial printing alone. But 
through the combination of a non-cytotoxic structural support material and coaxial design, 
successful generation of a large-scale scaffold can be generated. 
 
 
 The next element of study for coaxial neural tissue bioprinting was to assay 
whether encapsulated neural cells retained viability after the formation of bioprinted 
scaffold or underwent irreparable damage in the extrusion process. A neural cell line was 
encapsulated in physiologically buffered core material of the same composition as assayed 
above. Coaxial bioprinting of the cell-laden core and shell material was completed to the 
same design as seen in Fig 5-8. A Calcein-AM and Ethidium homodimer cell viability dye 
assay demonstrated a very high proportion of viable cells four days post-print (Fig 5-10, 
Green), whereas cells displaying positive ethidium homodimer fluorescence (dead cells) 
were barely present throughout the construct. This illustrates that the coaxial printing 
process itself, crosslinking process, and maintenance in neural cell differentiating 
conditions does not have detrimental effects on cell survival.  
Fig 5-9: Demonstration of core/shell filament formation from coaxial bioprinting. 
The core material was mixed with fluorescently-labelled beads (Red) to show 
separation of core and shell bioinks. Images were taken 24 hours post-print. Scale 
















 Finally, after demonstrating high retention of neural cell viability within the core of 
the bioprinted construct, it was necessary to determine whether neural differentiation 
characteristics such as neuritogenesis was also preserved within this collagen-based core 
material. Live cell imaging of the scaffolds after one week of neural differentiation 
displayed widespread neuritogenesis of cells within the construct (Fig 5-11). The neurites 
extended into the core biomaterial itself and were not restricted to cellular aggregates, 
displaying the successful interaction between the neural cells and the encapsulating matrix. 
This not only demonstrates the efficacy of bioprinting a structurally sound neural-
tissue construct from multiple bioinks, but that principles of neural cell differentiation, 
within conducive hydrogel scaffolds in simple cast-gel formats, can be translated into 
bioprinting methodologies.  
 
Fig 5-10: Cell viability assay of encapsulated neural cells in coaxial bioprinted 
structures. Calcein-AM staining of viable cells are shown in green, whereas 
ethidium homodimer staining (red) highlights dead cells. All cells were loaded 




5.4 Discussion and Conclusions 
The rise of bioprinting technology as a catalyst for tissue-engineering and regenerative 
medicine studies in recent years has generated much hope for the future of personalised 
medicine (Zhang et al., 2017). Compared to standard 3D encapsulation-based cell culture, 
bioprinting of cells in tailored biomaterials has many advantages to its use. Through the 
printing of cell-laden filaments in particular arrangements it has been shown that a 
pseudovasculature-like system can be generated that allows for extensive nutrient and 
oxygen diffusion in large, clinically-relevant sized 3D constructs (Kang et al., 2016). This is 
an inherent limitation in simple cast-gel cell culture techniques where an increase in 
scaffold volume limits the surface area by which to adequately diffuse nutrients. This also 
limits possible cell densities within these constructs, as cell density is increased to tissue-
like levels, so does the demand for oxygen and metabolic components. To obtain 3D neural 
cell cultures with cell densities approaching that of native tissue, the only way of achieving 
this in static culture is to limit construct size (Frampton et al., 2011).  
Fig 5-11: Live cell imaging of encapsulated neural cells undergoing 
neuritogenesis within the bioprinted core material after 7 days of 
differentiation. The neural cells displayed widespread propensity for neurite 
extensions (white arrow heads). Scale bars represent 50μm. 
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 The ability to design and control bioprinted scaffold complexity not only allows for 
tissue-like cellular composition and increased overall size of the scaffolds, but can also form 
complex structures that recapitulate elements of native-tissue morphology. For the printing 
of neural tissue, this has included the laminar layered composition of the cortex (Lozano et 
al., 2015). As well as the ability to mimic tissue composition and structure, such bioprinting 
techniques could be used to segregate or combine specific neural cell types within the 
same construct, but in a controlled manner. This would mirror the mixing of glial and 
neuronal lineages in iPSC-derived neural functionality assays (Odawara et al., 2016). 
 Successful reports of neural tissue extrusion-bioprinting are beginning to increase 
in frequency, with a wide array of polysaccharide- and protein-based polymers utilised in 
the production of neural tissue constructs (Thomas and Willerth, 2017; Knowlton et al., 
2018). However, the biomaterials used within these positive reports tend to lack high 
filament resolution or display limited interaction between embedded neural cells and the 
hydrogel scaffold i.e. low neuritogenesis. Here we have shown that biomaterial 
formulations shown to be conducive to positive neural differentiation and neuritogenesis in 
simple cast-gel formats (Chapters 2 and 4) were not amenable to the generation of free-
standing bioprinted neural constructs. As such, we focused on the modification of these 
materials by which to attempt to maintain positive neural cell viability and differentiation 
but also allow for the printability of the scaffolds.    
 Low concentration alginate and collagen scaffolds failed all used printability tests 
including pattern fidelity, string formation and multi-layer stacking. Even at very high 
alginate concentrations (8% w/v) this material failed to adequately generate a free-
standing string under extrusion and was unable to stack layered filaments without collapse 
and pooling. Pattern fidelity in a single layer did show promise, although this is not enough 
to conclude that base alginate alone is a suitable bioink. This mirrors similar methods of 
alginate bioprinting that form either composite blends with gelatin (Chung et al., 2013) or 
other polysaccharide polymers (Gu et al., 2017). 
 Preliminary tests of blending the mammalian glycosaminoglycan hyaluronic acid 
(HA) within collagen hydrogel formulations, did improve markers of printability. Pattern 
fidelity and string formation was greatly improved with 4% w/v addition of HA, albeit with 
lower multi-layer stacking outcomes. However, the soluble and non-crosslinked nature of 
HA within these scaffolds and the inherent increase in viscosity generated may adversely 
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affect scaffold stability under long term cell culture conditions and the ability of neural cells 
to undergo neuritogenesis in this modified collagen-based biomaterial.  
 To overcome this limitation, we employed the use of coaxial bioprinting, by which 
to segregate a neural-conducive inner core collagen-based biomaterial, and an outer shell 
support material based on alginate hydrogel formation. This coaxial technology has already 
been utilised to generate precursor cartilage tissue through separation of stabilising 
supporting material and the cell-laden biomaterial cargo, although with different bioink 
formulations (O’Connell et al., 2016; Duchi et al., 2017). Composite blends of alginate and 
gelatin bioinks were assayed for their printability characteristics and a final formulation 
that appeared promising for bioprinting applications was deduced (3% alginate and 5% 
gelatin concentration). This was combined with a modified collagen-based core material, 
that contained a 1% HA concentration to slightly increase bioink viscosity, to make it more 
amenable to the flow characteristics of coaxial extrusion bioprinting.  
 Assays of the combined coaxial printing process demonstrated clear separation of 
shell and core during extrusion, and a maintenance of free-standing string formation. 
Coaxial printing of an in silico designed two-layer grid pattern was recapitulated by the 
printing process, and the core/shell segregation was maintained throughout the printed 
construct. Ionic crosslinking of the alginate polymer within the shell material, through 
addition of calcium cations, resulted in a construct that could be handled and manipulated 
easily by hand. The gelatin component of the shell bioink was non-crosslinked into the 
hydrogel itself and undergoes sol-gel transition at physiological temperatures. However, 
after 24 hours within cell culture growth conditions (37⁰C, 5% CO2) the structural integrity 
of the construct was maintained. This demonstrates that the alginate component of the 
shell is widespread and robust enough after crosslinking to maintain scaffold shape fidelity, 
even after the possible solubilisation of the gelatin portion of the shell bioink. It is also a 
possibility that some level of gelatin retention is enabled through steric entangling of the 
gelatin and alginate chains during crosslinking. Either outcome is non-detrimental, as 
residual gelatin components would add to the stability of the construct, whereas any 
solubilised gelatin may increase the porosity of the shell hydrogel and allow for increased 
levels of nutrient diffusion. That being said, further work will need to be undertaken to 
ensure the stability of the scaffold during differentiation assays of hiPSC-derived neurons, 
that takes place over the course of months and not days. However, this initial data is a 
promising result in this endeavour.  
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 The maintenance of core/shell separation was further shown after printing through 
the use of fluorescently-labelled beads that indicated the location of core printed material. 
This result demonstrates the limited mixing and of core and shell components during the 
printing process and shows the limited turbulence generated under this method of coaxial 
bioprinting.  
 To determine how these bioink formulations and the coaxial printing process itself 
affected encapsulated neural cell viability, bioprinted constructs containing a neural cell 
line were produced to the same specifications as the bead-loaded scaffold. After four days 
post-printing, an assay of cell viability of the encapsulated neural cells revealed almost 
complete retention of living cells within the core bioink. This demonstrates that not only is 
the printing process itself amenable to high levels of cell survival, but as is the crosslinking 
process and the diffusion level of nutrients within the scaffold. Such a result is integral for 
forming constructs of increased cell density approaching that of native neural tissue. 
Another implication of this result is that the level of shear stress imposed on the 
encapsulated cells during the extrusion printing process is well tolerated. High shear stress 
has previously been shown to have detrimental effects on cell survival (Blaeser et al., 
2016), which is not seen under these bioprinting conditions.   
 Finally, to ensure that the collagen-based core bioink retained its ability to support 
neuritogenesis of encapsulated neural cells under differentiation conditions, we assayed 
whether neurite extension occurred after 7 days of neural differentiation within the 
coaxially printed scaffold. Live cell imaging did reveal neuritogenesis throughout the core of 
the scaffolds which indicates the favourable neural differentiation conditions within this 
core bioink formulation. Comparing this outcome to other published (although limited) 
neural-tissue bioinks would give valuable information on the practicality and efficacy of this 
bioink for neural tissue engineering. 
 Taken together, these data show the development of a coaxial format of 
generating self-supporting 3D bioprinted neural tissue scaffolds. Each element of the core 
and shell bioinks could further be tailored depending on design specifications or desired 
printing resolution, but form a strong foundation stone on which future bioprinted neural 
constructs can be fabricated. The retention of neural cell viability and the ability to undergo 
neuritogenesis within these scaffolds are a key factor in the progression of these 
techniques and must be at the forefront of future bioink formulations. The cell-based 
functionality of the desired tissue type is the true goal of experiments such as these, and so 
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a bioink that retains highly printable characteristics but loses cell functionality is an 
unacceptable outcome. 
 Projected future work from these experimental findings would be far reaching, but 
ultimately crucial to the development of higher resolution neural tissue models. Long term 
culture of such scaffolds must be shown to maintain sufficient integrity for confluent neural 
tissue formation to take place. The effect of temperature controlled extrusion can have 
striking repercussions on the printing characteristics of bioinks (Chung et al., 2013) and may 
be yet another method of modifying scaffold formation and resolution.  
 Furthermore, assessing the limits of cell densities possible within designed 
scaffolds such as this, will allow for the formation of more brain-tissue representative in 
vitro modelling practices. By combining this technology with long-term differentiation of 
hiPSC-derived neural cultures it will begin to be possible to generate more tailored and 
representative tissue morphologies that ultimately will push forward the frontiers of 
modern neuroscience.  
 
5.4.1 Summary of Chapter Findings 
 Low concentration collagen and alginate hydrogel solutions show poor bioprinting 
traits. 
 Increasing alginate concentrations has positive effects on pattern fidelity of a single 
printed layer but displays limited string formation and poor filament stacking 
properties. 
 Composite bioinks of collagen and hyaluronic acid show improved bioprinting traits, 
although the soluble nature of hyaluronic acid and increased viscosity of the bioink 
would make them poor single component bioink for neural tissue engineering. 
 Alginate and gelatin composite bioinks show differential printing characteristics heavily 
dependent on concentration and ratio to each other. A 3% alginate and 5% gelatin mix 
was found to have promising properties for a bio-printable material. 
 Coaxial printing of a collagen-based core material designed to be amenable to neural 
cell differentiation, and an alginate-gelatin shell bioink surrounding the core adding to 
the structural integrity of the scaffold, was developed. 
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 Core/shell separation was conserved throughout the printing process and could form 
two-layer in silico designed grid structures. 
 Acellular versions of the scaffold construct could be handled manually, and maintained 
structural integrity after storage under physiological conditions. 
 Separation of core and shell biomaterial components was demonstrated through 
fluorescent-bead loading of the core material, which displayed continued core/shell 
separation after maintenance at 37⁰C. 
 Neural cell encapsulation and growth within the bioprinted core component of the 
coaxial scaffold demonstrated the retention of high cell viability by day four post-
printing. 
 Neuritogenesis was prevalent by day 7 of differentiation post-print within the coaxial 
scaffold. Demonstrating conduciveness to neural differentiation within the core 
collagen-based bioink.  
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Chapter 6: Overall Conclusions and 
Future Directions 
 
The broad aim of this thesis was to study and develop multiple aspects of in vitro three-
dimensional forebrain neural tissue constructs from human stem cells. The main 
components of this goal were to; assay and analyse candidate biomaterial hydrogels as 
potential cell carriers for neural cell differentiation; to successfully differentiate and 
compare markers of neural maturation of dorsal and ventral forebrain neural cell identities 
from hiPSCs; to demonstrate the effects of a pro-neuritogenic hydrogel scaffold on hiPSC-
neural differentiation; and lastly, to modify and develop bioprinting techniques that allow 
for the generation of 3D neural tissue constructs through additive fabrication technologies.  
 Stem cell lineage specification is known to be driven strongly by the substrate 
stiffness of the materials in contact with the cells (Engler et al., 2006). Neural tissue 
modelling applications have therefore benefitted from matching the moduli of cell culture 
substrates to those of native brain tissue (Banerjee et al., 2009; Teixeira et al., 2009; 
McKinnon, Kloxin and Anseth, 2013). In this body of work, both alginate- and collagen type 
I-based candidate hydrogels displayed storage moduli lower than that recorded for native 
brain tissue, and both preserved cell viability of neural cells after encapsulation and over 
the course of differentiation. However, only collagen-based scaffolds allowed for 
neuritogenic events to occur. Alginate hydrogels covalently modified with neural matrix 
metalloproteinase (MMP)-cleavable motifs and laminin-binding moieties also failed to 
induce neurite extension morphology, although did elicit changes in neural marker protein 
expression, demonstrating a direct effect of hydrogel composition and modification on 
protein expression during neural differentiation. As a further direction of research, it would 
be valuable to assay whether other functionalisation groups (such as other MMP-sensitive 
motifs) elicit a similar effect on encapsulated neural cells, or whether modified reaction 
conditions, that would generate higher degrees of functionalisation, may overcome the 
steric hindrance imposed by the alginate environment and allow neuritogenesis to occur. In 
a similar vein, it would be crucial to understand whether this process is indeed relative to 
the covalently-bonded peptide moieties themselves, or whether the loss of carboxyl-
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groups used for the carbodiimide chemistry, impacts polymer chain ionic-crosslinking. It is 
possible that this effect mimics the sub-stoichiometric conditions seen in recent positive 
polysaccharide hydrogel neural tissue studies (Palazzolo et al., 2015). Indeed, it is entirely 
possible that a synergistic effect between restricted ionic cross-linking sites and native 
peptide motifs may take place.         
Some canonical neuronal marker expression profiles did show upregulation during 
the differentiation of encapsulated neural cells, but this upregulation did not reflect the 
level of neuritogenesis within the scaffold. This is an intriguing finding, as the upregulation 
of many standard neuronal markers has been used to demonstrate the success of a 
hydrogel scaffold’s composition for neural tissue engineering purposes in many published 
studies. This thesis shows however, that with a panel of cytoskeletal-associated markers, 
striking differences can be seen within protein marker expression profiles from neural cells 
in pro-neuritogenic and non-neuritogenic environments. However, it should be noted that 
the patterns of marker expression from pro-neuritogenic environments do not intrinsically 
follow those of planar culture differentiation. This suggests a strong interplay between the 
three-dimensional environment itself on neural differentiation kinetics and the ability to 
generate neurites within the hydrogel scaffold, that differs to planar culture. Further 
investigation to see if this holds true with other neural cell types, and with extended panels 
of markers will allow improved resolution of early neural differentiation responses in three-
dimensional environments.  
A possible limitation in the analytical power of the alginate and collagen hydrogel 
assays outlined in Chapter 2 relates to the constitutively high gene expression of many 
neuronal markers even under proliferative conditions of the neural cell line. Although 
protein marker expression showed clear and distinct patterns between culture conditions, 
gene marker expression fold-changes were very low over the course of differentiation. This 
may be related to the type of neural cell line used, which may employ post-transcriptional 
regulation of differentiation-associated genes to generate the neuritogenic phenotype 
(Lindenbaum et al., 1988; Perrone-Bizzozero, Cansino and Kohn, 1993). Other primary cells 
or neural cell lines may therefore show more robust gene expression changes during 
differentiation, but would also require longer periods of time in culture to generate a 
mature neural phenotype. As Chapter 2 was primarily based on biomaterial-suitability for 
future three-dimensional culture of iPSCs-derived neural cells and less an understanding of 
a specific neural cell line differentiation processes: the accelerated speed of differentiation 
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and neuritogenesis of PC12s under differentiating conditions was advantageous. From 
these results, the collagen-based hydrogel scaffold as a pro-neuritogenic environment was 
selected as the scaffold for downstream three-dimensional iPSC-based neural 
differentiation (Chapter 4). 
Accurate in vitro human forebrain modelling, be it for developmental or disease-
based study, requires the accurate recapitulation of in vivo cellular content. Forebrain 
cortical tissue is derived from both dorsal- and ventral-neural tube structures, with the 
development of complete cortical tissue driven by the tangential migration of ventrally-
derived cells into dorsal regions. In vitro “patterning” of iPSC-derived forebrain neural 
cultures however would predominantly generate either dorsal or ventral neural cell types. 
Therefore, to understand the timings and maturation events of ventrally-patterned and 
dorsally-patterned neural cell types derived from hiPSCs, we undertook parallel 
differentiation strategies to directly compare molecular and functional components of the 
differentiation process. Understanding the details of these processes will lead to more 
accurate and representative combinations of cell types from both pathways as is seen in 
vivo. The work in this thesis demonstrated that NPC pools from both patterned 
differentiation strategies were generated in comparable amounts early in the 
differentiation timeline, but that stark differences in expression existed between the 
dorsal-specific and ventral-specific NPC markers (PAX6 and NKX2.1 respectively) between 
neural cells from dorsal and ventral patterned differentiation pathways in planar culture. 
This separation of dorsal and ventral identity widened over the time-course of neural 
maturation with the segregated expression of pre-synaptic ventral-GABAergic markers and 
dorsal-glutamatergic markers dependent on the differentiation strategy. Interestingly, 
there was a consistent trend of upregulated neural marker gene and protein expression in 
ventrally-patterned hiPSC-derived neural cultures compared to dorsal-cultures. This may be 
indicative of an accelerated level of differentiation of cells derived from this pathway or a 
possible enrichment of neuronal cells. However, preliminary functional assays of neuronal 
electrophysiological activity demonstrated a more functionally-mature phenotype in 
ventrally-patterned neural cells, verified by higher numbers of induced action potentials 
following current stimulation, and larger sodium and potassium currents during invoked 
activity. Initial experiments to observe spontaneous activity of neural cell cultures via 
extracellular recordings, displayed activity in a subset of ventrally-patterned hiPSC-neural 
cultures that was not seen in cells from dorsal inductions. However, this induction of 
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functionally mature behaviour was only achieved through the use of media formulations 
previously shown to enhance electrical maturation of various neuronal cell types (Bardy et 
al., 2015). This reveals the potential for acceleration of other maturation processes within 
hiPSC-derived neural cells through media composition alone, and may be another tool by 
which to generate and modulate derived neuronal cell activity.  
This difference in neuronal marker expression and functional maturity can now act 
as a guide to understand how different combinations of these patterned neural cell types 
will interact when matured together in controlled mixed differentiation cultures. Perhaps 
through substrate patterning or other segregation methods, co-culture models based on 
these induction strategies can then generate truly representative models of complete 
human forebrain cytoarchitecture.  
To understand whether differentiation within pro-neuritogenic three-dimensional 
hydrogel environments had positive or negative effects on the efficiency or speed of neural 
maturation, hiPSC-derived NPCs (both dorsally- and ventrally-patterned) were 
encapsulated in collagen-based scaffolds. As was seen in Chapter 2 with differentiation 
studies on PC12s, hiPSC-derived neural cells were able to undergo extensive neuritogenesis 
throughout collagen scaffolds in all three directional axes. Early significant peaks of both 
NPC and mature neural marker expression were recorded from ventrally-patterned three-
dimensional neural cultures, whereas this accelerated maturation was not observed in cells 
from dorsally-patterned inductions. This accelerated upregulation of neural differentiation 
markers was also significantly higher than that seen from planar ventrally-patterned 
inductions. This is suggestive of a system by which the same scaffold environment may 
elicit differing effects on neural maturation depending on neural subtype specificity. It was 
also demonstrated that the hydrogel environment itself did not alter the patterning of 
differentiating neural cells themselves, and the morphogen driven separation of ventral 
and dorsal lineages was preserved within the three-dimensional scaffolds.  
However, markers of maturation at later time points in differentiation appeared 
lower in neural cells in three-dimensional scaffolds than was seen in planar culture. One 
possible explanation is the necessity of high neural cell densities by which to trigger the 
expression of genes associated with neuronal and synaptic maturation. The cell densities in 
this study were utilised to minimise cell death derived from low diffusion rates of oxygen 
and nutrients into the solid cast-gel constructs. This compromise to maintain cell viability 
may have negative effects on functional neural network formation. Other studies using 
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more tissue-representative cell densities, but employing smaller construct sizes or 
bioprinted grid structures to maintain viability, have shown promising results from three-
dimensional neural scaffolds (Frampton et al., 2011; Gu et al., 2017).  
Therefore, to overcome issues of cell density limitation within cast-formed three-
dimensional scaffolds, bioprinting strategies for additive fabrication of neural tissue 
formation were developed. The low biomaterial content of the hydrogels that show 
successful pro-neuritogenic neural differentiation results in low pre-gelation viscosities 
which make them unsuited for use as free-standing bioprinting inks or “bioinks”. To 
overcome this, a coaxial system using a pro-neuritogenic cell-laden collagen-based “core” 
and a structurally reinforcing outer “shell” of alginate and gelatin composite hydrogel, was 
developed to generate multilayered printed structures. These structures allowed for the 
successful segregation of cell-laden and acellular supportive elements that maintained a 
protected core structure of consistent diameter. Neural cell lines printed within this core 
retained high cell survival rates and displayed neurite extensions after 7 days of neural 
differentiation. 
Although in this instance only a two-layered grid structure was formed, this 
methodology can be further developed to generate much more complex tissue construct 
designs in a multi-layered fashion. The modification of grid-like print designs to introduce 
elements of pseudovasculature would also enable the increase of neural cell densities 
within bioprinted culture systems. To this end, the scaling up of in vitro neurological models 
to sizes relevant for human clinical translation may be possible. Further tailoring and 
refinement of the shell bioinks used in this study may also aid with the porosity of the 
scaffold, as the gelatin component of the bioink used was non-crosslinked with the alginate 
polymer, other than steric retention. It would therefore be necessary to observe the long-
term stability of such constructs and to modulate this with the alginate network forming 
the shell structure.   
Another advantage of using multiple bioink printing capabilities is the ability to 
localise and place specific neural cell types in known three-dimensional arrangements. 
Precise neurological models could then be developed to mimic specific brain tissue 
morphologies and cellular content. However, enhanced printing resolution would need to 
be developed to ensure that cellular placement and fibre arrangement was on the scale 
seen in vivo. Current methodologies of cellular placement and arrangement are quite crude 
by comparison. The refinement of these models could then easily be analysed through 
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assays of neural network formation and functionality and be used as the basis for highly 
representative neurological-disease models that stem from hiPSC-based modelling. In 
combination, the synergy of bioprinting methodologies and hiPSC-modelling of human 
neural development make a potent toolkit to further the study of neuroscience through 
purely in vitro study. 
In conclusion, this thesis has covered the development and biological assays of 
candidate biomaterials for neural tissue engineering. The major cellular subtype 
components of human forebrain formation have been generated from hiPSCs and the time-
lines of maturation and functionality directly compared. The same processes were 
modelled within three-dimensional environments that elicited changes in neuronal 
maturation rates dependent on subtype composition. Finally, pro-neuritogenic hydrogel 
scaffolds were adapted to bioprinting methodologies in order to increase the complexity of 
neural tissue architecture, and as a method of maintaining high cell viability with higher cell 
densities. This body of work will help inform the next generation of in vitro neurological 
modelling studies, with the hope of better understanding human brain development and 
disease. 
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